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resumo 
 
 
O Helicobacter pylori é um patogénico gástrico que coloniza mais de 
50% da população mundial e é considerado um agente carcinogénico de 
classe 1. No Helicobacter pylori, tal como acontece com outras bactérias 
Gram-negativas, a membrana externa é revestida por lipopolissacarídeos 
(LPS) formados por três domínios distintos: o lípido A, o core e uma cadeia 
alongada denominada O-chain (LPS, O-chain-core-lipid A~célula). As O-chains 
dos LPS expressam frequentemente antigénios de Lewis (Le
a
, Le
b
, Le
x
, Le
y
) 
que possuem um papel determinante na interacção com o hospedeiro, 
colonização e modulação/evasão do sistema imunitário.  
Nesta tese, demonstrou-se o potencial analítico da espectrometria de 
massa de electrospray (ESI-MS
n
) em modo positivo usando três tipos de 
analisadores (LIT, Q-TOF, QqQ) para identificar quantidades vestigiais de 
antigénios Le. Observou-se, após fomentar a sua fragmentação por colisão 
com um gás, que os antigénios de Lewis do Tipo 1 (Le
a
 e Le
b
) podiam ser 
distinguidos dos de Tipo 2 (Le
x
 e Le
y
) com base em fragmentações do resíduo 
de GlcNAc. Assim, enquanto açúcares ligados na posição O-4 do GlcNAc 
fragmentam apenas como resíduos (unidade-18 Da), resíduos ligado pelo O-3 
eram perdidos como resíduos e como unidade. Observou-se ainda que os 
resíduos de GlcNAc apresentavam uma fragmentação característica 
0,2
A2 do 
seu anel. Como resultado propõe-se que os iões resultantes da fragmentação, 
a m/z 372, e os iões a m/z 388 e 305 possam ser usados para distinguir o par 
de isómeros Le
a
/Le
x
, respectivamente, e os iões a m/z 372 e 534, 305 para 
distinguir o par Le
b
/Le
y
. Aplicou-se este conhecimento ainda na identificação 
dos antigénios de Tipo 2 (Le
x
 e Le
y
) nos LPS da estirpe de H. pylori NCTC 
11637. 
Nesta tese também se descreve que, para além das estruturas 
glicosiladas acima descritas, a H. pylori também produz glicosídeos ricos em 
manose e expressa/bio-acumula amilose (polissacarídeos constituído por α-
(1→4)-D-Glc.  
Observou-se que o fenómeno de bioacumulação era potenciado pela 
manutenção da bactéria em meio de agar, ao mesmo tempo que a quantidade 
de LPS expressa diminuía. Por outro lado, durante uma fase de crescimento 
exponencial em meio líquido F12, observou-se o comportamento oposto, isto 
é, um aumento da expressão de LPS e diminuição na expressão de amilose. 
Assim, sugere-se que, quando submetida a uma pressão selectiva induzida 
por condições ambientais específicas, o H. pylori seja levado a expressar 
amilose. 
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Estudos por RMN permitiram ainda a caracterização estrutural dos 
glicosídeos ricos em manose produzidos na estirpe virulenta H. pylori 968. A 
manana produzida por esta estirpe é constituída por resíduos de O-6 Man 
apresentando aproximadamente 80% destes resíduos ramificações na posição 
O-2. Nas cadeias laterais foram identificados resíduos de O-2 Man tanto em 
configuração α como β. Esta manana foi observada como parte de um 
heteropolissacarídeo constituído também por Glc, Gal e GlcNA e um domínio 
proteico.  
Estudos levados a cabo na estirpe virulenta H. pylori PTAV79 isolada 
de um paciente com refluxo gastro-esofágico revelaram LPS com O-chains 
compostas por unidades de LacNAc (antigénio i). Mesmo não apresentando O-
chains fucosiladas determinantes para a interacção com o hospedeiro, esta 
estirpe manteve a capacidade de colonizar a mucosa gástrica e promover um 
quadro patológico. No H. pylori PTAV79 foram ainda detectadas elevadas 
quantidades de ácido esteárico e amilose ligada a resíduos de glicerol (Gro). 
Os resíduos de Gro foram observados ligados a grupos fosfodiéster, sugerindo 
a expressão de glicoglicerofosfolípidos. Estes resultados apontam para que a 
amilose se encontre ligada à membrana externa da bactéria através de 
glicerofosfolípidos. Com base em estudos estruturais por GC-EI-MS, FTIR, 
ESI-MS, MALDI-TOF-MS e RMN foi ainda possível identificar um 
polissacarídeo ainda não descrito para a H. pylori composto pela seguinte 
unidade repetitiva de ácido aldobiourónico: [→3)-α-D-GlcA(1→4)-α-D-Glc(1→]. 
Uma abordagem proteómica permitiu ainda a primeira descrição para o H. 
pylori de uma proteína glicosilada não pertencente ao flagelo.  
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Helicobacter pylori, lipopolysaccarides, exopolysaccharides, cell surface 
glycans, Lewis antigens, amylose, mannan, cell-surface glycans 
 
abstract 
 
Helicobacter pylori is a widespread gastroduodenal pathogen 
recognized as a category 1 (definitive) human carcinogen. Like other Gram-
negative bacteria, it expresses cell-surface lipopolysaccharides comprising a 
lipid A moiety, a conserved core oligosaccharide and an elongated O-chain 
(LPS, O-chain-core-lipid A~cell). H. pylori O-chains have been recognized to 
contain mammalian Le blood group determinants (Le
a
, Le
b
, Le
x
, Le
y
) that exert 
much influence in the interaction with the host, namely adhesion to gastric 
cells, colonization, and modulation/evasion of immune responses.  
In this work, underivatized Lewis blood groups were studied by 
electrospray mass spectrometry (ESI-MS
n
) in the positive mode with three 
different mass analysers (Q-TOF, QqQ, and LIT) in order to establish the 
analytical basis for a reliable determination of trace amounts of Lewis antigens. 
It was observed that, under collision induced fragmentations, Type 1 Lewis 
antigens (Le
a
 and Le
b
) could be distinguished from Type 2 (Le
x
 and Le
y
) on the 
basis of specific fragmentations of the GlcNAc unit. While O-4 linked sugars of 
the GlcNAc are lost as residues, the O-3 linked sugars undergo fragmentation 
both as sugar units as well as sugar residues (unit -18 Da). Type 2 Le antigens 
also showed a characteristic cross-ring cleavage 
0,2
A2 of the GlcNAc. As a 
result, the product ions at m/z 388 and 305, characteristic of Le
x
, and 372, 
characteristic of Le
a
, are proposed to distinguish the trisaccharide isomers 
Le
x
/Le
a
. Also, the product ions at m/z 534 and 305, characteristic of Le
y
, and 
372, characteristic of Le
b
, are proposed to distinguish the tetrasaccharide 
isomers Le
b
/Le
y
. These diagnostic fragment ions were further applied in the 
identification of Lewis Type 2 antigens (Le
x
 and Le
y
) in the cell-surface of H. 
pylori NCTC 11637. 
In this thesis it is also described that, in addition to LPS, H. pylori is 
able to produce cell-surface mannan-rich glycosides and express/accumulate 
amylose-like glycans (α-(1→4)-Glc polysaccharide). 
Bioaccumulation of amylose was found to be enhanced with the 
subcultivation of the bacterium on agar medium, while LPS O-chains 
expression decreased. During exponential growth of the bacterium in F12 liquid 
medium, an opposite behaviour is observed, i.e. there is an increase in the 
overall amount of LPS and decrease in amylose content. As such, it is 
suggested that under certain selective pressures induced by specific 
environmental conditions, H. pylori might be led to express a phase-variable 
cell-surface α-(1→4)-D-Glc polysaccharide.  
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NMR structural studies carried out in mannose-rich glycans isolated 
from virulent strain H. pylori 968 allowed a characterization of this moiety. This 
strain was found to express a highly branched mannan formed by a backbone 
of α-(1→6)-linked mannopyranose units showing up to 80% substitution in the 
O-2 position. The side chains were found to contain O-2 linked Man residues 
both in α- and β- configurations.  
In addition, studies conducted in virulent strain PTAV79 isolated from a 
gastric biopsy specimen of a patient with gastroesophageal reflux disease 
revealed semi-rough LPS having O-chains composed of LacNAc (i-antigen) 
units. Even though lacking fucosylated O-chains this strain was still able to 
colonize the human stomach and promote disease. This strain also found 
expressed high amounts of stearic acid and amylose-like glycans that were 
observed linked to glycerol (Gro) residues. Furthermore, Gro was detected 
carrying phosphodiester moieties suggesting the existence of 
glycerophospholipids. These structures are thought to act as anchoring points 
of amylose-like glycans to the outer cell-surface lipidic bilayer. Fine analytical 
and spectroscopic techniques, namely GC-EI-MS, FTIR, ESI-MS, MALDI-TOF-
MS and NMR further permitted the identification of an unusual polysaccharide 
composed of aldobiouronic acid repeating units, [→3)-α-D-GlcA(1→4)-α-D-
Glc(1→].. In addition, a proteomic approach allowed the first report of a non-
flagelar H. pylori glycoprotein exhibiting O-glucuronosyl Ser residues. 
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 Helicobacter pylori 
 
Helicobacter pylori is a microaerophilic, Gram-negative bacterium taxonomically 
related to Campylobacter spp that colonizes the human gastric mucosa. H. pylori is one of 
the most widespread bacterial pathogens with a prevalence of up to 90% in developing 
countries and a worldwide infection rate of around 50%
1
. Its first isolation from the human 
stomach less than 30 years ago and the correlation of infection with gastric burdens was 
achieved by Robin Warren and Barry Marshall
2,3
 and resulted in dramatic changes in the 
field of gastroenterology. In addition, the persistence of a pathogen in an environment long 
thought to be sterile revealed one of the most sophisticated colonizers of humans. 
This knowledge had a major clinical impact in the management of gastric diseases 
such as gastritis and peptic ulcers initially regarded as resulting from unhealthy habits such 
as drink, smoking or unbalanced diet has well as nervous disorders. Additionally, in 1994, 
the International Agency for Cancer Research, an arm of the World Health Organization, 
declared H. pylori a class 1 (definite) human carcinogen
4
. These events and the 
peculiarities behind H. pylori further enhanced research and made these bacteria one of the 
hot-topics for scientists worldwide. In 2005 Warren and Marshall’s discovery was 
recognize with the award of a Nobel Prize of Physiology and Medicine and triggered what 
has now been considered one of the most studied microorganism in the world  
 
1.1.1. Microbiology  
 
H. pylori (Fig. 1.1) is a helix-shaped Gram-negative bacterium, about 3 µm long ad 
with a diameter of about 0.5 µm
1
. It is microaerophilic; that is, it requires oxygen, but at 
lower concentration than is found in the atmosphere. It contains a hydrogenase which can 
be used to obtain energy by oxidizing molecular hydrogen (H2) that is produced by 
intestinal bacteria
5
. It also produces oxidase, catalase, and urease which have been used to 
access the presence of the bacteria. H. pylori has further been described as having the 
ability to form biofilms both in vitro
6 
as in vivo
7
 and can change from the spiral to a 
possibly viable but nonculturable coccoid form
8
. This transformation is thought to occur 
when facing unfriendly environments, namely outside the human reservoir thus 
contributing to the epidemiology of the bacterium
9
. However, the coccoid form has 
demonstrated to be able to adhere to gastric epithelial cells in vitro
10
. 
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H. pylori possesses five major outer membrane protein (OMP) families
1
. The 
largest family includes known and putative adhesins thought to play a critical role in the 
interaction with the host. The other four families include porins, iron transporters, 
flagellum-associated proteins, and proteins with still unknown function. 
 
 
Figure 1.1. Electron micrograph of H. pylori (negative staining)
11
. 
 
Like other typical Gram-negative bacteria, the outer membrane of H. pylori consists 
of phospholipids and lipopolysaccharide (LPS) whose structures will be discussed in detail 
in sections 1.3 and 1.4. The outer membrane also contains cholesteryl glucosides, which 
have been found in few other bacteria
1
. H. pylori further exhibit 4–6 flagella responsible 
for its high mobility and colonization of the gastric mucous
12
.  
 
1.1.2. Pathogenicity factors   
 
Although infection with H. pylori almost always results in chronic active gastritis, 
most infected patients develop no complications and are free of any obvious clinical 
symptoms of this infection
13
. This led to the notion that some strains may be more virulent 
than others. Some of the most relevant virulence factors that have been responsible for 
aiding bacterial colonization and/or inducing pathology are further discussed bellow.  
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 - CagA 
The cytotoxin associated gene A (CagA) protein is a highly immunogenic protein 
with a molecular mass of approximately 149 kDa encoded by the cagA gene, which is 
present in 50 to 70% of H. pylori strains
1
 and is a marker for the presence of a genomic 
PAI (pathogenicity island). Eighteen of the cag PAI-encoded proteins serve as building 
blocks of a type IV secretion apparatus, which forms a syringe like structure capable of 
penetrating the gastric epithelial cells and facilitating the translocation of CagA, 
peptidoglycan, and possibly other bacterial factors into host cells, thus inducing 
morphological change and proinflammatory response
1
. Patients infected with CagA
+
 
strains usually have a higher inflammatory response and are significantly more at risk for 
developing a symptomatic outcome (peptic ulcer or gastric cancer) in Western populations, 
though not in Asian populations
1
. 
 
 
 
- VacA  
Approximately 50% of all H. pylori strains secrete VacA (vacuolating cytotoxyn), a 
highly immunogenic 95 kDa protein that induces massive vacuolization in epithelial cells 
in vitro. The VacA protein plays an important role in the pathogenesis of both peptic 
ulceration and gastric cancer
1
. Although VacA is not essential for in vitro growth of H. 
pylori, it was reported to significantly contribute to murine gastric colonization by H. 
pylori
1
. VacA forms pores in epithelial cell membranes. It also increases transcellular 
permeability, leading to the release of nutrients and cations
1
.  
Helicobacter pylori strains from different geographic areas exhibit clear 
phylogeographical differentiation; therefore, the CagA and VacA genotypes of H. pylori 
strains can serve as markers for the migration of human populations
14
. 
 
- Acid resistance 
The pH of the gastric mucosa is thought to vary between 4.0 and 6.5, but occasional 
acid shocks may occur. H. pylori thus requires mechanisms to protect itself from acute acid 
shocks and mechanisms to grow at pH values around 5.5
1
. One of such features is urease, 
an enzyme that catalyzes the hydrolysis of urea into carbon dioxide and ammonia thus 
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creating a buffered environment around the cells
15
. H. pylori also produces amidases, 
enzymes responsible for the degradation of amides into volatile carboxylic acids and 
ammonia that further assisting in the buffering of the surrounding medium
16
. 
Another strategy to avoid the acid environment of the human stomach is the spiral 
shape of H. pylori and the seven sheathed flagella present in one of its poles. It allows the 
bacterium to be highly motile even in very viscous mucus, allowing it to migrate to the 
mucus layer overlaying the gastric mucosa
17,18
. 
 
- Adhesins  
 H. pylori express many adhesins, responsible for the mediation of H. pylori to the 
gastric epithelium
1,18
. However, given the narrow host range, the multitude of adhesins 
probably reflects their importance for the bacterium. In this context the expression of 
lectins such as BabA and SabA and carbohydrates play a key role in host-bacteria 
interplay.  
The 78 kDa BabA protein probably represents the best-characterized H. pylori 
adhesion protein; it is encoded by the babA gene. BabA mediates binding to fucosylated 
Lewis b (Le
b
) blood group antigens on the human host cells
19
. 
SabA mediates binding to sialic acid containing glycoconjugates. H. pylori-induced 
gastric inflammation and gastric carcinoma are associated with the replacement of 
nonsialylated Lewis antigens by sialylated Le
x
 and sialylated Le
a
. Thus, the role of SabA is 
probably during the chronic inflammatory and atrophic disease stages
20
. 
 
1.1.3. Epidemiology 
There appears to be no substantial reservoir of H. pylori aside from the human 
stomach. Other animals harbour organisms that resemble H. pylori, but with the exception 
of nonhuman primates
21
 and, under particular circumstances, cats
22
, no others were found 
to be able to be colonized by H. pylori; thus H. pylori is considered to be host-specific.  
At least half the world's population is infected by the bacterium, making it the most 
widespread infection in the world
23
. In developing countries, 70 to 90% of the population 
carries H. pylori; while in developed countries (Western Europe, North America, 
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 Australia) the prevalence of infection is lower with rates estimated around 25% and 50%
24
. 
World wide distribution of H. pylori thus suggests a correlation between socio-economic 
status and infection, which has shown to be usually acquired in early childhood in all 
countries
1,25
. The infection rate of children in developing nations is higher than in 
industrialized nations, probably due to poor sanitary conditions. In developed countries it is 
currently uncommon to find infected children, but the percentage of infected people 
increases with age, with about 50% infected for those over the age of 60 compared with 
around 10% between 18 and 30 years
23
. Thus, in an era of “emerging” microbes, we might 
think of H. pylori as gradually “submerging” from probably near-universality several 
hundred years ago to the present situation when fewer than 10% of children in developed 
countries are becoming infected
26,27
. 
H. pylori is contagious, although the exact route of transmission is not yet 
known
9,28,29
. At present, the route of transmission is perhaps one of the most controversial 
areas of H. pylori research. Several reservoirs outside the human gastrointestinal tract have 
been suggested as sources of infection, but evidence is not conclusive. Person-to-person 
transmission by either the oral-oral or fecal-oral route is most likely
30
. Consistent with 
these transmission routes, the bacteria have been isolated from feces, saliva and dental 
plaque of some infected people
30
. Interfamilial spread appears to play a central role in 
transmission of the infection in both developing and developed countries
25
. H. pylori may 
also be transmitted orally by means of fecal matter through the ingestion of waste-tainted 
water, so a hygienic environment could help decrease the risk of H. pylori infection
30
. 
 
1.1.4. Clinical relevance of H. pylori infection  
 
Colonization with H. pylori is not a disease in itself but a condition that affects the 
relative risk of developing various clinical disorders of the upper gastrointestinal tract and 
possibly the hepatobiliary tract. Therefore, although gastric colonization with H. pylori 
induces histological gastritis in all infected individuals, only a minority develop any 
apparent clinical signs of this colonization
13
. It is estimated that H. pylori-positive patients 
have a 10 to 20% lifetime risk of developing ulcer disease and a 1 to 2% risk of developing 
distal gastric cancer
1
. The risk of development of these disorders in the presence of H. 
pylori infection depends on a variety of bacterial, host, and environmental factors that 
mostly relate to the pattern and severity of gastritis (Fig. 1.2). 
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Figure 1.2. Schematic representation of the factors contributing to gastric pathology and 
disease outcome in H. pylori infection (adapted from Kusters et. al.
1
). 
 
H. pylori infection also has been further associated with the development of gastric 
non-Hodgkin’s lymphomas
31
 and with another lymph proliferative disorder, gastric 
mucosa-associated lymphoid tissue (MALT) lymphoma (MALToma)
32,33
. Importantly, 
treatment of gastric MALToma patients with antibiotics that eradicate H. pylori often leads 
to regression of the tumour
34-36
.Thus, in total, H. pylori, a previously obscure organism, 
has now been associated with many of the most important diseases involving 
gastroduodenal tissue
26
. 
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 1.2. Gram-negative cell wall architecture  
Almost all prokaryotes possess cell walls external to their plasma membrane. Cell-
surface architecture is used to divide bacteria into two groups based on staining with Gram 
stain; Gram positive bacteria remain stained by crystal violet on washing, Gram negative 
bacteria do not.  
In both Gram-negative and Gram-positive bacteria, the cell wall is most exclusively 
formed by peptidoglycan, also known as murein, a composite of long polymeric strands of 
glycans crosslinked by stretchable peptides. The sugar moiety consists of alternating 
residues of β-(1,4) linked N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid 
(MurNAc) residues. Attached to the MurNAc is a peptide chain of three to five D-amino 
acids that can be cross-linked to the peptide chain of another strand resulting in a 3D 
elastic mesh-like network. However, while Gram-positive bacteria are characterized by a 
relatively thick cell wall consisting of multiple layers of protective peptidoglycan, Gram-
negative bacteria exhibit a single and thinner layer. Still, Gram-negative cell walls (Fig. 
1.3) have been found strong enough to withstand ~3 atm of turgor pressure
37
, tough enough 
to endure extreme temperatures
38
 and pHs
39
  and elastic enough to be capable of expanding 
several times their normal surface area
40
. Thus the Gram-negative cell wall is regarded as a 
remarkable strong, tough, and elastic structure and the main responsible for the protection 
of cellular contents
41,42
. 
 
Outer 
membrane
Cytoplasmatic
membrane
Periplasmatic
space
Cytosol
Membrane attached 
proteins
peptidoglycan
porin
Lipopolysaccharides
Outer membrane protein
Exopolysaccharides or Capsular polysaccharides (if present)
 
Figure 1.3. Schematic representation of a Gram-negative cell wall (adapted from
43
). 
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Gram-negative bacteria also present an additional outer surface membrane 
decorated with lipopolysaccharides (LPS) originating a much more complex cell-surface 
architecture than the one of Gram-positive bacteria. Some bacteria further produce capsular 
or extracellular polysaccharides (CPS/EPS) responsible for conferring extra protection to 
the cell, thus frequently regarded as pathogenicity phenotypes. 
 
1.2.1. Lipopolysaccharides (LPS) 
 
Lipopolysaccharides (LPSs) are vital to both the structural and functional integrity 
of the Gram-negative bacterial outer membrane. Ubiquitously expressed by all Gram-
negative bacteria, and containing several well-conserved domains, LPS also serves as one 
of the primary targets of the innate arm of the mammalian immune system
44
. The presence 
of LPS in the outer membrane confers stability to the bacterial membrane, protection 
against bacteriophages and certain antibiotics, as well as protection against the host 
defence mechanism during infections
44,45
. LPS are also regarded as powerful 
immunomodulators in infected hosts, and may cause endotoxic shock
43
. Most of them 
share a common architecture but vary considerably in structural motifs from one genus to 
another, species, and even within strains. The LPS are commonly formed by three distinct 
domains: a lipidic moiety termed lipid A that acts as anchoring point to the cell-surface; an 
inner oligosaccharide moiety termed core; and often elongated domains yielding repeating 
units termed O-chains.  
The lipid A endows the LPS with its range of immunological and endotoxic 
activities, although the degree of bioactivity of lipid A may be modulated by the saccharide 
portion of the LPS
46
. The structure of the lipid A moiety is highly conserved within each 
species, whereas the core oligosaccharide is more variable and the O-chain exhibits the 
higher variability
46
.  
The inner core is proximal to the lipid A and contains a high proportion of unusual 
sugars such as 3-deoxy-D-manno-octulosonic acid (Kdo) and L-glycero-D-manno heptose 
(Hep)
43.46
. The outer core extends further from the bacterial surface and is more likely to 
consist of more common sugars such as hexoses and hexosamines
43
. Onto this is attached, 
in most cases, a polymer of repeating saccharide subunits called the O-polysaccharide, or 
O-chain, also typically composed of common hexoses and hexosamines. This O-chain is 
not ubiquitous, however, it appears truncated or lacking in a number of Gram-negative 
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 strains
43
. Bacteria which colonise mucosal surfaces, for example, often express LPS with a 
truncated non-repeating O-chain known as lipo-oligosaccharide (LOS; oligomeric O-chain-
Core-Lipid A~cell)
43
. In addition, certain strains carry mutations in the well-conserved rfb 
locus (which contains a selection of genes involved in O-chain synthesis and attachment) 
and are termed rough mutants (Core-Lipid A~cell) to differentiate them from the wild-type 
smooth (S) strains which express O-chain bearing LPS (polymeric O-chain-Core-Lipid 
A~cell) (Fig. 1.4). LPS phenotypes yielding a complete core oligosaccharides (OS) and a 
small number of O-chain repeating blocks are sometimes also observable and termed semi-
rough (O-chain OS-Core-Lipid A~cell, SR). This classification in rough, semi-rough or 
smooth phenotypes had its origin on the characteristic shape of their colonies on agar 
plates. 
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Figure 1.4. Schematic representations of the enterobacterial Gram-negative cell envelope 
(left), a lipopolysaccharide structure (right), R, SR, and S indicate the structures of rough-
type, semi-rough type (with only one O-chain subunit) and smooth-type 
lipopolysaccharides, respectively (adapted C. Erridge et al.
44
 and Caroff and Karibian
47
) 
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1.2.2. Extracellular polysaccharides and Capsular polysaccharides 
(EPS/CPS) 
 
 A broad range of bacterial species are known to produce polysaccharide envelopes 
normally referred as capsules (CPS) or excrete polysaccharides (exopolysaccharides, EPS) 
to the surrounding media thus creating a strong and sticky framework
43
. Even though some 
controversy might prevail as far as differentiating CPS form EPS, distinction is generally 
based on presence of absence of cell bonding. While CPS, like the LPS, are considered to 
be covalently attached to the cell wall, the EPS molecules appear to be released onto the 
cell surface with no discernable means of attachment. The EPS and CPS are also, like the 
O-antigen in the LPS, normally built up by oligosaccharide repeating units into homo- or 
hetero-polymers. Inter-strain and specie variations are frequently observed as well as the 
introduction of branches and decoration elements such as substitution of both organic and 
inorganic molecules rendering additional structure complexity.  
 These structures are considered virulence factors as they are recognized as 
protection agents for the bacterial cell. They protect the cell against phagocytosis, retain 
water thus preventing cell from desiccation, and confer shielding against external 
aggressions, both biological such as virus and chemical (detergents or antibiotics)
43
. 
Furthermore they are responsible for bacteria adhesion to surfaces and other cells and the 
main cement in formation and maintenance of an alternative bacterial life style outside the 
natural reservoir providing harsh environments.  
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 1.3. Helicobacter pylori cell-surface LPS 
 
Like other typical Gram-negative bacteria, H. pylori cell-envelope is composed of 
LPS that, when biosynthetically completed, are composed by the three distinct structural 
domains mentioned in section 1.2: a polysaccharide (PS) known as O-chain (OPS), an 
oligosaccharide (OS) termed Core, and a fatty-acid rich endotoxin moiety named Lipid A 
(LPS: O-chain →Core→Lipid A~cell)
48
, that has demonstrated to yield low biological 
activity compared when with the Lipid A from other bacteria
49
 
Even though H. pylori clinical isolates were recognized to produce high-molecular 
weight (smooth) LPS with extended O-antigenic chains, strains yielding semi-rough LPS 
have also been observed. Long term subcultivation solid medium leads H. pylori strains 
that express smooth LPS phenotypes to express semi-rough and rough forms. However, 
when recovered to liquid medium this strains regain the capability to express smooth 
LPS
50,51
. Some strains were also found to express an additional DD-Hep oligomeric domain 
between the core OS and the Lewis O-chain (O-chain → Heptoglycan → Core→Lipid 
A~cell)
48,52,53.
  
Studies carried out less than ten years ago by Monteiro and colleagues resulted in 
the structural definition of the LPS polysaccharide moiety
48
. Furthermore, the classification 
for H. pylori LPS into glycotype families based on their structures has been purposed
48,54
.  
 
1.3.1. Lipid A  
 
 H. pylori lipid A (Fig. 1.5) is formed by a hydrophilic backbone of β-(1→6)-linked 
D-GlcNAc disaccharide 1-phosphate or, in lower abundance, ethanolaminephosphate
55
. In 
smooth-LPS, but not in rough-LPS, the O-4 position was partially substituted by another 
phosphate group. The fatty acid moiety comprises hexadecanoic (16:0), 3-
hydroxyhexadecanoic acids [16:0(3-OH)], and 3-hydroxyoctadecanoic [18:0(3-OH)] acids 
with minor amounts of dodecanoic (12:0) and tetradecanoic (14:0) acids.  
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Figure 1.5. Proposed chemical structures of (A) the predominant lipid A molecular 
structure found in H. pylori rough and smooth LPS and (B) a minor lipid A species found 
only in H. pylori smooth LPS. Numbers in circles refer to the number of carbon atoms in 
acyl chains. Further heterogeneity occurs by nonstoichiometric replacement of 3-(18:0)-O-
18:0. Polar headgroups are indicated by R’ (phosphate or ethanolaminephosphate) and R’’ 
(H or phosphate)
46
. 
 
1.3.1. The Core oligosaccharide  
 
 The core region is covalently attached through the reducing end of the lipid A by an 
acid-sensitive ketosidic linkage from 3-deoxy-D-manno-octulosonic acid (Kdo), an 
immutable component of the core, to the O-6 of the outer glucosamine unit of lipid A
48
. In 
H. pylori the core region has been found so far to be a conserved region formed by a linear 
phosphorylated (by a monoester phosphate or by a 2-aminoethylphosphate) backbone, 
αDGlcp-(1→3)-αDGlcp-(1→4)-βDGalp-(1→7)-DαDHepp-(1→2)-LαDHepp (1→3)[P/AEP 
→7]-LαDHepp-(1→5)-Kdo, that is extended by an additional side-branch DαDHepp residue 
appended to the O-2 position of the distal of the backbone glycan (Fig.1.6)
48
. A few H. 
pylori core oligossacharides also contain O-2 and O-6 substituted DDHep units as members 
of the DDHep side-branch. In some strains also a (1→6)-α-glucan antenna, αDGlcp-1-[→6-
αDGlcp-1]n→, was found to be connected to the O-2 site of the side-branch DαDHepp. 
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αDGlc(1→3)αDGlc(1→4)βDGal(1→7)DαDHep(1→2)LαDHep(1→3)LαDHep(1 →5)Kdo→Lipid A
P or AEP
7
→
αDGlc(1-[→6)αDGlc(1-]n→2~DαDHep
2
→
1
7
→
O-Chain
→
→
→
 
 
Figure 1.6. H. pylori LPS core structure. 
 
1.3.2. The Heptoglycan domain 
 
 As mentioned in the beginning of section 1.3, some H. pylori strains, namely strain 
MO19 and those from serogroups O:3 and O:6 have shown to express elongated 3-
substituted D-glycero-α-D-manno-Hepp oligomers thus forming an heptoglycan domain 
between the core and the O-chain (Fig. 1.7)
52
.  
 
O-chain-[→3)DαDHep(1-]n →6 or 2)DαDHep(1→2 or 6)DαDHep(1→Core  
 
Figure 1.7. Hepoglycan domain in strains MO19 and serogroups O:3 and O:6. 
 
Furthermore, strains isolated from asymptomatic hosts, which were found 
untypeable using monoclonal antibodies (mAbs) specific for Lewis antigens (Le
x
, Le
b
, Le
x
, 
or Le
y
) commonly expressed in H. pylori O-chains, contained instead elongated 
heptoglycans sometimes capped by an incomplete Lewis antigen
53
. This family of strains 
also yielded O-6 substituted DD-Hep as a common component of the inner region of the 
LPS.  
 
1.3.3. The O-chain  
 
Contrarily to the core, whose structure up until now has demonstrated to be 
conserved, the O-antigen chain (O-chain) region of H. pylori LPS shows considerable 
variability
48
. 
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In the early stages of H. pylori research, Penner et al.
56 
 developed a serotyping 
system based on different antigenicity of LPS molecules, which resulted mostly from 
structural variations in the O-antigenic chains and the presence of heptaglycan domains, 
whereby they defined six distinct H. pylori serotypes (O1 to O6). Subsequently, detailed 
structural
48
 and serological
57
 studies have shown that the H. pylori O-chains are unique in 
their structure as they express structures homologous to mammalian histo-blood group 
antigens termed Lewis antigens. Data arising from those studies allowed establishing a 
correspondence between O-chain structures and their serological classification (Fig. 1.8).  
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Figure 1.8. Known O-chain PS domains for serotypes O:1, O:2, O:3, O:4 and O:6 (adapted 
from Britton et al.
58
). 
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αLFuc
→ →→
Lewis O-chain 
Heptoglycan 
Lewis O-chain 
Elongated α glucan 
Glucoylated Lewis O-chain 
βDGal(1→4)βDGlcNAc(1___ →2 or 3)DαDHep__ →
n3
→
1
αLFuc
→→
Heptoglycan 
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 H. pylori normally expresses O-chains exhibiting a poly-LacNAc [→3)-β-D-
Gal(1→4)-β-D-GlcNAc(1→] structures decorated with multiple side chains of α-L-Fuc 
residues forming Type 2 internal Le
x
 determinants with terminal Type 2 Le
x
 and Le
y
. In 
some strains additional Type 1 Le
a
, Le
b
 and tumour associated sialyl-Le
x
 and H-1 
determinants, as well as the related blood groups A and B can be also observable in 
association with Le
x
 and LacNAc chains
48
 (Fig. 1.9).  
O-chains comprising typical Type 2 polyLacNAc backbones adorned with branches 
of α-D-Glcp or α-D-Galp linked to the O-6 position of the β-D-GalpNAc {→3)-β-D-Galp-
(1→4)[α-D-Glcp or Galp-(1→6)]-β-D-GlcpNAc(1→} were further identified in some 
strains. Structural studies carried out in H. pylori strain UA861 highlighted the presence in 
the non-reducing end of the galactosylated LPS O-chain of Le
x
 and Le
y
 and also of non-
fucosylated LacNAc and β-D-GalpNAc [→3)-β-D-Galp-(1→4. A limited number of 
internal Le
x
 units were further detected in this galactosyl polyLacNAc chain
48
. 
 
 
Figure 1.8. Blood group structures found in H. pylori LPS O-chains.  
 
Frequently incomplete Le antigens are observed implying that the building of Le 
determinants in H. pylori takes place through a sugar-by-sugar addition and not by a block-
by-block synthesis, as observed for other enteric bacteria
48
.  
In addition to the vast diversity of O-chain motifs between strains, there is also 
apparent micro-diversity within a population of cells
59-61
. Such is a consequence of strong 
phase variation (antigenic variation), a common phenomenon in microorganisms, 
characterized by a on or off switching in the expression cell surface epitopes such as outer 
β-D-Gal-(1→3)-β-D-GlcNAc
4
→
1
α-L-Fuc
β-D-Gal-(1→3)-β-D-GlcNAc
4
→
1
α-L-Fuc
2
→
1
α-L-Fuc
Type 1 chains
(β-D-Gal-(1→3)-β-D-GlcNAc)
Type 2 chains
(β-D-Gal-(1→4)-β-D-GlcNAc)
β-D-Gal-(1→4)-β-D-GlcNAc
3
→
1
α-L-Fuc
β-D-Gal-(1→4)-β-D-GlcNAc
3
→
1
α-L-Fuc
β-D-Gal-(1→4)-β-D-GlcNAc
3
→
1
α-L-Fuc
2
→
1
α-L-Fuc
2
→
2
α-Neu5Ac
α-GlcNAc(1→3)-β-D-Gal-(1→3)-β-D-GlcNAc
2
→
1
α-L-Fuc
Lea
H-1 chains
Leb
A-1
Sialyl-Lex Le
x Ley
α-Gal(1→3)-β-D-Gal-(1→3)-β-D-GlcNAc
2
→
1
α-L-Fuc
B-1
α-L-Fuc (1→2)-β-D-Gal-(1→3)-β-D-GlcNAc
α-GlcNAc(1→3)-β-D-Gal-(1→4)-β-D-GlcNAc
2
→
1
α-L-Fuc
H-2 chains
A-1
α-Gal(1→3)-β-D-Gal-(1→4)-β-D-GlcNAc
2
→
1
α-L-Fuc
B-1
α-L-Fuc (1→2)-β-D-Gal-(1→4)-β-D-GlcNAc
→ →→ → → →→→
→ → → →
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membrane proteins and LPS. The antigenic variation is most probably beneficial to H. 
pylori during the micro-environmental changes that the bacterium encounters in the course 
of colonization and persistent infection and as given H. pylori a selective advantage in its 
long history of evolution
62
. 
 
1.3.4. Classification of Helicobacter pylori LPS into glycotype families  
 
The LPS of H. pylori strains share the common characteristic of expressing O-
chains exhibiting structural homology with human histo-blood group antigens. However, 
particular fine structural details can be observed to differentiate these LPS molecules. 
Based on such assumptions, Monteiro
48
 proposed a classification to create a systematic 
grouping of H. pylori LPSs that could systematize and aid further investigation (Table 1.1).
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1.3.5. Role of Le antigens in H. pylori pathogenesis 
 
H. pylori cell-surface glycans and in particular Le antigens are active actors in the 
microbe-host interplay. They influence bacterial colonization and adhesion and have an 
active role in the establishment and persistence of infection and evasion of the immune 
responses
63
. Also, as chronic infection progresses, Le antigens have also been suggested to 
contribute to gastric autoimmunity that leads to gastric atrophy, a precursor state of gastric 
cancer
63
.  
 
Le phenotypes and gastric adaptation  
In the human stomach, Le
a
 and Le
b
 are mainly expressed on the surface of foveolar 
epithelia, whereas Le
x
 and Le
y
 are expressed predominantly by the mucus, chief and 
parietal cell of the gastric glands
64
. Thus, a variety of Le antigens are expressed within the 
ecological niche of H. pylori. Based on the recognition of Le antigen expression both by H. 
pylori and by the gastric mucosa, it has been purposed that bacterial molecular mimicry 
could be part of a long-term survival strategy
65,66
. This camouflage would allow H. pylori 
an escape from humoral response by preventing the formation of antibacterial antibodies 
because of cross-reaction with the host
63,65,66
. Therefore, selective pressure from the host is 
thought to have great influence in the establishment of a given H. pylori phenotype
65
. 
Of note is the fact that H. pylori strains expressing Le
x
 and those expressing Le
y
 can 
be isolated from the same host
67
 and that extensive diversity in expression of Le
x
 and Le
y
 
in H. pylori O-chains can occur overtime and in different regions of the human stomach
59
. 
Furthermore, simultaneous expression of Le
x
 and Le
y
 by one strain can also occur
48
 as well 
as strains expressing both type 1 and type 2 Le determinants
48
.
 
Moreover, genetic 
modification have been detected in H. pylori FucT genes that could be attributable to 
recombination events within and between genes resulting in genetic diversity that together 
with phase variation contributes to divergent LPS expression within an H. pylori 
community
68
. This reflects an ability and potential of the bacterium to adapt to different 
microniches and environmental conditions within the human stomach
63
. Thus, a 
combination of several factors might contribute to the observed diversity
63
, namely a 
selective pressure from the host, strong phase variation and genetic exchange by the 
bacteria
62,69,70
, and environmental pressures such as pH
71
 and availability of certain 
micronutrients such as iron
72
 within the gastric niche.  
22  
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 Role in adhesion  
 Le
x
 in the O-chains has been shown to mediate H. pylori adhesion to the human 
antral gastric mucosa
73
 by interaction with the gastric receptor galectin-3
74
, a galactose-
binding lectin. It is also known that strains with high Le
x
 expression exhibit higher 
colonization densities
75
. By assisting bacterial adhesion and interaction with the gastric 
mucosa, the expression of Le
x
 may enhance the delivery of secreted products into the 
gastric mucosa, thus promoting the development of gastric malignancies
76,77
. 
Noteworthy is the influence that pH gradients between the luminal side of the 
gastric mucus layer (pH ~2) and the surface of gastric cells (pH 7) may exert in H. pylori 
adhesion
63
. Le
x
 expression by H. pylori was found optimal at neutral pH and reduced at 
lower pH like the one observed in the mucus layer. By modulating expression of Le
x
, pH 
promotes free-swimming H. pylori in the mucus layer and adhesion at the epithelial cell-
surface
63
. Potentially, these bacteria in the mucus layer can act as a reservoir for 
continuous infection of the mucosa
63
.  
 
Influence in colonization 
H. pylori wild type strains and mutants lacking the ability to express O-chains and 
Le
x
 epitopes exhibit a significant decrease in the capability of colonizing mice
62
,
 
thus 
suggesting its key role in human colonization. Furthermore, knock-out in the expression of 
GDP-D-mannose pyrophosphorylase required for GDP-fucose synthesis thus resulting in a 
fucose-lacking O-chain (i-antigen) retrieved reduced mouse colonization and ablated 
interaction with the human gastric mucosa in situ
78
. However, some controversy still stands 
as far as upon the dependence of Le blood group expression to guarantee a successful 
colonization. Reports have been presented of clinical isolates from asymptomatic hosts 
lacking Lewis O-chains and expressing either elongated heptoglycans
48
 or α-(1→6) 
glucans that were able to colonize mice
79
. Such evidences suggest that the presence of 
Lewis O-chain, even though not absolutely required for colonization, might result in the 
incapability of cells to induce significant pathology. Such phenomena might arise from the 
inability in adhering to human receptor cells and/or the presence of elongated heptoglycans 
may prevent exposure of disease-causing bacterial cell-surface molecules
48
. 
 
 
  
 
Chapter I 
 
 
24 
 
 
 
 
Modulation of immune responses 
 In order to evade immune recognition, several variants often arise within a bacterial 
cell population with modifications in cell-surface glycosylations, especially at the O-chain 
level
80
.  
 H. pylori have been recognized to interact with surfactant protein D (SP-D), a lectin 
involved in antibody-independent pathogen recognition and elimination
81
. SP-D binds with 
H. pylori O-chain moiety resulting in bacterial immobilization and aggregation
80
. Also, 
there are reports demonstrating that H. pylori infection is more common in the absence of 
SP-D
81,82
, emphasizing an important influence of SP-D binding on the establishment of 
infection.  
Strain-to-strain and especially inner strain variability resulting from strong phase 
variation can also modulate interaction with gastric dentric cells
83-85
. The existence of Le-
negative variants within a population allows escaping binding to dentric cells and induces a 
strong Th1 cell response
84
. On the other hand, strains in the same population expressing 
Le
x
/Le
y
 bind dentric cells and enhance the production of IL-10 production, thus promoting 
Th2-cell response and blocks Th1-cell activation
84
, resulting in a mixed Th1/Th2-cell 
response
83
. The modulation of the host response allows a switch from an acute infection 
response to one that supports development of chronic infection since humoral response and 
antibody production are not associated with H. pylori eradication and protection
63,85
.  
It has also been advanced that upon prolonged H. pylori infection the patients might 
develop autoimmune responses leading to gastric damage
63
. These observations were 
backed by several studies describing the existence of anti-Le
x
 and anti-Le
y
 antibodies in 
the sera of host with acute prolonged infections
86-88
.  
 
1.3.6. H. pylori Lewis expression and human geographical distribution 
 
LPS from H. pylori isolated so far from North American and European populations 
predominantly express Type 2 Le
x
 and Le
y
 blood group epitopes
89
; conversely the 
expression of Type 1 chains among those populations is relatively rare
89
. In Latin America 
the Type 1 (but only Le
b
) was found dominant
90
, whereas in Asia, the prevalence rate of 
Type 1 can be up to 35% and both Le
a
 and Le
b
 can exist. It has been purposed that such 
differences arise from adaptation of H. pylori to the host Lewis phenotype. Furthermore, it 
has been demonstrated that H. pylori is submitted to selective pressure to express certain 
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 types of LPS phenotypes
68
. Thus, the milieu in a host will select for bacterial variants with 
particular characteristics that facilitate adaptation and survival in the gastric mucosa of that 
individual, and will shape the bacterial community structure. Following these 
considerations, it has been purposed that, Type 1 or 2 Lewis antigens from H. pylori 
isolates can be used as potential markers for identifying the geographical distribution in the 
worldwide human population. 
Moreover, since Lewis antigens of H. pylori are regarded as virulence factors 
facilitating colonization or inflammation, the selection of vaccine targeting the Lewis 
antigens will be different for patients from different geographical populations. However, 
further and broader studies are yet to be conducted until a trustful correlation can be 
established. 
 
1.3.7. H. pylori unusual cell-surface glycosides  
 
 In addition to LPS there have been reports of the production of other cell-surface 
glycans by H. pylori. Kocharova et al.
91
 described the expression of an unusual 
polysaccharide containing D-rhamnose (D-Rha), L-rhamnose (L-Rha) and 3-C-methyl-D-
mannose (D-Man3CMe), a sugar that up until then had never been observed in nature. The 
mentioned polysaccharide was composed by the following trisaccharide repeating unit: 
→2)-α-D-Manp3CMe-(1→3)-α-L-Rhap-(1→3)-α-D-Rhap-(1→ and was isolated from three 
Danish strains (D1, D3 and D6) found nontypeable using a variety of anti-Lewis and anti-
blood-group monoclonal antibodies.  
In addition, Monteiro et al.
92
 described an immunogenic formulation against H. 
pylori comprising a highly branched polymeric mannan formed by trisaccharide repeating 
units composed of terminal, O-2 and O-2,6 α-D-Man residues. This polysaccharide was 
isolated from H. pylori mutant strain NCTC 11637 pgm having a knock-out of the 
phosphomannomutase gene. 
  
 
Chapter I 
 
 
26 
 
 
 
 
1.4. Aims of the thesis 
 
The work that is being carried out by Professor Monteiro over the past ten years has 
clarified and brought into the spotlight several structural characteristics of H. pylori LPS 
isolated from a broad range of strains and clinical isolates. As discussed in section 1.3 cell-
surface glycans, and particularly Le antigens, have shown to be important legislators in the 
host-H. pylori interactions
63
. However, H. pylori O-chains often co-express trace amounts 
of isomeric Le determinants making their analysis challenging from the analytical point of 
view. Therefore, in this thesis attention is devoted to the establishment of analytical basis 
for the distinction of isomeric Le determinants relying on the capability of ESI-MS 
techniques to detect trace amounts of biological samples. 
Awareness of the biological implications of cell-surface sugars and their potential 
as therapeutic agents, namely as carbohydrate vaccines, the objective of this thesis is also 
to extend the current knowledge on the chemical structure of H. pylori glycans. Studies 
were carried out in H. pylori clinical isolates from Portuguese patients previously 
characterized in relation to their virulence profile. Special attention was devoted to the 
search and structural characterization of new cell-surface glycans (LPS, CPS/EPS, and 
glycoproteins) and their possible implication in the interaction with the human reservoir in 
pathology. The impact of in vitro growth in routinely used solid medium Columbia blood 
agar (CBA)
93
 and Ham’s F12
94
 liquid medium in the definition of H. pylori cell-surface 
glycan phenotypes was also evaluated. This knowledge will allow new insights on the 
influence of environmental pressures outside the human reservoir in the definition of H. 
pylori surface.  
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 2.1. Identification of the Samples 
 
 The following stains were used in this thesis: 
 
 H. pylori reference strain NCTC 11637, obtained from the National 
Collection of Type Cultures (London, England) and gently provided by 
Doctor Maria João Vieira from the Centre of Biological Engineering of the 
University of Minho (Braga, Portugal). H. pylori NCTC 11637 is vacA+ 
(s1,m1) and cagA+. 
 
 H. pylori clinical isolate 968 that was kindly provided by Dr. Maria de 
Lurdes Monteiro from the National Health Institute Dr. Ricardo Jorge 
(Lisbon, Portugal). It was isolated from a patient with a gastric ulcer and 
characterized as vacA+ (s1,m1) and cagA+. 
 
 H. pylori clinical PTAV79 that was kindly provided by Prof. Maria do Céu 
Figueiredo from the Institute of Molecular Pathology and Immunology at 
the University of Porto (Porto, Portugal). It was isolated from a patient with 
reflux esophagitis and characterized as vacA+ (s1,m1) and cagA+. 
 
 H. pylori clinical isolate 14255 that was kindly provided by Prof. Maria do 
Céu Figueiredo from the Institute of Molecular Pathology and Immunology 
at the University of Porto (Porto, Portugal). It was isolated from a patient 
with reflux esophagitis and characterized as vacA+ (s1,m1) and cagA+. 
 
2.2. Analytical approaches used in the characterization of H. pylori cell-
surface glycans 
 
 The global strategy used in this thesis for the structural characterization of H. pylori 
cell-surface glycans comprised an initial step of isolation from the bacterial cell wall. 
Subsequent actions involved an interactive combination of purification steps and 
evaluation of the extracts in relation to their sugars profile (composition, linkage, anomeric 
configuration). This approach allowed the isolation of fractions that were then analysed by 
fine analytical methods such as Nuclear Magnetic Ressonance (NMR) and Mass 
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Spectrometry (MS) and Fourier-Transformed Infrared Spectroscopy (FT-IR) as 
summarized in Fig. 2.1.  
Isolation
Separation
Purification
Size-Exclusion Chromatography
Affinity  Chromatography
SDS-PAGE
Acid/Enzymatic hydrolysis 
Phenol:Water Extraction
Dialysis
Sugars
Profile
Sugars Analysis
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Analytical 
Methods
2D NMR
MS
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Figure 2.1. Rough scheme of the strategy used in the structural analysis of H. pylori cell-
surface glycans. 
 
2.2.1. Isolation of cell-surface glycans 
 
The initial step in the isolation of H. pylori glycans comprised the isolation from 
their complex matrix, H. pylori cell-surface. The isolation of LPS/CPS or EPS from dry 
bacterial mass is conventionally initiated with phenol/water extraction1 (Fig. 2.2). In this 
step the bulk of the proteins are removed with the phenol-phase while glycan-rich 
biomolecules remain in the water-phase together with salts and residual phenol. The 
glycan-rich water extracts were then subjected to a dialysis against distilled water using 
membranes with a cut-off of 1,000 Da with the purpose of desalting the sample and 
remove the toxic phenol without losing oligomeric material. The material recovered from 
dialysis was found to contain LPS/CPS and/or EPS residual but also residual amounts of 
nucleic acids and frequently peptides and low Mw proteins. 
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Figure 2.2. The main steps in the purification of H. pylori cell-surface glycans. The weight 
values of 1 g of dry bacterial cells, < 10 mg of freeze-dried material and < 1 mg of smooth 
LPS result from medium values observed for H. pylori NCTC 11637.  
 
 
The molecular complexity of carbohydrate structures like the ones expressed at the 
cell-surface of H. pylori makes their characterization a challenging task from the analytical 
point of view. Furthermore, the presence of impurities and high heterogeneity at the glycan 
level makes the interpretation of analytical data difficult or sometimes impossible. Pure 
extracts are therefore essential to achieve a successful characterization. In this thesis 
samples were subjected to a pre-purification step by Size Exclusion Chromatography on a 
Bio-Gel P6 (separation limit: 1,000 - 6,000 Da). This procedure allowed separating semi-
rough and rough LPS (LOS) and other oligomeric glycans from high Mw smooth LPS and 
CPS and/or EPS. Furthermore, it revealed effective in the removal of DNA and peptides 
from the high Mw fraction. It can also be seen in Fig. 2.2 that, generally, from an initial 
biomass of approximately 1 g less than 1 mg of LPS was obtained.  
 
2.2.2. Purification of cell-surface glycans 
 
 The high heterogeneity and complexity shown by the high Mw glycan-rich water 
extracts frequently led to additional purification steps, namely by affinity chromatography 
and SDS-PAGE. 
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Affinity chromatography  
In this thesis glycans were fractionated based on their affinity to the amphiphilic 
polypeptide polymyxin-B, an antibiotic recognized for its affinity for LPS2,3. They were 
also fractionated according to their affinity to concanavalin A, a lectin that binds terminal 
α-D-mannosyl and α-D-glucosyl residues4.  
 
SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a 
technique used to separate biomolecules, in particular proteins according to their 
electrophoretic mobility (a function of length of polypeptide chain or molecular weight). In 
SDS gel electrophoresis, samples acquire identical charge per unit mass due to binding of 
SDS which results in fractionation by size. In this thesis this technique was employed to 
highlight possible protein-carbohydrate interactions in samples recognized to contain both 
classes of biomolecules. Different staining agents were used to reveal the bands, namely 
coomassie5 for proteins and periodic acid-Shiff for carbohydrates6. The bands stained with 
both agents where considered to exhibit protein-carbohydrate associations6.  
 
2.2.3. Chemical degradation/derivatization of glycans  
 
De-lipidation 
To increase solubility and to simplify the analysis of LPS, the lipid part was sometimes 
removed. This was accomplished by mild acidic hydrolysis, which selectively cleaves the ketosidic 
linkage of Kdo7. In this thesis mild hydrolysis was performed by treatment with 1% acetic acid at 
100 °C for 30-60 min and centrifugation to remove the water insoluble lipid A7.  
 
Smith degradation  
 In this thesis the presence of glycans in SDS-PAGE gels has been accessed by the 
formation of aldehydes in the sugar rings that further react with Schiff reagent creating a 
purple-magenta colour6. The formation of aldehydes is accomplished based on a Smith 
degradation involving a sequential treatment of sugars with NaIO4 (sodium metaperiodate), 
sodium borohydride and dilute acid8. The oxidation yields a product in which vicinal 
hydroxyl groups have been oxidised to aldehydes by cleavage of carbon-carbon bonds 
(Fig. 2.3). Residues without any vicinal hydroxyl groups should thus remain unaffected.  
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Figure 2.3. Illustration of a periodate oxidation.  
 
Determination of monossaccharide composition  
The monosaccharide composition of the isolated extracts was evaluated by the 
alditol acetate (aa) method as described by Harris et al.9 (Fig. 2.4). The first step comprises 
the hydrolysis of all glycosidic linkages in the polysaccharide. The rate of hydrolysis of 
glycosidic bonds can differ significantly. For example, 6-deoxyglycosides hydrolyses 10 
times faster than glycosides while uronic acids are partially resistant to normal acid-
catalysed hydrolysis because of the inductive effect of the carboxyl group10. In this thesis 
polysaccharides have been degraded to their monomers by acid hydrolysis using 4 M 
trifluoroacetic acid (TFA) at 100ºC for 3h as reported by Monteiro et al.11. TFA is easy to 
evaporate and therefore preferable. The monosaccharides are then reduced by NaBH4 to 
alditols to simplify the chromatogram obtained by gas chromatography (GC). The 
mutarotation is hereby overcome and a single derivative for each monosaccharide is 
formed. To promote the volatility, the alditols are acetylated originating alditol acetates 
(AA) (Fig. 2.4).  
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Figure 2.4. General representation of sugars analysis on a polysaccharide composed of O-
4 linked α-Glc units.  
 
The derivatives are identified from retention times compared to standards and by 
their mass spectra, if necessary. 
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Linkage analysis 
The linkage pattern of each monosaccharide in a given polysaccharide was given 
by derivatization to partially methylated alditol acetates (pmaa) according to Ciucanu and 
Kerek12 (Fig. 2.5). Although this information can be obtained non-destructively by NMR 
spectroscopy, methylation analysis can be used alone or complemented with NMR 
spectroscopy. The polysaccharides are first dissolved in dimethyl sulfoxide (DMSO), a 
polar aprotic solvent that dissolves both polar and nonpolar compounds, and an excess of 
NaOH is then added to the medium. Sodium hydroxide acts as an exsiccating agent and at 
the same time allowing the deprotonation of DMSO forming the dimethylsulphinyl anion 
(DMSO-). DMSO- is the responsible for the deprotonation of hydroxyl groups of the sugar 
residues yielding a polyanion. The alkoxy groups are further reacted with methyl iodide 
and a fully methylated polysaccharide is obtained. The sample is then hydrolysed, reduced, 
and acetylated to produce volatile partially methylated alditol acetates (PMAA). The 
PMAA are identified from their retention times on GC as well as from their characteristic 
electron ionization (EI) mass spectra. Reduction was performed with NaBD4 to label 
anomeric carbon (C-1). 
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Figure 2.5. General representation of linkage analysis on a polysaccharide composed of O-
4 linked α-Glc units.  
 
The linkage analysis of sugars with carboxyl function raises some problems due to 
the conversion of the carboxyl group into a non-volatile sodium carboxylate. This problem 
was overcome in the present thesis by reducing the carboxylic group with LiAlD4 
according to what was described by Lindberg and Lönngren13 and Redgwell and 
Selvendran14 prior to the above described procedure (Fig. 2.6).  
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Figure 2.6. General representation of linkage analysis on a polysaccharide composed of O-
4 linked α-GlcA units.  
 
Partial Acid hydrolysis 
 In order to obtain fragments suitable for Electrospray ionization (ESI) mass 
spectrometry analysis, isolated glycans were subjected to partial acid hydrolysis using 
TFA. TFA was easily evaporated at 40ºC under a steam of N2 and the resulting 
oligosaccharides were recovered by Size-Exclusion Chromatography using a Bio-Gel P2 ( 
100 – 1800 Da). 
 
2.2.4 Gas chromatography (GC) 
 
Gas Chromatography (GC) was used in 
this thesis to separate volatile components of a 
mixture, namely alditol acetates from sugars 
analysis (Fig. 2.7) and partially methylated alditol 
acetates from linkage analysis. 
In GC, a small amount of the sample to be 
analyzed (1 µL) is drawn up into a syringe and 
injected in a hot injector port of the gas chromatograph where it is volatilized. Separation 
of the different components of a mixture occurs from the interaction with a mobile phase, 
in this case He and a stationary phase (Fig. 2.8). The stationary phase used in this thesis 
was a DB-1 capillary column (30 m length, 0.32 mm internal diameter, and 0.25 µm film 
thicknesses), a non-polar stationary phase composed of 100% dimethyl-polysiloxane.  
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Figure 2.7. Sugar analysis GC chromatogram on a DB-1 column of H. pylori 968 glycan-
rich water extracts. 
 
Since the partitioning behaviour is dependant on temperature, the separation 
column is usually contained in a thermostat-controlled oven. Separating components with a 
wide range of boiling points is accomplished by starting at a low oven temperature and 
increasing the temperature over time to elute the high-boiling point components.  
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Figure 2.8. Schematic representation of a GC. 
 
Coupling the GC separation with MS detector allowed the identification and 
quantification of trace amounts of compounds (nano-fentomole range). This was of 
primary importance when dealing with complex biological matrices and low abundance of 
starting material. In the present thesis 2-deoxy-Glc was used as internal standard for the 
quantification of the identified sugars15. 
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 2.2.5. Nano High performance liquid chromatography (HPLC) 
 
High-performance liquid chromatography (or High 
pressure liquid chromatography, HPLC), as its designation says, 
allows fractioning of samples in a liquid phase. It uses a column 
that holds chromatographic packing material (stationary phase), a 
pump that moves the mobile phase(s) through the column, and a 
detector that shows the retention times of the molecules. Retention 
time varies depending on the interactions between the stationary 
phase, the molecules being analyzed, and the solvent(s) used. 
Nano HPLC uses a capillary column and, by decreasing of inner 
diameter of the stationary phase, it allows injecting a small amount of sample with and 
increasing sensitivity16. Therefore, it was used in this thesis to separate trace amounts of 
protein digests prior to MALDI-TOF analysis.  
 
2.2.6. Nuclear Magnetic resonance  
 
 NMR is widely used for structure analysis of 
carbohydrates. About 1 mg of sample can be enough for a 
complete structural assignment. The method is non-destructive and 
relies on the magnetic properties of some nuclei. In this thesis the 
NMR active isotopes 1H, 13C, and 31P nuclei are used for structural 
analysis. 
 
Sample preparation  
All NMR experiments in the present thesis were acquired in D2O to reduce the 
complexity of the obtained NMR spectra since deuterium and protons are not observed at 
the same frequency17. By doing so, also the protons of hydroxyl, carboxyl, amine and 
amide groups are exchanged with deuterium further simplifying the sepctra. However, to 
achieve 100% exchange of deuterium with water protons is difficult and usually an intense, 
broad signal from HDO was observed in the spectrum. In order to decrease its intensity, 
the samples were repeatedly dissolved in D2O and lyophilised. Furthermore, the spectra of 
unknown samples were acquired with increased temperatures in relation to the defined 
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temperature. By doing so it was possible to move the HDO signal allowing the 
visualization of overlapped signals18.  
 
One dimentional (1D) spectra and the structural reporter region 
 1D 1H spectra are easy to acquire and do not require high amounts of material. 
Visual observation can readily provide information on the purity, concentration, and 
heterogeneity of the sample. Based on the anomeric region (~4.5 and 5.5. ppm) it is 
possible to estimate the number of different type of sugars in the samples17. The existence 
of acetate or methyl groups (δH 1.2-2.3 ppm) can also be easily accessed from the 1D 
spectrum. Samples containing sialic acids or 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) 
will be immediately obvious as well17. Therefore, 1D 1H NMR was routinely used to 
screen samples and easily access their purity and composition. Furthermore, both by 
observation of the chemical shift (δα > δβ) and measuring the vicinal coupling constant 
between H-1 and H-2 (3J1,2), it was possible to get information on the anomeric 
configuration17,19. If the sugars have axial-equatorial orientation they present a 3J1,2 α ~3 
Hz (α-anomer) and if they have an axial-axial orientation 3J1,2 β ~7 Hz (α-anomer)
17,20. 
However, if the sugar residue is in a manno-configuration (chair configuration D-4C1 or L-
1C4) like for Man of the heptoses observed in H. pylori core, this distinction is not 
straightforward. In these cases couplings are less than 3 Hz and the signals are usually not 
resolved due to line broadening17,19. In these cases the 3JC1,H1 values can be used, being 
168-174 Hz for α-pyranosyl residues and 160-167 Hz for β- pyranosyl residues17,19,20.  
 
2D homonuclear techniques 
Nuclear Magnetic Resonance (NMR) of glycans can be challenging, primarily due 
to spectral overlap; carbohydrate ring protons generally resonate over a relatively narrow 
spectral region (3.2-4.0 ppm)20. Therefore, it was frequently necessary to apply 2D 
homonuclear techniques such as correlated spectroscopy (COSY) and total correlated 
spectroscopy (TOCSY) to reduce the overlap by resolving the proton signals over two 
dimensions20. 2D COSY shows correlations between directly coupled protons allowing for 
example to determine H-2 from its correlation with the anomeric proton and from H-2 
determine H-3 and so on20. However, problems arise from strong coupled spins such as H-
6 and H-6’ that resonate close to the spectrum diagonal17. In the 2D TOCSY the 
magnetization can be transferred through the coupled network of spins of a given sugar 
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 from the anomeric position through the ring protons and even beyond in heptoses or 
octoses17. Due to high signal overlapping in complex spectra, the cross-peaks with the 
anomeric have been used as a reference region20. By crossing data from COSY and 
TOCSY it was possible to assign the majority of the ring protons from the observed sugars. 
Another NMR technique used was the 2D nuclear Overhauser enhancement spectroscopy 
(NOESY) which provided through-space information about nucleus less than 5 Å apart20. 
Also, in NOESY spectra, the intensity of the signal is directly correlated with the spatial 
distance between protons20.  
Backed by proton chemical shifts determined by COSY and TOCSY, it was 
possible to identify NOE patterns in the NOESY spectra that were used primarily to 
confirm the anomeric configuration of sugars17,20. NEOSY experiments were also used to 
establish the order of monosaccharide units in a given glycan and permitted the 
confirmation of previously assigned glycosidic linkages17,20.  
 
2 D heteronuclear techniques  
1H detected 1H-13C correlated NMR methods take advantage of the chemical shift 
dispersion of the 13C nucleus and are more sensitive than 13C direct detection17,20. In this 
thesis two experiences have been used, the heteronuclear single quantum coherence 
(HSQS) and heteronuclear multiple bond correlation (HMBC). The HSQC experience 
correlate directly linked 1H to 13C nuclei and was extensively used in this thesis to assign 
carbon chemical shifts without the need to acquire much less sensitive 13C spectra17,20.. An 
HSQC spectrum highlighting characteristic 1H and 13C chemical shift ranges are presented 
in Fig. 2.9 and chemical shifts are resumed in Table 2.1. 
Additionally, the HMBC allowed the identification of two and three-bond 
correlations and was most useful in the identification of glycosidic linkages20. However 
this experience is much less sensitive than HSQC, requiring long acquisition times to 
obtain information17. For that reason its utilization was sometimes prohibitive due to the 
low amounts of glycans available in this work (<200 µg).  
1H-31P NMR HMBC correlations were also used to determine phosphorilation sites 
in sugars.  
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Table 2.1. Characteristic carbon and proton chemical shifts for cabohydrates20  
 
Spectral region 
 
δH (ppm) δC(ppm) 
   
 
Carbonyl Carbons 
(uronic acids, acetyl or 1-carboxyethyl ethers) 
 
 165-185 
   
Anomeric region 4.4-5.5 95 and 110 
   
Ring region 3.2-4.5 50-85 
   
Nitrogen-bearing carbons  50-60 
   
Carbons linking other sugars  75-85 
   
unsubstituted ring carbons  65-75 
   
O-substitution 1.2-0.6 15-30 
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Figure 2.9. The typical chemical shift ranges of signals from the carbon and proton in 
carbohydrates. 
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 Diffusion ordered spectroscopy (DOSY) 
 DOSY experiments provide a way to separate the different compounds in a mixture 
based on the differing translation diffusion coefficients21. Therefore, differences in the size 
and shape of the molecule, as well as physical properties of the surrounding environment 
such as viscosity and temperature of each chemical species in solution can contribute to the 
separations. Similar to an analytical chromatographic experiment, the DOSY spectrum 
presents an individual component 1H spectrum along a diffusion (molecular mass) axis. It 
was therefore used in this thesis to evaluate the heterogeneity of samples22.  
 
Databases of chemical shift information 
 Tabulated chemical shift data for monosaccharides and polysaccharides are a 
valuable resource for aiding structural assignment of polysaccharides. In this context the 
existence of databases capable of gathering information is a precious help in NMR 
interpretation. One of the most important is the database CASPER23,24  having a web 
interface at http://www.casper.organ.su.se/casper. This database has been tested 
extensively and used to simulate 13C spectra of grater than 200 structures with excellent 
reliability17. Therefore, this database has been used in this thesis to evaluate the accuracy 
of both 1H and 13C chemical shift assignments and the accuracy of the proposed structures.  
 
2.2.7. Mass spectrometry  
 
Mass-spectrometry (MS) is a highly 
sensitive analytical technique, allowing structural 
characterization within the nano-fentomole 
range25. An MS experience comprises three 
general steps: ionization of the sample, separation 
according to mass/charge ratio, and detection (Fig. 
2.10). In this thesis three types of ionization 
methods were used, Electron impact (EI), 
eletrospray ionization (ESI), and Matrix Assisted 
Laser Desorption Ionization Time-of-Flight 
(MALDI). Different types of analyzers were also 
used to separate the generated ions, namely 
 
 
 
Chapter II 
52 
 
 
 
 
 
 
 
quadrupole, a linear ion-trap (LIT), a quadruple-orthogonal acceleration time-of-flight (Q-
TOF) and a triple quadrupole (QqQ). 
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Figure 2.10. Schematic observation of a mass spectrometry experience.  
 
EI-MS 
EI was used in the ionization of gas-phase alditol acetates and partially methylated 
alditol acetates generated during sugar and linkage analysis. These low molecular weight 
molecules were volatilized and separated by GC and then ionized and fragmented by EI 
and detected by a quadrupole detector in positive mode26. Therefore, only positively 
charged ions are detected.  
EI is a relatively harsh form of ionization producing a wide range of molecular 
fragments. The electron impact source consists of a heated filament that produces electrons 
which are accelerated to another electrode called the ion trap. Sample vapour diffuses into 
the electron beam and become ionized and fragmented. The size of the fragment ion 
depends on the electron energy, which is controlled by the accelerating potential on the ion 
trap electrode26. Both aa and pmaa were bombarded by electrons with a kinetic energy of 
70 electron volts which was enough to break the molecules into smaller fragments26. The 
ions produced are driven by a potential applied to an ion-repeller electrode away from the 
ion source into the accelerating region of the mass spectrometer, where mass analysis takes 
place26. By coupling GC separative technique to MS analysis it is possible to generate a 
chromatogric profile associated with an array of MS spectra. This allows the detection of 
compounds based on retention time and their characteristic fragmentation spectrum under 
EI conditions.  
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 The mass detector of the GC-MS used was a quadrupole (Fig. 2.11) consisting of 4 
circular rods, set perfectly parallel to each other. In quadrupoles, the ions are separated in 
relation to their mass/charge ratio (m/z) based on the stability of their trajectories under a 
constant voltage and oscillating electric fields that are applied to the rods26. 
 
+~
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IONS
 
Figure 2.11. Schematic representation of a quadrupole.  
 
ESI-MS 
ESI-MS was extensively used in this thesis to analyze oligosaccharides resulting 
from partial acid hydrolysis and enzymatic treatments previously separated by size-
exclusion chromatography in Bio-Gel P2.  
During standard electrospray ionisation (Fig. 2.12) the sample is dissolved in a 
polar, volatile solvent and pumped through a narrow stainless steel capillary27. A high 
voltage is applied to the tip of the capillary, which is situated within the ionisation source 
of the mass spectrometer and, as a consequence of this strong electric field, the sample 
emerging from the tip is dispersed into an aerosol of highly charged droplets, a process that 
is aided by a co-axially introduced nebulising gas flowing around the outside of the 
capillary (Fig. 2.12). This gas, usually nitrogen, helps to direct the spray emerging from the 
capillary tip towards the mass spectrometer. The charged droplets diminish in size by 
solvent evaporation, assisted by a warm flow of nitrogen known as the drying gas which 
passes across the front of the ionisation source (Fig. 2.12). Eventually charged sample ions, 
free from solvent, are released from the droplets, some of which pass through a sampling 
cone or orifice into an intermediate vacuum region, and from there through a small 
aperture into the analyser of the mass spectrometer, which is held under high vacuum.  
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Figure 2.12. Schematic representation of ionization by ESI. 
 
Electrospray ionisation is known as a "mild" ionisation method as the sample is 
ionised by the addition or removal of a proton, with very little extra energy remaining to 
cause fragmentation of the sample ions. This technique was used to study oligosaccharides 
with molecular weight lower than 1200-1600 Da and all experiments relied on positive 
mode detection. Resulting from the high affinity of carbohydrates for alkali metals, they 
were mainly detected as sodium adducts ([M+Na]+)25. However, in cases where the 
concentration of H+ is high or when there is a lower concentration of sodium ions, the 
protonated specie was found predominant ([M+H]+). Higher molecular weight material 
generally originates multiple charged molecular-related ions such as (M+nH)n+ in positive 
ionisation mode which are not easy to interpret25. In those cases, analysis was carried out 
by MALDI-TOF-MS. 
All available ESI-MS analyzers (LIT, Q-TOF, and QqQ) further allowed tandem 
mass spectrometry (MS2) experiments by allowing the fragmentation of the [M+Na]+ ions. 
Fragmentation of these ions occurs mainly in the glycosidic linkage even though some 
cross-ring fragmentations can be observed thus generating valuable structural 
information25.  
The ion-trap mass spectrometer uses three electrodes to trap ions in a small 
volume27 (Fig. 2.13). The mass analyzer consists of a ring electrode separating two 
hemispherical electrodes. A mass spectrum is obtained by changing the electrode voltages 
to eject the ions from the trap. The advantages of the ion-trap mass spectrometer include 
compact size, and the ability to trap and accumulate ions to increase the signal-to-noise 
ratio of a measurement. The pulsing of the ion gate differentiates ion traps from "beam" 
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 instruments such as quadrupoles where ions continually enter the mass analyzer. The time 
during which ions are allowed into the trap, termed the "ionization period", is set to 
maximize signal while minimizing space-charge effects. Space-charge results from too 
many ions in the trap that causes a distortion of the electrical fields leading to an overall 
reduction in performance. The ion trap is typically filled with helium to a pressure of about 
1 mtorr. Collisions with helium dampen the kinetic energy of the ions and serve to quickly 
contract trajectories toward the centre of the ion trap, enabling trapping of injected ions. 
Trapped ions are further focused toward the centre of the trap through the use of an 
oscillating potential, called the fundamental radio-frequency (rf), applied to the ring 
electrode. An ion will be stably trapped depending upon the values for the mass and charge 
of the ion, the size of the ion trap, the oscillating frequency of the fundamental rf, and the 
amplitude of the voltage on the ring electrode.  
 
Figure 2.13. Ions are trapped by electric and magnetic potentials. This design has the 
advantage of allowing the selection of specific ions thus rejecting the rest.  
 
The capability of ion trap analyzers to hold ions for long periods allowed further 
fragmentations (MSn experiments) thus resulting in additional structural information.  
Oligosaccharides were also analyzed in an ESI-Q-TOF-MS mass spectrometer, that 
comprised both a quadrupole and TOF analyzers arranged orthogonally with a collision 
cell separating the two27 (Fig. 2.14). When operating in MS mode the quadrupole is not 
used as an analyser, merely as a lens to focus the ion beam into the second (time-of-flight) 
analyser which separates the ions according to their mass-to-charge ratio. In the TOF 
analyzer the ions are accelerated by an electric field of known strength27. As a result, ions 
with the same charge have an equal kinetic energy and therefore their velocity becomes 
dependent on the mass, thus lighter ions reach the detector first. When in MS2 mode, the 
molecular ions of each of the species present fragments that can be independently selected 
and transmitted through the quadrupole, which is now used as an analyzer, to transmit 
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solely the ions of interest into the collision cell which lies in-between the first and second 
analyzers. An inert gas such as argon is introduced into the collision cell and the sample 
ions are bombarded by the collision gas molecules which cause them to fragment prior to 
entering the TOF analyzer27. 
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Collision 
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(MS2)
Argon
TOF 
+
+ +
-
-
 
Figure 2.14. Schematic representation o a Q-TOF-MS apparatus.  
 
Analysis of oligosaccharides was also carried out in a triple quadrupole mass 
spectrometer where there is an arrangement of three quadrupoles27 (Fig. 2.15). The first 
(Q1) and third (Q3) quadrupoles serve as mass filters, whereas the middle (q2) quadrupole 
serves as a collision cell. This collision cell is a radiofrequency only quadrupole (non-mass 
filtering) using an inert gase such as Ar, He or N gas to provide collision-induced 
dissociation of a selected precursor ion that is selected in Q1. Subsequent fragments are 
passed through to Q3 where they may be filtered or scanned27. 
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Figure 2.15. Schematic representation of a Q-TOF-MS apparatus. 
 
MALDI-MS 
 MALDI-MS and MS/MS experiments were used in this thesis both to analyse high 
molecular weight oligosaccharides and to identify peptides resulting from trypic digestion 
of high molecular weight glycoproteins. In MALDI, the analyte has to be pre-embedded in 
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 an excess of low molecular weight mass UV-absorbing matrix. For sugars, it was used 2,5-
dihydroxybenzoic acid28 while for peptide analysis it was used α-cyano-4-
hydroxycinnamic acid. A pulse is fired at the matrix, which absorbs enough energy to 
transfer some of this to the sample, which leads to sputtering of analyte and matrix ions 
from the surface of the mixture27. In this way energy transfer is efficient and also the 
analyte molecules are spared excessive direct energy that may otherwise cause 
decomposition (Fig. 2.16).  
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Analyte/Matrix 
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mass   
analyzer
Matrix ion
 
Figure 2.16. Schematic representation of the ionization of the sample in MALDI. 
 
MALDI is also a "mild" ionisation method, resulting predominantly in the 
generation of singly charged molecular-related ions regardless of the molecular mass, 
hence the spectra are relatively easy to interpret. Fragmentation of the sample ions does not 
usually occur. The produced ions are then analysed by TOF. Even though the mass 
accuracy depends on the type and performance of the analyser of the mass spectrometer, 
most modern instruments should be capable of measuring masses to within 0.01% of the 
molecular mass of the analyzed ions27. Furthermore, the MALDI-TOF mass spectrometer 
also allowed tandem mass experiments that provided additional structural information  
 
2.2.8. Fourier transform infrared (FTIR) spectroscopy  
 
Infrared spectroscopy relies on the fact that bonds 
and groups of bonds vibrate at characteristic frequencies. A 
molecule that is exposed to infrared radiation absorbs 
infrared energy at frequencies which are a characteristic of 
the molecule. Therefore, it was of great usefulness in this 
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thesis to evaluate the purity of samples as well as, taking advantage of characteristic bands, 
infer the presence of certain classes of molecules. One of the most informative regions in 
the study of polysaccharides is fingerprint region from 800-1200 cm-1 29. The presence of 
proteins could also be inferred by the characteristic amide bands at 1650 resulting from 
C=O group (amide I band) and at 1550 from N-H group (amide II band)30 and lipids by 
characteristic absorvances in the region between 2959-2852 cm-1 resulting from CH, CH2 
and CH3 asymmetric and symmetric stretching modes of fatty acids
31. 
 The Fourier Transform Infrared (FTIR) spectrometer obtains infrared spectra by 
first collecting an interferogram of a sample signal with an interferometer, which measures 
all of infrared frequencies simultaneously. An FTIR spectrometer acquires and digitalizes 
the interferogram, performs the FT function, and outputs the spectrum.  
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Abstract 
 
With the intent of contributing for a carbohydrate-based vaccine against the 
gastroduodenal pathogen Helicobacter pylori, we report the structural characterization of 
a cell-surface mannose-rich glycans isolated from a virulent strain H. pylori 968. Sugars 
and linkage analysis and 1D and 2D 
1
H NMR revealed that this strains expresses a highly 
branched mannan formed by a backbone of α-(1→6)-linked mannopyranosyl residues 
showing up to 80% substitution in the O-2 position. The side chains were found to contain 
O-2 linked Man residues both in α- and β- configurations, as follows: 
 →6)-α-D-Manp-(1→6)-α-D-Manp-(1→
2
→
n
R
1
R = α-D-Man; 
→[2)-α-D-Man-(1]n→2)-α-D-Man;
→[2)-β-D-Man-(1]n→?
→
 
In addition, this strain also expresses cell-surface lipopolysaccharides (LPS) yielding 
partially fucosylated polyLacNAc O-chains. However, affinity assays with Polymyxin-B, 
Concanavalin A, as well as SDS-PAGE and DOSY NMR experiments, revealed no 
association between the mannan and the LPS moieties. Furthermore, they demonstrated 
that the expressed mannan is part of a much more complex heteropolymeric structure 
containing Glc, Gal, and GlcNAc connected to a protein domain. H. pylori cell-surface 
mannans seem to be directly implicated in the mediation of host-microbial interactions 
and immunological modulation. This is the first report of their expression by a Gram-
negative bacterium.  
 
Keywords: Cell-surface glycans; Helicobacter pylori; lipopolysaccharide; mannan; vaccine. 
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1. Introduction 
Helicobacter pylori is a widespread Gram-negative bacteria that colonizes the 
gastric mucosa of about 50% of the global human population
1,2
. H. pylori infection is 
currently recognized to be a crucial event in the induction of gastric malignancies such as 
gastritis, gastric atrophy, and peptic and duodenal ulcers
3,4
. It is also directly correlated 
with an increased risk of developing gastric cancer
5
, the reason why it is classified as a 
class I (definitive) human carcinogen
6
. As of yet, there is no vaccine against this bacteria 
and control of infection is accomplished by various combinations of antibiotic regimes
7
. 
However, this treatment is gradually losing effectiveness due to the rise of antibiotic 
resistant strains
8
 urging the need for new eradication strategies. Based on the proven 
success of carbohydrate based-vaccines against several pathogenic bacteria
9,10
, much 
attention has been drawn towards the identification and structural characterization of H. 
pylori cell-surface glycans.  
Like other Gram-negative bacteria, H. pylori expresses cell-surface 
lipopolysaccharides (LPS) that exert much influence in the mediation of host-pathogen 
interactions, namely the adhesion to gastric cells and modulation of the host immune 
response
11,12
. It is now well established that H. pylori LPS comprise three distinct 
structural domains constituted by an elongated O-antigenic chain (O-chain), an 
oligosaccharide core, and a fatty-acid rich endotoxin moiety, the Lipid A (O-
chain→core→Lipid A ~ cell)
13
. H. pylori O-chains are known to mimic the glycosylation 
in the gastric niche
13
 by expressing fucosylated glycosides analogous to some mammalian 
histo-blood-group antigens, namely, the Lewis determinants (Le
a
, Le
b
, Le
x
, sialyl Le
x
, Le
y
) 
and the blood groups A and linear B
14
. H. pylori serotypes O:3 and O:6 further present an 
heptoglycan (D-glycero-α-D-manno-heptoses) domain between the Le O-chain and the core 
region (O-Chain→Heptoglycan→Core→Lipid A ~ cell)
14-16
. Also, some strains have 
shown elongated α-(1→6)-Glc chains linked to the core
14,17 
or, as recently observed for H. 
pylori serotype O:2, an O-chain composed of alternating O-2- and O-3-linked α-D-
glucopyranose residues [→2)-α-D-Glcp-(1→3)-α-D-Glcp-(1→]n
16
. 
In addition to the LPS, it has been recently demonstrated that H. pylori 
bioaccumulates considerable amounts of amylose-like glycans under specific 
environmental pressures such as subcultivation in solid medium
18
. The same study points 
out the existence of terminal, O-2, O-6 and O-2,6 linked Man residues in the cell-surface 
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 glycan rich extracts of H. pylori strains NCTC 11637 and clinical isolates 968 and 14255
18
. 
Furthermore, it was suggested that growing H. pylori in Ham’s F12 liquid medium 
enhances the expression of Man
18
. Further reinforcing the evidences of cell-surface 
mannose containing molecules, both H. pylori coccoid and spiral cellular forms have 
shown to agglutinate with the α-Man specific lectin of Pisum sativum
19
. In addition, 
coccoid cells have also demonstrated to agglutinate with the α-Man specific lectins of Lens 
culinaris and Narcissus pseudonarcissus
19
. Despite these evidences, up to now only one 
report has been presented addressing the origin and structural organization of H. pylori 
cell-surface mannose-rich polysaccharides (mannans)
20
. However, this polysaccharide was 
isolated from H. pylori mutant strain NCTC 11637 pgm having a know-out of the 
phosphomannomutase gene
20
. Silencing of phosphomannomutase was described as 
responsible for the reduction of the overall amount of expressed polysaccharides thus 
facilitating the extraction and purification of external glycocalyx material regarded as 
yielding Man-rich polysaccharides
20
. In the mentioned report, Monteiro et al.
20
 described 
an immunogenic formulation against H. pylori comprising a highly branched polymeric 
mannan formed by trisaccharide repeating units composed of terminal, O-2 and O-2,6 Man 
residues
20
. Still, no structural studies have been conducted in wild type strains casting 
some doubt on the expression of the mutant-originated mannan by normal cells. In order to 
clarify this matter, the present study engages in the structural characterization of mannose-
rich glycans isolated from H. pylori clinical isolate 968 previously recognized as 
expressing high amounts of Man
18
.
 
 
2. Experimental 
 
2.1. Bacterial cultures 
H. pylori 968 was isolated from a gastric biopsy of a patient diagnosed with a 
peptic ulcer was provided by the Centre of Biological Engineering of the University of 
Minho (Braga, Portugal).  
 
2.2. Definition of virulence profile  
H. pylori virulence determinants cytotoxin-associated protein (cagA) and 
vacuolating cytotoxin (vacA) encoded by the cagA and vacA genes were accessed by 
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polymerase chain reaction (PCR). Primers VA1F and VA1xR were used to amplify vacA s 
region, resulting in a fragment of 176 bp for type s1 variants and a fragment of 203 bp for 
type s2 variants
21
. To amplify the vacA m region, a mixture of forward primers MF1.1, 
MF1.2, MF1.3, and MF1.4 and reverse primer MR1 was used, resulting in the 
amplification of fragments of 107 and 182 bp for m1 and m2 strains, respectively
22
. The 
presence of cagA was detected with primers CagAF and CagAR, yielding a product of 183 
bp
21
. PCR primers and conditions were as previously described
21,22
. PCR products were 
visualized by electrophoresis on 2% agarose gels as described by Sambrook et al.
23
. 
 
2.3. Bacterial growth in Columbia blood agar  
H. pylori cells isolated from gastric biopsies by recovery to pre-warmed Gelose 
Columbia solid media supplemented with 5% horse blood (bioMérieux, France) and 
incubated at 37ºC for 72 h, on a microaerophilic atmosphere generated by a CampyGen gas 
pack (Oxoid, United Kingdom). Cells were subcultivated after 48 h incubation periods in 
the conditions described above.  
 
2.4. Bacterial growth in F12 liquid media  
Cells were grown on Ham’s F12 defined liquid media without the addition of 
enhancing growth factors. The medium was inoculated with cellular extracts obtained from 
CBA growth media. Cells were allowed to grow for 24 h in a glass flask under 
microaerophilic atmosphere under gentle stirring at 37ºC. 
 
2.5. Purity assessment of bacterial growth  
Purity assessment was assured by using a highly specific peptide nucleic acid probe 
in a fluorescence in situ hybridization procedure, according to the protocol described by 
Guimaraes et al.
24
. For every experiment a negative control was performed simultaneously 
where all the steps described above were carried out but where no probe was added during 
the hybridization procedure. Microscopy visualization was performed using an Olympus 
BX51 (OLYMPUS Portugal SA, Porto, Portugal) epifluorescence microscope equipped 
with one filter sensitive to the Alexa fluor 594 signalling molecule attached to the PNA 
probe (Excitation 530 to 550 nm; Barrier 570 nm; Emission LP 591 nm).  
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 2.6. Extraction and purification of cell-surface glycans 
Cell-surface glycans were isolated from cells using the hot phenol:water extraction, 
according to Westphal and Jann
25
. The aqueous layer was dialyzed against distilled water 
using a 1,000 Da cut-off membrane and lyophilized. The resulting material was fractioned 
by Gel Permeation/Adsorption Chromatography (GPC) on a polyacrylamide Bio-Gel P-6 
(Bio-Rad) (fractionation range: 1,000-6,000 Da) (1.0 m length and 1.0 cm diameter) 
column using distilled water as the eluting solvent at constant flow rate of 0.33 mL/min. A 
portion of the initial material was suspended in degassed distilled water and introduced in 
to the column. Fractions of 2.8 mL were collected. The mass content in the fractions was 
estimated on evaporative light scattering detector SEDEX55 (SEDERE France) and further 
assayed for total sugars with the phenol-H2SO4 method
26
. Exclusion and total volume were 
calibrated with blue dextran 2,000 kDa and glucose, respectively.  
 
2.7. Sugars composition and linkage analysis 
Sugars composition analysis was performed by the alditol acetate method as 
described by Harris et al.
27
. The hydrolysis was done in 4 M trifluoroacetic acid (TFA) at 
100ºC for 3 h, followed by reduction with NaBH4 and subsequent acetylation with acetic 
anhydride in the presence of 1-methylimidazole. Alditol acetates derivatives were analyzed 
by gas chromatography mass spectrometry (GC-MS), performed in an Agilent 
Technologies 6890N Network Gas Chromatograph connected to an Agilent 5973 Selective 
Mass Detector. The GC was equipped with a DB-1 capillary column (30 m length, 0.32 
mm internal diameter, and 0.25 µm film thicknesses). The samples were injected in 
splitless mode (time of splitless 1.00 min), with the injector and detector operating at 220 
and 230ºC, respectively, using the following temperature program: 100ºC (1 min) → 
150ºC at 5ºC min
-1
 (8 min) → 159ºC at 0.5ºC min
-1
 (5 min) → 250ºC at  5ºC min
-1
 (2 min) 
→ 320ºC at 2ºC min
-1
 (2 min). The carrier gas (He) had a flow of 1.7 mL min
−1
, with an 
average linear velocity of 47 cm.s
-1
 and a solvent delay of 9 min. The column head 
pressure was 5.34 psi. The mass spectrometer was operated in the electron impact mode at 
70 eV, scanning the mass range m/z 40–500 and performing 3.18 scans s
-1
.  
Linkage analysis was carried out by methylation with NaOH/CH2SO/CH3I, as 
described by Ciucanu and Kerek
28
. The methylated polysaccharides were hydrolyzed with 
TFA 2M at 121ºC for 1 h, reduced by NaBD4, and acetylated with acetic anhydride in the 
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presence of 1-methylimidazole. The partially methylated alditol acetates were analyzed by 
GC-MS using the chromatographic conditions described previously, using the following 
temperature program: 45ºC (5 min) → 140ºC at 10ºC min
-1
 (5 min) → 170ºC at 0.5 ºC min
-
1
 (1 min) → 280ºC at 15ºC min
-1
 (5 min)  
 
2.8. Protein quantification 
Total protein content was estimated by the bicinchoninic acid (BCA) method using 
bovine serum albumin (BSA) as standard, according Smith et al.
29
. 
 
2.9. Affinity chromatography using Polymyxin-B  
Mannose-rich material isolated on the void volume of the Bio-Gel P6 column was 
fractionated based on its affinity to Polymyxin-B. Fractionation was performed according 
to Arafat et al.
30
 in a Polymyxin B-agarose (Sigma Chemical Co.) column with 0.5 cm 
length and 0.25 cm diameter, operated at 5ºC a constant flow rate of 0.2 mL.min
-1
. The 
resin was equilibrated with an endotoxin-free 0.1 M ammonium bicarbonate buffer pH 8.0. 
The sample was dissolved in the buffer to a final concentration of 0.5 mg.mL
-1
, centrifuged 
to remove suspended particles and the resulting supernatant was loaded into the column. 
Non-retained material was recovered by elution with with endotoxin-free buffer and the 
retained material recovered by elution with 1% sodium deoxycholate in buffer endotoxin-
free solution.  
 
2.10. Affinity chromatography using a Concanavalin-A  
Mannose-rich material isolated on the void volume of the Bio-Gel P6 column was 
fractionated based on its affinity to the Concanavalin A lectin. Fractionation was 
performed on a Concanavalin A (Conc A) from Canavalia ensiformis (Jack Bean) agarose 
conjugate (Sigma) column with 0.5 cm length and 0.25 cm diameter, operated at 5ºC a 
constant flow rate of 0.33 mL/min. Prior to elution the column was pre-washed with a 
wash solution composed of 1 M NaCl, 5 mM MgCl2, 5 mM MnCl2, and 5 mM CaCl2 and 
equilibrated with a buffer solution of 20 mM Tris 0.5 M NaCl at pH 7.4. The sample was 
dissolved in the buffer to a final concentration of 1 mg.mL
-1
, centrifuged to remove 
suspended particles and the resulting supernatant was loaded into the column. Non-retained 
material was recovered by elution with the buffer and retained material was recovered in a 
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 stepwise elution using 5 mM, 25 mM and 100 mM of methyl-α-D-mannopyranoside in 
buffer solution.  
 
2.11. Gel electrophoresis 
Mannose-rich material isolated on the void volume of the Bio-Gel P6 column was 
fractionated under SDS-PAGE conditions using a 12.5% polyacryamide gel. Following 
protein separation, the gels were stained PAS (periodic acid Schiff) according to Doerner 
and White
31
 to detect the glycoproteins and coomassie for general protein detection. Gel 
images were collected using Gel Doc Translluminator (Gel DOC XR, BioRad). Following 
this, the gel bands were recovered for sugars analysis. 
 
2.12. NMR experiments 
1
H, 
13
C and 
31
P NMR spectra were recorded on a Bruker AMX 600 spectrometer 
equipped with a TXI probe at 310 K and a Varian vnmrs 600 equipped with triple-
resonance (
1
H, 
13
C, 
15
N) cryoprobe and recorded at 310 K. Two-dimensional (2D) NMR 
correlation spectroscopy (COSY), total correlation spectroscopy (TOCSY), nuclear 
Overhauser effect spectroscopy (NOESY) and heteronuclear spin quantum correlation 
(HSQC) spectroscopy were performed using the instrument’s Bruker software. Prior to 
performing the NMR experiments, the samples were lyophilized three times with D2O 
(99.9%). The HOD peak was used as the internal reference at δH 4.761 for 
1
H NMR 
spectroscopy, and orthophosphoric acid (δP 0.0) as the external reference for 
31
P NMR 
experiments. Just before the NMR experiments were carried out, a D2O sample containing 
TMS (δH 0.00) was run to aid in the reference the HOD signal. The DOSY experiment was 
recorded on a Bruker AMX 500 equipped with a BBI probe at 310 K. 
 
3. Results and discussion  
 
3.1. H. pylori 968 clinicopathological and virulence characterization  
H. pylori strain 968 was recovered from a gastric biopsy specimen of a patient with 
peptic ulcer. Polymerase chain reaction (PCR) characterization of this strain virulence 
profile highlighted the presence of cagA, the terminal gene of the cag pathogenicity island 
(PAI). The cag PAI encodes a type IV secretion system through which the CagA protein is 
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injected into host epithelial cells
32
. H. pylori strains containing cagA are associated with 
increased risk of peptic ulcer disease and gastric carcinoma
2,33
. In addition, H. pylori 968 
was also found to carry the s1/m1 type vacA gene. vacA encodes the VacA cytotoxin, a 
protein that induces vacuolization in cultured epithelial cells. H. pylori strains containing 
the s1/m1 genotype, meaning that the signal-region comprises allelic variant s1 and the 
middle-region comprises allelic variant m1, are frequently associated with peptic 
ulceration and gastric carcinoma
2,33
. 
 
3.2. Pre-characterization of H. pylori 968 glycan-rich water extracts  
H. pylori 968 was grown in CBA solid medium and Ham’s F12 liquid medium, 
both without the addition of growth enhancing factors that could constitute external 
sources of polysaccharides. For example, the frequently used fetal bovine serum
34
 contains 
significant amounts of polymeric Man in its composition (data not shown). Cell-surface 
glycans were isolated in the aqueous phase resulting from hot phenol:water extraction 
performed on intact bacterial cells. The sugars composition of these extracts are presented 
in Fig. 1 in terms of µg per mg of dry biomass and correspond to the mean value from 
three independent growth batches. The results show that CBA glycan-rich extracts were 
mainly composed by Gal (2.5 µg/mg), Glc (1.8 µg/mg), GlcNAc (1.7 µg/mg), and Rib (1.0 
µg/mg). Lower amounts (<1 µg/mg) of DD- (0.8 µg/mg) and LD-Hep (0.7 µg/mg), Man (0.6 
µg/mg), Fuc (0.4 µg/mg), Rha (0.1 µg/mg), and traces of Ara were also detected. Rib 
indicates the presence of ribonucleic acids while Fuc, Glc, Gal, GlcNAc, and DD- and LD-
Hep are normally found in H. pylori LPS
14
 forming what appears to be a highly 
heterogeneous fraction. As observed for the solid CBA medium, the carbohydrate material 
present in the Ham’s F12 liquid medium also yield considerable amounts of Rib (3.3 
µg/mg), Gal (2.3 µg/mg), GlcNAc (2.2 µg/mg), and Glc (1.1 µg/mg), and lower content of 
Fuc (0.8 µg/mg), DD- (0.6 µg/mg) and LD-Hep (0.6 µg/mg), Rha (0.2 µg/mg), and Ara (0.1 
µg/mg). However, in this case, the major sugar after Rib was Man (2.6 µg/mg) in a 
concentration approximately five times higher than what was observed in the cells 
recovered from routinely used culture media CBA. The enhanced expression of Man upon 
growth in Ham’s F12 liquid media thus suggests the production of Man-rich glycans.  
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Figure 1. Sugars composition of H. pylori 968 glycan-rich water extracts resulting from 
growth in solid medium (CBA) and Ham’s F12 liquid medium. 
 
Linkage analysis (Table 1) confirmed that the F12 material was mainly composed 
by mannopyranosyl residues consisting of terminal (10.3%), O-2 linked (12.0%), O-2,6 
linked (9.0%) units, and O-6 Man (4.3%). Considerable amounts of O-4 linked Glc (9.6%) 
arising from amylose-like glycans
18
 and O-3 linked Gal (10.1%) and O-4 linked GlcNAc 
(8.5%), recognized as LPS O-chain sugars
14
, were also present. The similar proportion of 
O-3 linked Gal and O-4 linked GlcNAc indicates O-chains exhibiting N-acetyllactosamine 
(LacNAc) moieties [→3)Gal(1→4)GlcNAc(1→]. Equal amounts of terminal Fuc (3.4%) 
and O-3,4 linked GlcNAc (4.0%) residues and the absence of branched Gal residues, also 
suggest the expression of Type 1 Le
a
 and/or Type 2 Le
x
 blood group determinants
14
. The 
presence of LPS was further confirmed by the identification of terminal and O-3 linked 
Glc, O-4 linked Gal, O-7 DD-Hep, and O-2, O-2,7 and O-3,7 linked LD Hep, normally 
observed in the core, and O-6 linked GlcNAc from Lipid A
14
.
  
The Ham’s F12 Man-rich material was then eluted in a Bio-Gel P6 column 
originating a major peak corresponding to the void volume (Mw > 6,000 Da). Linkage 
analysis performed on this partially purified material (Table 1) revealed a slightly Man-
enriched material, mainly resulting from an increase in the percentage of O-2 linked Man. 
Conversely, the overall amounts of O-4 linked Glc decreased significantly, from 10.2% to 
3.5%, denoting that the amylose-like glycans in the original water extracts had a Mw lower 
to 6,000 Da. The percentage of LPS assigned sugars remained mostly unchanged when 
compared with the non-purified material, showing the presence of semi-rough (oligomeric 
O-chain-core-Lipid A) and smooth phenotypes (polymeric O-chain-core-Lipid A).  
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Table 1. Linkage profile of the sugars in glycan-rich extracts from the H. pylori 968 non-
purified material and partially purified material recovered in the void volume of a P6 
column (Mw > 6,000 Da).  
 
Relative Molar Ratio (%) 
 Linkage Type  
non-purified 
 
partially-purified 
   
LPS   
   
O–Chain   
   
T-Fuc 3.4 2.8 
→6) Glc 4.2 7.9 
T-Gal 1.7 3.4 
→3) Gal 10.1 11.9 
T-GlcNAc 1.8 2.5 
→4) GlcNAc 8.5 7.1 
→3,4) GlcNAc 4.0 3.1 
   
Core   
   
*
T-Glc 2.8 3.9 
→3) Glc 1.1 2.2 
→4) Gal 5.9 2.6 
T-DD-manno-Hep 0.2 v 
T-LD-manno-Hep 0.3 v 
→2) DD-manno-Hep 0.5 0.4 
→2) LD-manno-Hep 0.9 0.5 
→3) LD-manno-Hep 0.6 0.4 
→7) DD-manno-Hep 1.0 0.4 
→7) LD-manno-Hep 0.5 0.6 
→3,7) LD-manno-Hep 0.8 0.5 
→2,7) DD-manno-Hep 1.4 0.9 
   
Lipid A   
   
→6) GlcNAc 0.7 0.3 
   
Mannose-rich glycans   
   
T-Man 10.3 10.8 
→2) Man 12.0 19.2 
→6) Man 4.3 3.8 
→2,6) Man 9.0 9.5 
   
Amylose-like glycans   
   
T-Glc
* 
  
→4)Glc 9.6 3.5 
→4,6)Glc 0.6 - 
   
Unassigned Sugars   
   
→2) Ara 0.6 - 
→6) Gal 3.2 2.8 
   
 
Terminal Glc residues can either be addressed to amylose-like polymers or to non-reducing ends of the LPS 
core. v – Vestigial amounts; > 0.5% total sugars. 
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 3.3 NMR studies on partially purified Man-rich glycans 
The 
1
H Nuclear Magnetic Resonance (NMR) spectrum of the Man-rich fraction 
recovered from the P6 Bio-Gel column (Fig. 2) exhibited several resonances in the 
anomeric region δ1H 4.9 to 5.4 ppm thus reflecting the sample high heterogeneity shown by 
linkage analysis (Table 1).  
3.63.84.04.24.44.64.85.05.25.4 ppm
ab
I
II
III
IV
5.4          5.2           5.0 4.8          4.6          4.4           4.2           4.0       3.8           3.6           3.4          (ppm)
1H
A
E
C
B
 
Figure 2. 
1
H NMR spectrum of the Man-rich material recovered in the void volume of a 
P6 column (Mw > 6,000 Da). 
 
Combined data from 2D 
1
H-
13
C HSQC experiments (Fig. 3), linkage analysis 
(Table 1), and available literature
35-38
 resulted in the assignment of the resonances at δ1H/13C 
5.31/101.90 (residue A), 5.12/99.71 (residue B), and 5.05/103.20 (residue C), respectively 
to O-2 Man, O-2,6 Man, and terminal Man, all in α configuration. A weak resonance at 
δ1H-1 4.88 (Residue D in Table 2), resulting from vestigial amounts of α-O-6 Man residues 
(>5%, Table 1), in α configuration
35
, was also observed. Sequential assignment of proton 
signals for spin systems A-D were obtained from the 2D 
1
H-
1
H COSY (results not shown) 
and TOCSY (Fig. 4). 
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(ppm)
ppm
4.654.704.754.804.854.904.955.005.055.105.155.205.255.305.35 ppm
98.0
98.5
99.0
99.5
100.0
100.5
101.0
101.5
102.0
102.5
103.0
103.5
104.0
104.5
105.0
105.5
98.0
99.0
100.0
101.0
102.0
103.0
104.0
105.0
5.30             5.20             5.10              5.00             4.90              4.80             4.70          4.60    
(ppm)
→2)-α-D-Manp (A)
→2,6)-α-D-Manp (B)
→6)-α-D-Manp (E)
T-α-D-Manp (C) 
→3)-β-D-Galp (b)
→3)-α-D-Galp (IV)
Residue I 
→6)-α-D-Manp (III)
 
Figure 3. Anomeric region of the 2D 
1
H–
13
C HSQC spectrum of the Man-rich material 
recovered in the void volume of a P6 column (Mw >6,000 Da). 
 
ppm
4.955.005.055.105.155.205.255.305.35 ppm
3.3
3.4
3.5
3.6
3.7
3.8
3.9
4.0
4.1
4.2
4.3
4.4
4.5
AH1-H2
IH1-H2
AH1-H3
BH1-H2
BH1-H3
BH1-H4
IIH1-H2
IIH1-H3
CH1-H2
EH1-H2
EH1-H3
IIIH1-H2
IIIH1-H3
IIIH1-H4 IVH1-H3
IVH1-H4
3.3
3.4
3.5
3.6
3.7
3.8
3.9
4.0
4.1
4.2
4.3
4.4
4.5
5.35          5.30          5.25          5.20         5.15     5.10         5.05          5.00          4.95
(ppm)
1H
1H (ppm) 
Figure 4 Anomeric region of the 2D 
1
H-
1
H TOCSY spectrum of the Man-rich material 
recovered in the void volume of a P6 column (Mw > 6,000 Da). 
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 The H-6 protons of O-2,6 Man residues have also been assigned from the HSQC 
spectrum (Table 2) based on characteristic downfield shift of Man residues at δ13C 62.30 to 
68.00 ppm upon substitution at the O-6 position
35,38
. The identified resonances have been 
summarized in Table 2 and were found to be in accordance with previous reports
35,36
.  
 
Table 2. 
1
H NMR chemical shifts (ppm) from 2D COSY and 2D TOCSY and 13C 
chemical shifts from HSQC spectra of Man-rich fraction 
 
Residue 
 
 
 
H-1/C-1 
 
 
H-2/C-2 
 
 
H-3/C-3 
 
 
H-4/C-4 
 
 
H-5/C-5 
 
 
H-6/C-6 
 
 
NOE with 
anomeric  
 
 
LPS O-chain 
       
a 
→3)-β-D-Gal 
4.45 
103.03 
3.52 
- 
3.68 
- 
- - - - 
       - 
b 
→4)-β-D-GlcNAc 
 
4.65 
102.56 
3.84 
- 
- - - - - 
 
Mannose moiety        
A 
→2)-α-D-Man 
5.31 
101.99 
4.12 
79.42 
3.98 
71.15 
- - - 
A1 (M); B2 
(W) 
        
B 
→2,6)-α-D-Man 
5.12 
99.71 
4.05 
- 
3.71 
71.02 
3.91 
72.90 
- 
3.91, 3.70 
68.00 
B2 (M); B6 
(S) 
        
C 
T- α-D-Man 
5.05 
103.4 
4.08 
- 
3.85 
71.73 
- 
- 
 
3.90, 3.77 
62.30 
C2 (S); A2 
(W) 
        
D 
→6)-α-D-Man 
4.88 
- 
3.98 
- 
- - - - -  
        
E 
→2)-β-D-Man 
4.92 
101.20 
4.41 
79.33 
3.91 
71.70 
- - - 
D2 (S); D3 
(S); B2 (VW) 
        
 
Other structural motifs        
I 
Unassigned 
Residue 
5.15 
99.99 
3.69 
70.70 
- 
- 
- - - I2 (S); III6 (S) 
        
II 
Unassigned 
Residue 
5.10 
108.7 
4.13 
82.41 
4.00 
84.50 
- - - - 
III 
→6)-α-D-Glc 
5.08 
99.8 
3.36 
72.71 
3.62 
73.81 
- 
- 
- 
3.92, 3.68 
68.01 
III2 (M); IV3 
(VW) 
        
IV 
→3)-α-D-Gal 
5.00 
101.1 
4.27 
70.78 
3.86 
74.20 
- 
 
- - 
IV2 (S); IV3 
(S) 
 
 
Legend: S - strong NOE; M – medium NOE; W – weak NOE; VW – very weak NOE. 
 
Additionally, NOESY experiments (Fig. 5) confirmed the α-configuration of spin 
system A assigned to O-2 Man residue by showing a medium intensity NOE (Nuclear 
Overhauser Effect) between the anomeric proton at 5.31 ppm and its H-2 at 4.12 ppm. 
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Residue A also exhibited a low intensity inter NOE between its H-1 and the H-2 of residue 
B at 4.05 ppm demonstrating that O-2 linked Man are linked to the O-2 position of O-6 
Man residues. It further revealed connectivity between the anomeric proton of residue B at 
5.12 and its H-6 protons at 3.70 and 3.91 ppm highlighting the presence of sequential O-6 
linked B residues. The spin-system C corresponding to terminal Man residues showed a 
single medium intensity inner NOE between its anomeric proton at 5.05 ppm and the H-2 
at 4.08 ppm confirming its α configuration. A NOESY spectrum acquired with a longer 
mixing time (data not shown), even though resulting in strong signal overlapping, allowed 
to detect a very weak connectivity between H-1 and the H-2 of residue A and of residue B. 
This observation led to conclude that O-2 linked α-Man side chains are terminated by α-
Man residues and that some branches exhibit just one terminal residue. Combined 
information from NMR and linkage analysis thus suggest that H. pylori 968 expresses a 
mannan consisting of α-(1→6)-linked mannopyranose units with approximately 80% of O-
2 substituted residues. Side chains were found to be composed by terminal and O-2 linked 
α-Man residues.  
 
ppm
4.904.955.005.055.105.155.205.255.30 ppm
3.2
3.3
3.4
3.5
3.6
3.7
3.8
3.9
4.0
4.1
4.2
4.3
4.4
4.5
3.2
3.9
4.0
4.1
4.2
4.3
4.4
4.5
(ppm)
1H
IIIH1
-IIIH2
(M)
AH1
-AH2
(M)
AH1
-BH2
(W)
BH1
-BH2
(M)
IH1
-IH2
(M)
IH1
-IIIH6
(S)
EH1
-EH2
(S)
EH1
-EH3
(S)
BH1
-BH6
(S)
CH1
-CH2
(M)
EH1
-BH2
(W)
IVH1
-IVH3
(S)
IVH1
-IVH2
(M)
5.30          5.25           5.20           5.15      5.10           5.05           5.00          4.95           4.90 1H (ppm)  
Figure 5. Anomeric region of the 2D 
1
H-
1
H NOESY spectrum of the Man-rich material 
recovered in the void volume of a P6 column (Mw > 6,000 Da). The intensity of the 
observed NOEs are labelled as follows: S: strong; M: medium; W: weak. 
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 The integration of A-C anomeric resonances in the 
1
H NMR spectrum retrieved a 
proportion of O-2, O-2,6, and terminal Man of approximately 1:1:1 suggesting the 
existence of a repetitive unit in this mannan. However, the proportion between α-Man 
residues calculated from the 
1
H NMR spectrum revealed significantly lower amounts of O-
2 linked Man residues than that shown by linkage analysis (Table 1). A residue E could 
also be assigned to the resonances at δH1/13C 4.92/101.25 ppm and showed in the 
TOCSY/HSQC spectra δH2/C2 at 4.41/79.33 ppm and δH3/C3 at 3.91/71.71 ppm. 
Furthermore, the NOESY spectrum (Fig. 5) exhibited a strong H-1/H-2 inner and inner 
NOE and a strong H-1/H-3 inner NOE. These assignments are consistent with previous 
reports for inner chain O-2 linked Man residues in β configuration
39,40
. The NOESY 
spectrum of residue E highlighted the connectivity between its anomeric proton and the H-
2 of residue B, revealing that some of the O-6 mannose side chains had O-2 linked β-Man 
residues.  
The NMR studies also showed an array of low intensity signals from 5.50 to 5.34 
ppm assigned to α-Hep from the LPS as well as O-3 and O-4 linked α-Glc residues and 
signals at 4.4 to 4.7 ppm assigned to O-3 linked Gal and O-4 linked GlcNAc residues in β 
configuration, characteristic of O-chains
14,41
.  
Other resonances were observed in the α-anomeric region of the 
1
H spectrum (Fig. 
1), namely at 5.15 ppm (residue I) exhibiting a carbon chemical shift of 99.95 ppm (Fig. 
3). However, the anomeric region of the COSY and TOCSY (Fig. 2) spectra showed for 
this residue a single cross-peak with the H-2 proton at 3.69 ppm. The strong signal 
overlapping observed in the ring region prevented the identification of other inner-ring 
protons and the absence of other cross-peak further compromised its identification. 
Another unassigned low intensity resonance was detected at 5.10 ppm (Residue II in Table 
2) and revealed a highly deshielded C1 chemical shift at 108.7 ppm (data not shown). Two 
additional strong resonances were detected at δ 5.19 ppm and 5.00 ppm and assigned, 
based on its anomeric chemical shifts and linkage analysis, to α-O-6 linked Glc (residue 
III) and α-O-3 linked Gal (residue IV) respectively. Still, it should be pointed out the 
considerable shift upfield exhibited by the H-2 proton of residue O-6 in relation to a linear 
O-6 linked structure
42
. Additionally, the NOESY spectrum (Fig. 4) exhibited a cross-peak 
between the anomeric proton of residue I and H-6 protons of residue II at 3.92 ppm and 
3.68 ppm confirming both the assignment of residue II to O-6 Glc and the connectivity 
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between the two residues. It also showed a weak intra-residue NOE between the H-1 of 
residue II and the H-3 of residue III (Table 2) therefore confirming the assignment of 
residue III to O-3 Gal and revealing that residue II is linked to the O-3 position of residue 
III. In addition, the NOESY also highlighted the existence of contiguous O-3 linked α-Gal 
residues by showing a strong H-1/H-3 NOE at 5.00/3.85 ppm in addition to the H-1/H-2 
inner NOE at 5.00/4.27 ppm (Fig. 5). Interestingly, the integration of the anomeric protons 
of residues I, II, and III in the 
1
H NMR spectrum (Fig. 2) revealed a proportion of 
1.0:1.0:1.5, thus consistent with the observation of sequential O-3 linked α-Gal residues, 
also seen by linkage analysis (Table 2). These observations thus suggest the following 
structural motif: α-Residue I-(1→6)-α-D-Glc-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→. The 
experimental proton and carbon chemical shifts recovered from the COSY, TOCSY, and 
HSQC spectra for residues II and III (Table 2) matched the theoretical simulation for the 
oligosaccharide sequence →6)-α-D-Glc-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→ using 
CASPER
45
. This calculation revealed a low overall error of 6.38 ppm between the 
predicted and experimental data further confirming the mentioned assignment. However, 
the NOESY spectrum revealed no connectivity between the described structural motif and 
the mannan moiety or LPS related signals.  
 
3.4. Purification of mannose-rich glycans using polymyxin-B  
The H. pylori 968 Man-rich fraction isolated in the void volume of the Bio-Gel P6 
column was fractionated according to its ability to bind to the amphiphilic polypeptide 
polymyxin-B, an antibiotic recognized for its affinity for LPS
43,44
. The starting material 
(Table 3) contained 24% of proteins and 36% of sugars. Its sugars composition was in 
accordance with linkage analysis (Table 1) by revealing a high percentage of Man (40% of 
Man) and lower amounts of LPS (19% of Gal, 13% of GlcNAc, and 2% of Fuc, DD-Hep, 
and LD-Hep), amylose-like glycans (15% Glc), and ribonucleic acids (6% Rib). This 
material was then loaded into an agarose immobilized polymyxin-B column and 
approximately half, composed of 33% of proteins and 28% of sugars, showed no affinity to 
the column. The non-retained fraction (Table 3) was found mainly composed of Man 
(46%), although other sugars were present. The absence of Fuc, DD- and LD-Hep residues 
was indicative that the polymyxin B column successfully retained the LPS moiety. The 
non-retained material was found not significantly enriched in Man when compared with 
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 the starting material, which shows that some Man containing molecules interacted with the 
column. Conversely, the material recovered from the column using sodium deoxycholate 
(Table 3) was mainly composed by LPS (22% Gal, 23% GlcNAc and ~4% of Fuc, DD- and 
LD-Hep). However, both the 1% and 5% sodium deoxycholate eluted material still yielding 
considerable percentages of Man (16-27%), Glc (13-23%), and Rib (3-10%). Therefore, 
even though the bulk of Man containing molecules revealed no affinity to polymyxin-B, 
these results demonstrate its presence among LPS-rich material. Such behaviour shows the 
amphiphilic behaviour of some of the Man-rich molecules and raises the doubt about of the 
existence of a Man moiety in the LPS. In addition, the detection of proteins in all fractions 
may result from a possible protein-carbohydrate association.  
 
3.5. Purification of mannose-rich glycans using concanavalin A  
H. pylori mannose-rich fraction isolated in the void volume of the Bio-Gel P6 
column (Table 1) was fractionated according to its ability to bind concanavalin A, a lectin 
recognized to bind to terminal α-D-mannosyl and α-D-glucosyl
45
 residues.  
The starting material for this experience was found to have a similar composition to 
the one used for polymyxin-B essays (Table 3), however it contained a lower percentage of 
sugars (21%) and higher protein content (32%). Elution through the agarose immobilized 
concanavalin A column originated a sugars-poor (7% of sugars) non-retained fraction 
yielding 23% of proteins. Sugars analysis highlighted that the sugars moiety was almost 
exclusively composed of ribonucleic acid (60% Rib) and residual amounts of Man (11%), 
Gal (13%), and GlcNAc (9%). Moreover, the non-retained fraction yielded approximately 
39% of the starting material thus demonstrating that the bulk material showed affinity to 
concanavalin A.  
The retained fraction was recovered in a stepwise elution using 5 mM, 25 mM, and 
100 mM methyl-α-D-mannopyranoside. The main retained fraction yielding 27% of the 
initial material. It revealed a high percentage of proteins (31%) and low amount of sugars 
(17%), mainly Man-rich material (39%) but also LPS (25% Gal, 9% GlcNAc, 4% Fuc, 3% 
LD-Hep, and 2% DD-Hep) and amylose-like glycans (18% Glc). Conversely, the 25 mM 
methyl-α-D-mannopyranoside fraction (19% of the starting material) showed 26% of 
proteins and a high percentage of sugars (45%), 55% of which Man and 21% of Glc, 17% 
of Gal, and 7% of GlcNAc. The absence of Fuc and traces of Hep revealed a LPS free 
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material implying a lack of connectivity between the Man-rich glycans and the LPS, as 
previously suggested upon fractionation in the polymyxin B column. Interestingly, this 
fraction showed a proportion between Man:Glc:Gal:GlcNAc of approximate 4:2:2:1 thus 
similar to the one observed in the LPS-free material non-retained by polymyxin-B (Table 
3). This observation suggests a common structural origin for these sugars. The remaining 
material was recovered with 100 mM methyl-α-D-mannopyranoside and resulted in a 
fraction with 32% of sugars and 19% of proteins. Contrasting with the 25 mM obtained 
material, it showed to be mainly composed of LPS and low amounts of Man (9%). 
Furthermore, it contained significant amounts of Fuc (9%) which denotes a high 
expression of Le determinants as well as DD- (9%) and LD-Hep (11%) residues, suggesting 
a prevalence of semi-rough LPS phenotypes. The strong interaction of this LPS forms with 
concanavalin A can be most likely explained by the existence of terminal α-Glc and Hep 
residues in a manno configuration
 
at the LPS core
14
.  
 
3.6. SDS-PAGE/GC-MS evaluation of protein-carbohydrate associations  
 A portion of the Man-rich material isolated in the void volume of the Bio-Gel P6 
column and used as starting material for polymyxin-B essays was fractionated under SDS-
PAGE conditions. To evaluate possible protein-carbohydrate associations, the gels were 
stained with coomassie for general protein detection and periodic acid Schiff (PAS) to 
detect the glycosidic moiety
46
. Both stainers allowed the distinction of five bands (Fig. 6), 
corresponding to the non-migrated material (>100 kDa), 36 kDa, 32 kDa, 16 kDa, and 12 
kDa, thereby showing that all fractions exhibit proteins with carbohydrate domains. These 
bands were then removed from the gel and were submitted to sugars analysis (Table 3). To 
our knowledge, this is the first report demonstrating the feasibility of performing neutral 
sugars analysis directly in SDS-PAGE bands, although colorimetric methods for detection 
of uronic acids and total sugars have been already performed
47
. Sugars analysis of the non-
migrated material showed high amounts of GlcNAc (28%), Gal (26%), 9% of Fuc and 6% 
of DD- plus LD-Hep, leading to conclude that it was mainly composed of high-molecular 
weight smooth-type LPS. In addition, the presence of 20% of Glc might be indicative of 
polymeric amylose-like glycans while the 5% of Rib residues has its origin in bacterial 
RNA. However, the amount of Man in this band was 5%, thus considerably low, 
suggesting that the bulk of the Man-rich material has a molecular weight lower than 100 
  
 
H. pylori cell-surface mannan 
111 
 
 
 
 kDa. Conversely, the 36 kDa band presented Man as its main sugar (37%), even though 
also yielding 45% of sugars from LPS. These results also highlight that both the non-
migrated material and the 36 kDa fraction are a heterogeneous mixture of Man-rich 
glycans, LPS, and proteins. As it was previously observed in the 36 kDa band, the nearby 
fraction at 32 kDa also presented Man as main sugar (44%) but it was found devoid of 
LPS. Furthermore, it also contained approximately 24% of Glc and Gal as well as 9% of 
GlcNAc revealing a proportion of 4:2:2:1 of Man:Glc:Gal:GlcNAc. Interestingly, similar 
proportions of these sugars have been also observed in other Man-rich LPS-free fractions, 
namely the non-retained material from polymyxin-B and 25 mM methyl-α-D-
mannopyranoside eluted material from concanavalin A columns (Table 3). These 
observations further reinforce the existence of a mannose-rich glycan containing a proteic 
domain and lower amounts of Glc, Gal, and GlcNAc in its composition. Furthermore, the 
lower molecular weight material in the band at 16 kDa also corresponded to a mixture of 
Man-rich material and LPS. However, its sugars composition revealed high percentages 
core-belonging DD- (12%) and LD-Hep (14%) indicating the presence of semi-rough LPS. 
Like the band at 36 kDa, the band at 12 kDa also did not exhibit LPS. However in this case 
the main sugars were Glc (40%) and Gal (46%) while Man corresponded only to 10% of 
the total sugars.  
12 kDa
16 kDa
32 kDa
36 kDa
Non-migrated 
(>100 kDa)
Coomassie PAS
 
Figure 6. SDS-PAGE of H. pylori 968 partially purified material recovered in the void 
volume of a P6 column (Mw >6,000 Da). Two of the replicates were revealed with 
coomassie and two with PAS
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3.7. Linkage analysis on concanavalin A Man-rich fractions  
 The Man-rich fractions recovered from the concanavalin-A column were evaluated 
in relation to their glycosidic linkage profile (Table 4). The linkage pattern observed for 
the 5 mM methyl-α-mannopyranoside eluted fractions confirmed a heterogeneous mixture 
of Man-rich material, LPS, and amylose-like glycans previously suggested by sugars 
analysis (Table 3). However, it showed a lower percentage of O-2 linked Man (8.0%) 
residues when compared with the starting material (19.2%, Table 1) while the percentage 
of the other residues remained mostly unchanged. This observation further suggests that 
some of the mannan branches are single Man residues. In addition, the O-6 mannan 
backbone in this fraction exhibited a mean percentage of branching residues of 70%, thus 
lower than what was found in the starting material (80%). The LPS moiety in this fraction 
was composed by more than 62% of O-chain sugars; in particular O-3 linked Gal and O-4 
GlcNAc. Like in the previous fraction, the 25 mM methyl-α-mannopyranoside eluted 
fraction also presented Man as main sugar. However, its mannans showed higher 
percentages of terminal and O-2,6 Man residues (~22%) and similar amounts of O-6 
(5.1%) Man residues, therefore showing a higher branching degree, around 80%. It should 
also be pointed out that the high degree of O-6 substituted D-mannopyranosyl residues 
(26.7%) is known to inhibit the interaction with concanavalin A
48
. However, this effect is 
thought to be strongly compensated by the high percentage of α-terminal residues (22.4%) 
thus explaining the affinity of these mannans to concanavalin A. In addition, this fraction 
contained 7-10% of terminal and O-6 linked Glc and O-3 Gal and lower percentages (<5%) 
of O-3 and O-4 Glc, terminal and O-6 linked Gal and terminal and O-4 linked GlcNAc that 
had been assigned to the LPS moiety in LPS-containing fractions. Due to the absence of 
LPS in this fraction these sugars should be referred as unassigned (Table 4) and a possible 
association with the mannan moiety may be though to occur. Contrasting with the previous 
two fractions, the material with higher affinity to Concanavalin A was found to be 
composed mainly by LPS, thus confirming what had been suggested upon sugars analysis 
(Table 3). The LPS moiety contained over 40% of core material, in particular DD- and LD-
Hep residues as well as terminal Glc (5.8%), O-3 Glc (4.6%), and O-4 Gal (4.8%), 
revealing low molecular weight LPS. The high percentage of terminal Glc (5.8%) and the 
presence of Hep residues in a manno configuration is though to be responsible by the 
observed high affinity to Concanavalin A.  
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Table 4. Linkage profile of the sugars observed in H. pylori 968 fractions showing affinity 
to concanavalin A. 
 
Relative Molar Ratio (%) 
 
 
[methyl-α-D-mannopyranoside] 
 
Linkage Type 
 
5 mM 
 
25 mM 100 mM 
    
LPS    
    
O–Chain    
    
T-Fuc 3.0 - 7.0 
→6) Glc 9.0 - 2.4 
T-Gal 1.9 - 3.5 
→3) Gal 10.7 - 17.3 
T-GlcNAc 0.3 - 4.5 
→4) GlcNAc 5.0 - 8.9 
→3,4) GlcNAc 1.5 - 5.4 
    
Core    
    
*
T-Glc 6.2 - 5.8 
→3) Glc 1.1 - 4.6 
→4) Gal 6.3 - 4.8 
T-DD-manno-Hep v - 0.7 
T-LD-manno-Hep v  0.9 
→2) DD-manno-Hep 0.3 - 1.2 
→2) LD-manno-Hep 0.9 - 6.0 
→3) LD-manno-Hep 0.6 - 2.8 
→7) DD-manno-Hep 0.9 - 3.9 
→7) LD-manno-Hep 0.8 - 2.9 
→3,7) LD-manno-Hep 0.8 - 2.2 
→2,7) DD-manno-Hep 1.2 - 2.5 
    
Lipid A    
    
→6) GlcNAc 1.0 - - 
    
Mannose-rich glycans    
    
T-Man 11.4 22.4 1.4 
→2) Man 8.0 10.2 10.9 
→6) Man 4.8 5.1 - 
→2,6) Man 11.5 21.6 1.2 
    
Amylose-like glycans    
    
T-Glc
* 
- 9.1 - 
→4)Glc 8.1 4.2 0.3 
→4,6)Glc - - - 
    
Unassigned Sugars    
    
→3) Glc - 2.5 - 
→6) Glc - 6.8 - 
T-Gal  2.3  
→4) Gal - 0.8 - 
→3) Gal - 10.1 - 
→6) Gal 4.7 2.0 - 
T-GlcNAc - 1.5 - 
→4) GlcNAc - 1.4 - 
    
 
*
 Terminal
 
Glc residues can either be addressed to amylose-like polymers or to non-
reducing ends of the LPS core.v – Vestigial amounts; > 0.5% total sugars. 
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 In addition, the O-chain moiety, formed by LacNAc units (17.3% of O-3 Gal and 8.9% of 
O-4 GlcNAc), exhibited the highest degree of fucosylation (7.0% of Fuc and 5.4% of O-
3,4 GlcNAc) among the three fractions. Conversely, the Man content in this fraction did 
not exceeded 15% (Table 3 and Table 4), prevailing O-2 linked Man (~80% of the total 
Man) in relation to the other Man residues. Also, no O-6 residues were detected, revealing 
a 100% substituted O-6 mannan exhibiting elongated side chains of O-2 Man residues.  
 The structural diversity observed for the mannan moiety throughout the three 
studied fractions further suggests the absence of a structure formed by repeating blocks but 
rather a random organization showing different branching degrees and side chain 
extensions and even substitution.  
 
3.8. Diffusion Ordered Spectroscopy and 
31
P NMR studies on concanavalin A Man-
rich fractions 
The Man-rich fractions recovered from the concanavalin A column with 5 mM and 
25 mM methyl-α-mannopyranoside were studied by Diffusion Ordered Spectroscopy 
(DOSY) to evaluate a possible association between the mannan moiety and other structural 
motifs. The DOSY spectra (Fig. 7) exhibits in the x-axis the 
1
H NMR signals pointing out 
the anomeric resonances of Man residues A-C and E (Table 2) and in the y-axis the 
diffusion coefficient. The spectrum of the 5 mM fraction (Fig. 7a) was characterized by a 
significant dispersion of the proton signals along the y-axis (0.1 to 3.0 µm/s) highlighting 
the structural heterogeneity suggested by sugars (Table 2) and linkage analysis (Table 4). 
Even tough the spectrum in Fig. 7a exhibited strong signal overlapping in the anomeric and 
ring regions, it was still possible to observe that the signals from residues A-C and E 
exhibited the same diffusion coefficient (~0.3 µm/s). However, other resonances in the α-
anomeric region from 5.13-4.88 ppm have also shown similar diffusion coefficients 
suggesting a possible association with the Man moiety. Conversely, the DOSY spectrum of 
the 25 mM fraction (Fig. 7b) revealed for all the 
1
H NMR signals a similar diffusion 
coefficient around 2.5 µm/s. This value also demonstrated that the Man-rich glycans in this 
fraction have a lower Mw than the ones observed in the material with lower affinity to 
concanavalin A. The existence of proteins (Table 3) and also considerable amounts of Glc 
and Gal as well as GlcNAc (Table 3 and Table 4) in this fraction reinforces the thesis of a 
heteropolymeric Man-rich glycan, possibly containing a protein domain.  
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Both fractions were also screened for phosphorous content by 
31
P NMR but 
revealed no signs of phosphorylation.  
 
m2/s
5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
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A BC
E
Man-rich 
glycans0.5
1.0
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2.
2.5
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3.5
5.5        5.0          4.5         4.0          3.5          3.0         2.5        2.0          1.5         1.0          0.5 1H (ppm)
a
m2/s
(x10-9)
 
ppm
5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
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A
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E
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4.0
4.5
5.0
5.
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b
 
Figure 7. DOSY analysis of the Man-rich concavalin A retained material eluted with a) 5 
mM and b) 25 mM methyl-α-D-mannopyranoside. 
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 4. Discussion 
The expression of vestigial amounts of Man at H. pylori cell-surface has been long 
postulated
16,19
 and found widespread among several strains
18,19,55
. Despite these 
observations, the structural assignment of H. pylori cell-surface Man has remained 
overlooked, most likely due by its low biological abundance. Based on these 
considerations, the present work engaged in the structural characterization of H. pylori 
Man-rich glycans from wild type strain H. pylori 968 previously recognized by over-
expressing Man
18
. H. pylori 968 was recovered from the gastric biopsy of a Portuguese 
patient diagnosed with a peptic ulcer and characterized as carrying virulence markers 
cagA
+
 and vacA
+
. This virulent strain was cultivated in routinely used CBA
17
 and also in 
Ham’s F12 liquid medium, a medium known by its capability to overcome H. pylori high 
fastidiousness
34,54
, i.e. difficult to culture outside the human reservoir
56
. Cultivation in F12 
liquid medium has been shown to promote the expression in vitro of cell-surface 
phenotypes similar to those observed in vivo
18
. Our work also shows that this medium also 
enhances the production of Man by H. pylori cells when compared with CBA. This 
observation suggests that the expression of Man by H. pylori may be considerably higher 
in vivo when compared with long-term laboratory maintained strains.  
The high amounts of Man observed in Ham’s F12 grown cells might be also 
explained by pH changes in the culture medium from an initial pH 6.5 to approximately 
5.0. These variations exert strong influence in gene expression and modulation of the 
activity of the enzymes related with the biosynthesis of GDP-D-Man
52,53
. In H. pylori, 
GDP-D-Man is mainly produced from D-fructose-6-phosphate in a three step pathway
53-55
 
and the first and third steps are catalyzed by a bifunctional phophomannose 
isomerase/GDP-D-mannose phosphorylase, an enzyme only found in bacteria and involved 
in the expression of capsular polysaccharides
55
. GDP-D-Man is the main precursor of 
GDP-L-Fuc used by H. pylori in the fucosylation of LPS O-chains
56 
using a pathway with 
three additional steps
61
. A decrease in pH from 6.5 to 5.0 has been recognized to enhance 
the expression of the wbcJ gene, encoding a protein homolog involved in the conversion of 
GDP-Man to GDP-Fuc
53
. Thus, pH conditions encountered in H. pylori 968 culture 
medium may be considered to favour the fucosylation of LPS O-chains. However, the 
enzymes involved in the conversion of GDP-D-Man into GDP-L-Fuc have been described 
to have optimal pH activities at 6.5 and 8.0, respectively
59
, which may contribute to an 
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increase in the pool of GDP-D-Man residues available for the production of Man-rich 
glycans. It should also be pointed out that GDP-D-Man is also the precursor of other 
activated nucleotides, namely GDP-6-deoxy-D-talose and GDP-D-Rha
60
, which that might 
explain the trace amounts of Rha detected in glycan-rich water extracts.  
Structural studies conducted on the Man-rich glycans recovered from Ham’s F12 
liquid medium led to conclude that H. pylori 968 co-expressed at its cell-surface complex 
Man-rich heteropolymers, LPS yielding partially fucosylated polyLacNAc O-chains units, 
and low amounts of amylose-like glycans. The structural heterogeneity of cell-surface 
water extracts was found to be the major drawback for the characterization of H. pylori 
Man-rich glycans. Moreover, the assignment of lower amounts of Glc, Gal, and GlcNAc to 
this mannan was only possible by combining information from affinity to polymyxin-B 
and concanavalin A, SDS-PAGE and DOSY experiments. In addition, these experiences 
strongly suggest that the mannan moiety is part of a hetepolimeric glycan containing a 
protein domain. However, the low amount of material available resulting from the reduced 
growth rates exhibited by H. pylori hampered a full structural characterization. Still, NMR 
experiments demonstrate that Man-rich glycans are formed by a sugar backbone consisting 
of α-(1→6)-linked mannopyranose units exhibiting up to 80% branching at the O-2 
position and side chains composed of O-2 linked residues. Interestingly, the O-2 side chain 
residues were found to be either in α- or in β-anomeric configuration. Similar mannans has 
been observed in cell-surface of several other microorganisms, namely in the cell wall of 
yeasts such as Candida albicans
56
, Candida catenulate
57
, and Candida sojae
37
, and fungi 
such as Cryphonectria parasitica
36
, or in the form of phosphorylated mannans and 
arabinomannans in mycobacteria
58
. They have further been detected at the cell-surface of 
Gram-positive bacteria like Corynebacterium diphtheriae
38
 and those belonging to the 
genus Kribbella
59
, as well as in exopolysaccharides from Gram-negative Pseudomonas 
syringae pv. ciccaronei
35 
and Porphyromonas gingivalis
61
. However, some structural 
variability was observed mainly in the percentage of branching of the backbone and 
substitution pattern of its side chains. Mannan side-chains similar to the ones of H. pylori 
968, exhibiting both terminal and/or O-2 linked Man in α and/or β configurations have also 
been described in yeasts
39,57
 and Gram-positive
38
 bacteria. However, this is the first report 
of their expression by a Gram-negative bacterium. Moreover, the microorganism mannans 
may present O-3 linked Man, terminal Glc
35
, and α-D-Ara
38,59 
as side chains. The structural 
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 diversity observed may be thought to also occur in H. pylori 968 where considerable 
amounts of unassigned terminal and O-6-Glc and O-3-Gal were systematically found in 
Man-rich extracts.  
Alpha mannans were also observable as O-chains in the LPS of Gram-negative 
enterobacteria Hafnia alvei strain PCM 1223
60
, Citrobacter braakii
62
, Escherichia coli 
serotype O8
63
, and O9
64
 and Klebsiella pneumoniae serotype O5
75
. However, in H. pylori 
968, experimental evidences point towards an association not with lipids but with proteins. 
Furthermore, in the mentioned cases, the mannan backbone was formed by O-2 and O-3 
linked Man residues whereas in H. pylori 968 the backbone is formed by O-6 and O-2,6 
linked Man.  
H. pylori cell-surface mannans seem to be directly implicated in the mediation of 
host-microbial interactions and immunological modulation. In agreement with these 
considerations, proves have been presented that H. pylori cells can interact with the 
mannose-binding lectin (MBL) protein
65
, coded by the MBL-2 human gene, a key 
component in systemic and mucosal innate immunity
66-68
. MBL was found to induce 
bacterial elimination
69,70
 by activating the complement system and to promote 
complement-independent opsonophagocytosis
71
. Besides activating local immune 
responses against the bacteria, the interaction between H. pylori mannans and the MBL 
protein may also exert much influence in the clinical outcome resulting from infection. 
Differences have been extensively explained by a conjugation of aspects, namely bacterial 
virulence markers
72
, host genetic factors
73
, and environmental pressure. Among these, 
mammalian Le blood groups expressed at H. pylori cell surface are recognized has the 
main glycan mediators in the interaction with the host’s immune system. Several studies 
have been pointing out that abnormalities in the MBL protein in H. pylori-positive hosts 
potentiate gastric pathologies such as severe gastric mucosal atrophy
74
, chronic gastritis, 
and gastric cancer
75,76
. MBL deficiencies
77
 are common among many human 
populations
73,78
. By correlating genotypic variations in MBL proteins and particular 
clinical presentations, the mentioned studies highlight the importance of mannose-
mediated phenomena in pathogenesis. Furthermore, they demonstrate the existence of 
other cell-surface glycans in addition to Le determinants acting as players in bacteria-host 
interactions turning the spotlight towards the up until now overlooked H. pylori cell-
surface mannans.  
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H. pylori mannans are also thought to have an antigenic potential resulting from 
their capability of activating and triggering immune responses
73
 making then potential 
candidates to include in a carbohydrate-based vaccine. Furthermore, they overcome some 
of the limitations shown by other glycans found in H. pylori cell-surface, namely amylose-
like polysaccharides widespread through nature and LPS that are known to express 
mammalian Lewis histo-blood group determinants
14
.  
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Abstract 
 
The present work concerns Helicobacter pylori virulent strain PTAV79 isolated 
from a gastric biopsy specimen of a patient with gastroesophageal reflux disease. This 
strain was recognized to yield virulence markers cytotoxin-associated gene (cagA) and 
vacuolating cytotoxin (vacA) and was found to express semi-rough cell-surface 
lipopolysaccharides (LPS; oligomeric O-chain-core-Lipid A~cell) with O-chains 
composed of LacNAc (i-antigen) units. The absence of fucosylated Lewis blood groups 
has been reported to negatively influence the bacteria’s capability of colonizing the human 
stomach and promoting gastric malignancies. However, the results from H. pylori 
PTAV79 suggest that i-antigen phenotype did not compromise gastric colonization. This 
strain also found expressed high amounts of stearic acid and amylose-like glycans that 
were observed linked to glycerol (Gro) residues. Furthermore, Gro was detected carrying 
phosphodiester moieties suggesting the existence of glycerophospholipids. These 
structures are thought to act as anchoring points of amylose-like glycans to the outer cell-
surface lipidic bilayer. Fine analytical and spectroscopic techniques, namely GC-EI-MS, 
FTIR, ESI-MS, MALDI-TOF-MS and NMR further permitted the identification of an 
unusual polysaccharide composed of [→3)-α-D-GlcA(1→4)-α-D-Glc(1→] repeating units 
generally known as aldobiouronic acid. In addition, a proteomic approach allowed the first 
report of a non-flagelar H. pylori glycoprotein exhibiting O-glucuronosyl serine residues.  
 
Keywords: Helicobacter pylori, bacterial antigens, lipopolysaccharides, Lewis blood 
groups, amylose. 
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Introduction 
Helicobacter pylori is a microaerophilic, spiral-shaped, flagellated Gram-negative 
bacterium that colonizes the human gastric mucosa. This microorganism is considered one 
of the most widespread bacterial pathogens with a prevalence of up to 90% in developing 
countries and a worldwide infection rate of around 50% (Farinha and Gascoyne 2005, 
Kusters et al. 2006). 
Infection generally occurs during childhood and induces a strong local immune 
response in the gastric mucosa (Ferrero 2005). This response is not only ineffective in 
eliminating the bacterium from its preferred niche, but may actually contribute to the 
development of gastric lesions (Moran 2008). H. pylori infection leads to chronic gastritis 
in all individuals, a condition that will persist for the host lifetime if infection is not treated. 
An estimated 15% to 20% of infected individuals will develop more severe disease such as 
peptic ulcer disease, gastric carcinoma, and mucosa-associated lymphoid tissue (MALT) 
lymphoma (Montecucco and Rappuoli 2001, Sugiyama 2004, Ferreira et al. 2008). 
Furthermore, the close relationship between infection and gastric carcinoma (Graham 
2000, Santacroce et al. 2008, Mbulaiteye et al. 2009) has granted H. pylori the recognition 
as a class 1 (definitive) human carcinogen (IARC Working Group 1994) by the World 
Health Organization. 
Glycans on bacterial cell envelope have been long recognized as key mediators in 
the definition of host-microbial interactions and as main legislators in the establishment of 
symbiotic or pathogenic behaviours (Hooper and Gordon 2001). Like other Gram-negative 
bacteria, H. pylori expresses cell-surface lipopolysaccharides (LPS) that comprise, when 
biosynthetically complete, three structural domains: a polysaccharide (PS) known as O-
chain, an oligosaccharide termed core, and a fatty-acid rich endotoxin moiety named lipid 
A (LPS: O-chain→Core→Lipid A~cell). Monteiro (2001) demonstrated that H. pylori 
expresses elongated O-chains exhibiting fucosylated glycosides analogous to some 
mammalian Lewis histo-blood-groups, namely internal Le
x
 units, with terminal Le
x
 or Le
y
 
and, in some strains, with additional Le
a
, Le
b
, H-1, tumor associated sialyl Le
x
 antigens as 
well as blood groups A and B.  
Bacterial camouflage based host’s molecular mimicry has been pointed out as 
responsible for immune evasion, gastric adaptation and colonization thus contributing to 
the persistence of infection (Appelmelk et al. 2000, Moran 2008, Kobayashi 2009). In 
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 addition, Le antigens also play a role in bacterial adhesion to gastric cells through galectin-
3, a gastric receptor for polymeric Le
x 
(Fowler et al. 2006, Moran 2008). On the other hand 
the expression of fucosylated Le antigens has a strong influence in innate immune 
recognition of H. pylori by surfactant protein D (Moran et al. 2006). Also Le antigen 
expression affects both the inflammatory response and T-cell polarization that develops 
after infection (Moran 2008). In agreement with these considerations are the reports of 
clinical isolates from asymptomatic hosts lacking Lewis O-chains and expressing either 
elongated DD-heptoglycans (Monteiro et al. 2001) or α-(1→6) glucans (Altman 2003). 
These findings suggest that the presence of Lewis O-chain, even though not absolutely 
required for colonization, might result in the incapability of cells to induce significant 
pathology (Moran 2008). Here we report for the first time an H. pylori wild-type strain 
isolated from a symptomatic patient that expresses non-fucosylated O-chains. 
On the other hand, the continuous increase in antibiotic-resistant H. pylori strains is 
becoming a serious worldwide threat (Vakil 2008) urging the development of alternative 
therapeutic and prophylactic strategies. Considering the proven success of carbohydrate-
based vaccines in dealing with bacterial infections (Vliegenthart 2006) we further engaged 
in the identification and structural characterization of glycan antigen candidates to include 
in a future multivalent vaccine against H. pylori. 
 
Material and methods 
 
Bacterial cultures 
Helicobacter pylori clinical isolate PTAV79 was obtained from a gastric biopsy 
specimen of a male patient with gastroesophageal reflux disease.  
 
Definition of virulence profile  
H. pylori virulence determinants cytotoxin-associated protein (cagA) and 
vacuolating cytotoxin (vacA) encoded by the cagA and vacA genes were accessed by 
polymerase chain reaction (PCR). Primers VA1F and VA1xR were used to amplify vacA s 
region, resulting in a fragment of 176 bp for type s1 variants and a fragment of 203 bp for 
type s2 variants (van Doorn et al. 1998a). To amplify the vacA m region, a mixture of 
forward primers MF1.1, MF1.2, MF1.3, and MF1.4 and reverse primer MR1 was used, 
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resulting in the amplification of fragments of 107 and 182 bp for m1 and m2 strains, 
respectively (van Doorn et al. 1998b). The presence of cagA was detected with primers 
CagAF and CagAR, yielding a product of 183 bp (van Doorn et al. 1998a). PCR primers 
and conditions were as previously described (van Doorn et al. 1998a, van Doorn et al. 
1998b). PCR products were visualized by electrophoresis on 2% agarose gels as described 
by Sambrook et al. (1989). 
 
Bacterial growth in Columbia blood agar  
H. pylori cells isolated from gastric biopsies were recovered to pre-warmed Gelose 
Columbia solid media supplemented with 5% horse blood (bioMérieux, France) and 
incubated at 37ºC for 72 h, on a microaerophilic atmosphere generated by a CampyGen gas 
pack (Oxoid, United Kingdom). Cells were subcultivated after 48 h incubation periods in 
the conditions described above.  
 
Bacterial growth in F12 liquid media  
Cells were grown on Ham’s F12 defined liquid media without the addition of 
enhancing growth factors. The medium was inoculated with cellular extracts obtained from 
CBA growth media. Cells were allowed to grow for 24 h in a glass flask under 
microaerophilic atmosphere under gentile stirring at 37ºC, as described by Testerman et al. 
(2001). 
 
Purity assessment of bacterial growth  
Purity assessment was assured by using a highly specific peptide nucleic acid probe 
in a fluorescence in situ hybridization procedure, according to the protocol described by 
Guimaraes et al. (2007). For every experiment a negative control was performed 
simultaneously where all the steps described above were carried out but where no probe 
was added during the hybridization procedure. Microscopy visualization was performed 
using an Olympus BX51 (OLYMPUS Portugal SA, Porto, Portugal) epifluorescence 
microscope equipped with one filter sensitive to the Alexa fluor 594 signalling molecule 
attached to the PNA probe (Excitation 530 to 550 nm; Barrier 570 nm; Emission LP 591 
nm).  
 
 
  
 
H. pylori LPS lacking fucosylated O-chains 
131 
 
 
 
 Extraction and purification of cell-surface glycans 
Cell-surface glycans were isolated from cells using the hot phenol:water extraction 
according to Westphal and Jann (1965). The aqueous layer was dialyzed against distilled 
water using a 1,000 Da cut-off membrane and lyophilized. The resulting material was 
fractioned by Gel Permeation/Adsorption Chromatography (GPC) on a polyacrilamide 
Bio-Gel P-6 (fractionation range: 6,000-1,000 Da) (1 m length and 1.0 cm diameter) 
column using distilled water as the eluting solvent at constant flow rate of 0.33 mL/min. A 
portion of the initial material (approximately 7.5 mg) was suspended in degassed distilled 
water and introduced in the column. Fractions of 2.8 mL were collected. The mass content 
in the fractions was estimated on evaporative light scattering detector SEDEX55 (SEDERE 
France) and further assayed for total sugars with the phenol-H2SO4 method (Dubois et al. 
1956). Exclusion and total volume were calibrated with blue dextran of 2,000 kDa and 
glucose, respectively.  
 
Sugars composition and linkage analysis 
Sugars composition analysis was performed by the alditol acetate method as 
described by Harris et al. (1988). The hydrolysis was done in 4 M trifluoroacetic acid 
(TFA) at 100ºC for 3 h, followed by reduction with NaBH4 and subsequent acetylation 
with acetic anhydride in the presence of 1-methylimidazole. Alditol acetates derivatives 
were analyzed by gas chromatography-mass spectrometry (GC-MS), performed in an 
Agilent Technologies 6890N Network Gas Chromatograph connected to an Agilent 5973 
Selective Mass Detector. The GC was equipped with a DB-1 capillary column (30 m 
length, 0.32 mm internal diameter, and 0.25 µm film thicknesses). The samples were 
injected in splitless mode (time of splitless 1.00 min), with the injector and detector 
operating at 220 and 230ºC, respectively, using the following temperature program: 100ºC 
(1 min) → 150ºC at 5ºC min
-1
 (8 min) → 159ºC at 0.5ºC min
-1
 (5 min) → 250ºC at  5ºC 
min
-1
 (2 min) → 320ºC at 2ºC min
-1
 (2 min). The carrier gas (He) had a flow of 1.7 mL 
min
−1
, with an average linear velocity of 47 cm s
-1
 and a solvent delay of 9 min. The 
column head pressure was 5.34 psi. The mass spectrometer was operated in the electron 
impact mode at 70 eV, scanning the mass range m/z 40–500 and performing 3.18 scans s
-1
.  
Linkage analysis was carried out by methylation with NaOH/Me2SO/CH3I, as described by 
Ciucanu and Kerek (1984). The methylated polysaccharides were hydrolysed with TFA 
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2M at 121ºC for 1 h, reduced by NaBD4, and acetylated with acetic anhydride in the 
presence of 1-methylimidazole. The partially methylated alditol acetates were analyzed by 
GC-MS using the chromatographic conditions described previously, using the following 
temperature program: 45ºC (5 min) → 140ºC at 10ºC min
-1
 (5 min) → 170ºC at 0.5 ºC min
-
1
 (1 min) → 280ºC at 15ºC min
-1
 (5 min)  
Glucuronic acid was determined by reduction of carboxylic groups performed on partially 
methylated samples by an adaptation of the method described by Lindberg and Lönngren 
(1978) and Redgwell and Selvendran (1986). Samples were dissolved in 1 mL 
tetrahydrofuran and reduced with 20 mg of LiAlD4 for 4 h at 65º C. The excess of LiAlD4 
was destroyed by addition of 20 µL of ethanol and 20 µL of water followed by 
neutralization with a 2 M H3PO3 solution. Partially methylated reduced glycosides were 
then extracted with CHCl3/CH3OH (2:1 v/v), evaporated to dryness and hydrolysed with 2 
M TFA at 2M at 121ºC for 1h, reduced with NaBD4, acetylated and analysed as described 
above for linkage analysis.  
 
Partial acid hydrolysis and isolation of oligomeric units  
A portion of fraction A (2.0 mg) and of fraction B (1.5 mg), both resulting from the 
Bio-Gel P6 column, were treated with 100 mM TFA for 30 min at 100º C. After 
hydrolysis, the TFA was evaporated under a steam of N2 at room temperature and the 
resulting material was re-suspended in 200 µL of water and fractionated by Gel 
Permeation/Adsorption Chromatography on a polyacrilamide Bio-Gel P2 (fractionation 
range: 100-1,800 Da) (0.5 m length and 1.0 cm diameter) using degassed distilled water as 
eluent. Fractions of 1.0 mL were collected. The mass content in the fractions was estimated 
by evaporative light scattering detector SEDEX55 (SEDERE France) and the presence of 
sugars was confirmed by the use of phenol-H2SO4 (Dubois et al. 1956). In the case of 
fraction A, some of the non-hydrolyzed material, and corresponding to the void volume, 
was combined, concentrated and re-hydrolyzed with 500 mM TFA for 1 h at 100º C. The 
material resulting from the second hydrolysis was further fractionated in the above 
described conditions. The carbohydrate content of the fractions resulting from acid 
hydrolysis was determined by phenol-H2SO4 method (Dubois et al. 1956) and the protein 
content evaluated by the bicinchoninic acid (BCA) method according to Stoscheck (1990).  
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 Gel electrophoresis and tryptic digestion 
Fraction A was separated using the tricine system according to Schagger (2006). 
Following protein separation, gel was stained using colloidal coomassie and periodic acid 
schiff (PAS) to detect the presence of glycoproteins (Doerner and White 1990). The 
protein bands were excised with a pipette tip from the gel and transferred into an 
eppendorf. The gel pieces were washed three times with 25 mM NH4HCO3 /50 % ACN, 
one time with ACN and dried in a SpeedVac (Thermo Savant). Twenty five µL of 10 
µg/mL sequence grade modified porcine trypsin (Promega) in 25 mM NH4HCO3 was 
added to the dried gel pieces and the samples were incubated overnight at 37ºC. Extraction 
of tryptic peptides was performed by addition of 10% formic acid /50% ACN three times 
being lyophilized in a SpeedVac (Thermo Savant). 
 
Nano-HPLC  
HPLC analyses were performed using an Ultimate 3000 ‘‘Dionex”. Twenty µL of 
each sample (2 µg of peptide extract) were injected onto a C18 trapping column (Zorbax 
300SB-C18, 5 µm particle size, 5 x 0.3 mm, Agilent Technologies) using an auto sampler. 
The sample was washed over the trapping column for 3 min with 95% buffer A (water, 
0.1% TFA), 5% Buffer B (ACN, 0.1% TFA) at a flow rate of 30 µL/min. Flow was then 
reversed over the trapping column, and sample was eluted onto a 150 mm × 75 µm Zorbax 
300SB capillary analytical C18 column with 3.5 µm particle size (Agilent Technologies) at 
a flow rate of 0.3 µL/min. A linear gradient of 5% Buffer B to 55% Buffer B is run over a 
period of 35 min. The column was then washed with a 3 min gradient from 55% to 90% 
Buffer B, followed by a 5 min hold at 90% Buffer B. The column was then re-equilibrated 
in 5% Buffer B prior to future analyses. The peptides eluting off the monolithic capillary 
column were directly deposited onto 384-well MALDI plates at 20 s intervals for each spot 
using Probot (LcPackings) adding 170 nL of alpha-cyano-hydroxycinnamic acid (α-
CHCA, Sigma) (20mg/ml in 70% acetonitrile/0.1% TFA with the addition of 10 fmol of 
Glu-fibrinopeptide as internal standard).  
 
ESI-MS  
Partially hydrolyzed fractions resulting from treatment of fraction A and fraction B 
with TFA were studied by ESI-MS in a Q-TOF (Micromass) instrument. Prior to ESI-MS 
analysis fraction B acid released oligosaccharides were exposed to a Dowex cation-
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exchange resin to remove the excess of cations. Samples were introduced into the 
electrospray source at a flow rate of 10 µL min
-1
. The cone voltage was set at 35 V and 
capillary voltage at 3 kV. Source temperature was at 80°C and desolvation temperature at 
150°C. Tandem mass spectra (MS/MS) were obtained by collision-induced decomposition 
(CID), using argon as the collision gas (measured pressure in the Penning gauge ~6 x 10
-5
 
mbar). In MS and MS/MS experiments, TOF resolution was set to ~9,000 (FWHM). The 
collision energies used for sodium adducts were 30 eV for all studied compounds. Data 
acquisition was carried out with a MassLynx 4 data system. 
 
MALDI-TOF-MS 
Material resulting from acid hydrolysis of fraction A with 500 mM TFA for 1 h at 
100º C was analyzed by MALDI-TOF MS on 4800 MALDI-TOF/TOF analyser (Applied 
Biosystems, Fostercity, CA). The sample was mixed with α-CHCA in a proportion 1:1 and 
0.5 µL of analyte:matrix mixture was placed on to the MALDI plate and left to dry at room 
temperature. The MS spectra were acquired on a MALDI-TOF/TOF mass spectrometer 
(4800 Proteomics Analyzer, Applied Biosystems, Europe) in the positive ion reflector 
mode. Spectra were obtained in the mass range between 800 and 4500 Da with ca. 1500 
laser shots. MS/MS analysis of selected precursor ion was performed at collision energy of 
2 kV with air as a collision gas at a pressure of 2x10
-7
 Torr. 
Peptide mass spectra resulting from trypsin digestion and nano-HPLC separations were 
performed in the above described conditions. For each sample spot, a data dependent 
acquisition method was created to select the 10 most intense peaks, excluding those from 
the matrix or trypsin autolysis for subsequent MS/MS data acquisition. 
 
Database search 
Spectra were processed and analyzed by the Global Protein Server Workstation 
(Applied Biosystems, Foster City, CA, USA), which uses internal Mascot (Matrix Science 
Ltd, U.K.) software for searching the MS/MS data. Searches were performed against an 
internal database created based on all Helicobacter pylori available on Uniprot (2009-07-
30) using the following criteria: 40ppm MS precursor tolerance, 2 missed cleavages, 
variable modifications for Asn, Ser and Thr residues (HexNac, Glucuronosyl, Hex). 
Positive identifications were accepted when confidence level was up to 95%. 
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 Nuclear Magnetic Resonance spectroscopy 
1
H, 
13
C and 
31
P NMR spectra were recorded on a Bruker AMX 600 spectrometer 
equipped with a TXI probe at 310 K. Two-dimensional (2D) NMR correlation 
spectroscopy (COSY), total correlation spectroscopy (TOCSY), heteronuclear spin 
quantum correlation (HSQC) spectroscopy and heteronuclear multiple bond correlation 
(HMBC) spectroscopy experiments were performed using the instrument’s Bruker 
software. Prior to performing the NMR experiments, the samples were lyophilized three 
times with D2O (99.9%). The HOD peak was used as the internal reference at δH 4.721 for 
1
H NMR spectroscopy, and orthophosphoric acid (δP 0.0) as the external reference for 
31
P 
NMR experiments. Just before the NMR experiments were carried out, a D2O sample 
containing TMS (δH 0.00) was run to aid in the reference the HOD signal. 
 
FTIR spectroscopy 
 FTIR spectra were collected on a Perkin Elmer BX Spectrometer with a single 
reflectance horizontal ATR cell (Golden Gate, equipped with a diamond crystal). The data 
was recorded in a spectral range of 4000 – 600 cm
-1
 with a resolution of 1 cm
-1
 and 256 
scans were acquired and co-added before Fourier transformation. 
 
Results 
 
Clinicopathological and virulence characterization  
H. pylori strain PTAV79 was recovered from a gastric biopsy specimen of a patient 
with gastroesophageal reflux disease. Polymerase chain reaction (PCR) characterization of 
this strain virulence profile highlighted the presence of cagA, the terminal gene of the cag 
pathogenicity island (PAI). The cag PAI encodes a type IV secretion system through which 
the CagA protein is injected into host epithelial cells (Backert and Selbach 2008). H. pylori 
strains containing cagA are associated with increased risk of peptic ulcer disease and 
gastric carcinoma (Figueiredo et al. 2002, Kusters et al. 2006). In addition, H. pylori 
PTAV79 was also found to carry the s1/m1 type vacA gene. vacA encodes the VacA 
cytotoxin, a protein that induces vacuolization in cultured epithelial cells (Kusters et al. 
2006). H. pylori strains containing the s1/m1 genotype, meaning that the signal-region 
comprises allelic variant s1 and the middle-region comprises allelic variant m1, are 
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frequently associated with peptic ulceration and gastric carcinoma (Atherton et al. 1995, 
Figueiredo et al. 2002). 
 
Isolation and pre-characterization of cell-surface glycans 
H. pylori PTAV79 was characterized in relation to its glycan cell-surface 
phenotype. Glycosides-rich material was primarily isolated in the aqueous phase resulting 
from hot phenol:water extraction performed on intact bacterial cells. Approximately 8.5 
mg of a heterogeneous sugars-rich material was obtained from 4 g of biomass. Sugars 
analysis of the non-purified extract presented on Table I confirmed heterogeneity by 
revealing a material mainly composed of Glc (57%) but also exhibiting considerable 
amounts of Gal (10%) and GlcNAc (13%) in proportions of approximately 1:1 as well as 
low percentages (<10%) of Gro (4%), Rib (6%), Man (3%), DD-Hep (3%) and LD-Hep 
(4%). Glc, Gal, GlcNAc, DD- and LD-Hep are common sugars in H. pylori LPSs (Monteiro 
2001) thus suggesting the presence of this class of biomolecules. Gro residues have been 
found in H. pylori cell-surface as part of glycerophospholipids (Hirai et al. 1995) while Rib 
residues result from residual oligonucleotides coming from bacterial RNA. Man has been 
recurrently observed, even though always in residual amounts (<5% of total sugars), in H. 
pylori glycan-rich water extracts (Monteiro 2001). However, its origin and structural 
assignment is, at the moment, still unclear (Ferreira et al. 2009). On the other hand, the 
high amounts of Glc observed in H. pylori PTAV79 seems to be common among H. pylori 
strains (Monteiro 2001, Britton et al. 2005, Ferreira et al. 2009).  
 
Table I. Sugars analysis of non-purified glycan-rich water extracts and fractions A and B 
resulting from elution in a Bio-Gel P6 column.  
Molar Ratio (%) 
Fractions  
Gro 
 
 
Rib 
 
 
Man 
 
 
Glc 
 
 
Gal 
 
 
GlcNAc 
 
 
DD-Hep 
 
 
LD-Hep 
 
         
Non-purified  4 6 3 57 10 13 3 4 
A
 
8 - 1 84 3 4 v v 
B - 6 3 13 32 35 6 5 
         
v – Vestigial amounts; > 0.5% total sugars 
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 Fractionation of cell-surface glycans  
With the objective of decreasing the molecular heterogeneity of glycan-rich water 
extracts and unveil more information about its composition, the isolated glycans were 
further fractionated in a polyacrylamide Bio-Gel P6 column (6 000 - 800 Da). 
Fractionation resulted on the elution profile shown in Figure 1, exhibiting two main 
fractions, A and B. Fraction A, corresponding to the void volume (>6,000 Da), comprised 
approximately 65% of the initial material, while fraction B corresponding to the inclusion 
volume (<6,000–1,000 Da), corresponded to the remaining 35%. Fraction A, 
corresponding to the void volume (>6,000 Da), comprised approximately 65% of the initial 
material, while fraction B corresponding to the inclusion volume (<6,000–1,000 Da), 
corresponded to the remaining 35%. Fraction A (Table I) was found to be most exclusively 
composed of Glc (84%), having low amounts of Gro (8%), Man (1%), Gal (3% total 
sugars) and GlcNAc (5%). Vestigial DD-Hep and LD-Hep residues were also observed. 
Conversely the oligomeric material (fraction B, Table I), yielded mainly Gal (32%) and 
GlcNAc (35%) in proportions of approximately 1:1. As a result, the percentage of Glc in 
this fraction was found to be significantly lower than what was observed for the non-
purified material and fraction A (around 13%). Fraction B was also found enriched in both 
DD- (7%) and LD- (6%) Hep residues when compared to the non-purified material and 
fraction A. Furthermore, no Gro residues were found in fraction B. Thereby results suggest 
that high-molecular weight Glc-rich glycans were mainly isolated in fraction A while 
lower molecular weight material corresponding to LPS can be found in fraction B. 
0
500
1000
0 50 100 150 200 250
Volume (mL)
E
L
S
D
 (
m
V
) 
  
 x
0
0.05
0.1
0.15
0.2
A
4
9
0
 n
m
  
  
  
 x
ELSD
A 490nm
Inclusion range (6 000 – 1 000 Da)
A
B
E
L
S
D
 (
m
V
) 
  
 x
A
4
9
0
 n
m
  
  
  
 x
 
Fig. 1. H. pylori PTAV79 glycan-rich extract elution profile on a Bio-Gel P6 column. 
Letters A and B correspond to isolated fractions. 
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Structural studies on partially purified material 
The linkage profile held by the identified sugars was evaluated by GC-EI-MS of the 
permethylated alditol acetate (pmaa) derivatives released after acid hydrolysis of the 
original glycans. Non-purified material (Table II) has shown to be mainly composed of O-
4 linked Glc residues (around 56%) vowing for the presence of amylose-like polymers as 
described by Ferreira et al. (2009). 
 
Table II. Sugar linkage profile and fatty acid composition of non-purified glycan-rich 
water extracts and fractions A and B resulting from elution in a Bio-Gel P6 column.  
Relative Molar Ratio (%)  
Linkage Type 
Non-purified Fraction A Fraction B 
    
LPS    
    
O–Chain    
    
T-Gal 1.7 - 8.3 
→3)Gal 7.1 v 25.2 
T-GlcNAc 1.8 - 7.0 
→4) GlcNAc 7.9 v 22.4 
    
Core    
T-Glc
1
 2.8 - 5.5 
→3)Glc 4.1 - 5.4 
→4)Gal 2.7 - 4.2 
→2)DD-manno-Hep 0.5 - 1.2 
→2)LD-manno-Hep 0.9 - 2.5 
→3)LD-manno-Hep 0.6 -  
→7)DD-manno-Hep 1.0 - 1.8 
→7)LD-manno-Hep 0.5 - 0.9 
→2,7)DD-manno-Hep  0.8 - 0.7 
→3,7)LD-manno-Hep  1.4 - 1.2 
    
Lipid A    
→6) GlcNAc 0.7 - 2.4 
    
Glucan-rich glycans    
    
T-Glc  3.1 - 
→3)Glc - 5.7
2
 - 
→4)Glc 55.8 65.2 9.3 
→4,6)Glc 0.6 0.8 0.5 
    
Fatty Acids    
    
C18:0 (stearic acid) 9.1 25.2 1.5 
    
 
1
Terminal
 
Glc residues can either be addressed to amylose-like polymers or to non-
reducing ends of the LPS core. 
2
In the absence of LPS O-3 linked Glc residues were 
assigned to the Glucan-rich moiety.  
v – Vestigial amounts; > 0.5% total sugars 
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 However of considerable amounts of terminal O-3 linked Gal (7.1 %) and O-4 linked 
GlcNAc (9.7 %) recognized as LPS O-chain sugars were also detected. In addition, 
terminal and O-3 linked Glc, O-4 linked Gal, O-7 DD-Hep and O-2, O-2,7 and O-3,7 linked 
LD Hep core-belonging residues as well as O-6 linked GlcNAc commonly found in Lipid A 
(Monteiro 2001) confirmed the existence of LPS suggested by sugars analysis (Table I). 
Furthermore, the non-purified material revealed the presence of a C-18:0 fatty acid methyl 
ester (9.1 %, Table II). This reveals the existence of stearic acid, a common fatty acid of H. 
pylori Lipid A moiety (Monteiro et al. 2000, Moran et al. 1997). 
After fractionation through the Bio-Gel P6 column the majority of the O-4 linked 
Glc and stearic acid residues were isolated in fraction A (Table II). In addition this fraction 
also showed low amounts of terminal (3.1% of total sugars) and O-3 linked Glc (5.7%).  
Conversely, linkage analysis confirmed that fraction B was essentially composed of 
LPS (Table II), revealed by the existence of O-chain sugars, namely terminal (8.3% of total 
sugars) and O-3 linked Gal (25.2%) and terminal (7.0%) and O-4 linked GlcNAc (22.4%) 
residues. Lower amounts (<6%) of terminal and O-3 linked Glc, O-4 linked Gal, O-7 DD-
Hep and O-2, O-2,7 and O-3,7 linked LD Hep units (Table II) that make up the core 
oligosaccharide region of the LPS (Monteiro 2001) were also observed. In addition 
1
H 1D 
nuclear magnetic resonance (NMR) studies in fraction B (data not showed) revealed weak 
unresolved resonances at δH1 5.0-5.45 ppm. This signals showed that the Hep residues 
observed in sugars (Table I) and linkage (Table II) analysis were in α-manno configuration 
(Aspinall 1999, Aspinall and Monteiro 1996, Monteiro 2001). 
ESI-MS spectra of the oligosaccharides released after partially acid hydrolysis with 
TFA revealed several ions originated from the LPS, resumed in Table III. The ions were 
found dehydrated as a result of strong acid treatment and protonated. Due to their high 
affinity for alkali metals, oligosaccharides normally ionize as sodium adducts (Ferreira et 
al., 2010, Zaia 2004). However, in this case, exposure to a Dowex cation-exchange resin 
prior to analysis to remove the excess of sodium ions resulted in the observation of only 
protonated species. Several core building blocks were identified (Table III), namely the 
ions at m/z 508 assigned to [Hep2-Kdo-H2O+H]
+
, at m/z 536 to [Hep(AEP)-Kdo-H2O+H]
+
, 
m/z 700 to [Hep2-Hep(AEP)-H2O+H]
+
, m/z 728 to [Hep-Hep(AEP)-Kdo)-H2O+H]
+
, m/z 
860 to [Hep2-Hep(AEP)-Kdo)-H2O+H]
+
, m/z 1082 to [Hex-Hep2-Hep(AEP)-Kdo)-
H2O+H]
+
, m/z 1244 to [Hex2-Hep2-Hep(AEP)-Kdo-H2O+H]
+
 and at m/z 1406 to [Hex3-
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Hep2-Hep(AEP)-Kdo)-H2O+H]
+
. Assignments of Hex residues to either Glc or Gal as 
presented in Table III were made according to Monteiro (2001). The ions at m/z 508, m/z 
536, m/z 700, m/z 860, m/z 1082, m/z 1244 and m/z 1406 were also found to carry Kdo 
residues (Table III) recognized as the anchoring point of the glycosidic region of the LPS 
to the Lipid A moiety (Monteiro 2001). 
 
Table III. ESI-MS of the oligosaccharides obtained from the hydrolysis of fraction B. The 
presented assignments were confirmed by ESI-MS/MS and made according to previously 
published structures (Monteiro 2001). 
 
m/z 
 
assignment 
  
Core Ions 
508 [Hep-Hep(AEP)-H2O+H]
+
 
536 [Hep(AEP)-Kdo-H2O+H]+ 
700 [Hep-Hep-Hep(AEP)-H2O+H]
+
 
728 [Hep-Hep(AEP)-Kdo-H2O+H]
+
 
860 [Hep-Hep-Hep(AEP)-Kdo-H2O+H]
+
 
1082 [Gal-Hep-Hep-Hep(AEP)-Kdo-H2O+H]
+
 
1244 [Glc-Gal-Hep-Hep-Hep(AEP)-Kdo-H2O+H]
+
 
1406 [Glc-Glc-Gal-Hep-Hep-Hep(AEP)-Kdo-H2O+H]
+
 
 
O-chain-Core Ions 
396 [GlcNAc-Hep-H2O+H]
+
 
711 [GlcNAc-Hep-Hep(AEP)-H2O+H]
+
 
903 [GlcNAc-Hep-Hep-Hep(AEP)-H2O+H]
+
 
942 [LacNAc-Hep-Hep-Hep-H2O+H]
+
 
953 [GlcNAc-LacNAc-Hep-Hep-H2O+H]
+
 
1123 [GlcNAc-Hep-Hep-Hep(AEP)-Kdo-H2O+H]
+
 
1315 [GlcNAc-Hep-Hep-Hep-Hep(AEP)-Kdo-H2O+H]
+
 
1430 [LacNAc2-Hep-Hep-Hep-H2O+H]
+
 
  
O-chain Ions 
366 [LacNAc-H2O+H]
+
 
528 [LacNAc-Hex+H]
+
 
569 [GlcNAc-LacNAc-H2O+H]
+
 
731 [LacNAc2-H2O+H]
+
 
893 [LacNAc2-Hex+H]
+
 
1096 [LacNAc3-H2O+H]
+
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 Furthermore, ESI experiments highlighted the existence of 2-aminoethylphosphate groups 
(AEP) linked to inner core Hep residues as it can be seen in the MS/MS spectrum of the 
ion at m/z 728 assigned to [Hep-Hep(AEP)-Kdo-H2O] (Figure 2a). When induced to 
fragmentation by collision with a gas, the ion at m/z 728 originated three major ions at m/z 
536 assigned to [Hep(AEP)Kdo-H2O+H]
+
 by loss of an Hep residue (Hepres, 192 Da), the 
ion at m/z 508 assigned to [Hep-Hep(AEP)-H2O+H]
+
 resulting from the loss of a Kdores 
(220 Da) and the ion at m/z 316 assigned to [Hep(AEP)-H2O+H]
+
 by the combined loss of 
an Hepres and a Kdores (412 Da) demonstrating the Hep-AEP linkage. These results 
together with previous reports (Monteiro 2001), suggest that the AEP moiety is O-7 linked 
to the innermost LD-Hep of the core region, linkage analysis (Table II) revealed vestigial 
amounts of O-3,7 linked LD-Hep.  
The observation by ESI-MS of an AEP moiety was reinforced in a 
31
P NMR 
experiment carried out at pD 6.0 (data not shown). The 
31
P spectrum of intact fraction B 
exhibited a single resonance at δ 0.05 ppm that, according to Aspinall and Monteiro 
(1996), Aspinall et al. (1999), and Monteiro (2001) is characteristic of a phosphodiester 
group. In addition a 2D 
1
H-
31
P HMBC experiment (data not shown) highlighted 
connectivity between the phosphorus nucleus and a proton resonance at δH-7 3.72 ppm in a 
region of the spectrum that, according to Müller-Loennies et al. (1994), is occupied by H-7 
protons of Hep residues. The information given by this 2D NMR experiment confirmed the 
O-7 linkage of the AEP motif to the inner core O-3 linked Hep residue that was suggested 
by linkage analysis.  
The prevalence of O-3 linked Gal and O-4 linked GlcNAc residues in proportions 
of approximately 1:1 in fraction B suggests the expression of O-chains composed of 
LacNAc moieties [→3)Gal(1→4)GlcNAc(1→]. In accordance with this observation, the 
1
H NMR spectrum of fraction B (data not shown) exhibited two dominant anomeric 
resonances at δH-1 4.69 ppm (J1,2 6.9 Hz), and at δH-1 4.47 ppm (J1,2 7.0 Hz) that, based on 
previous reports (Aspinall et al. 1999, Monteiro 2001, Monteiro et al. 2000), are attributed 
to β-Gal and β-GlcNAc respectively. The presence of amido-methyl protons (-COCH3) in 
the GlcNAc units was responsible for the observation of a singlet at δ 2.05 ppm in the 
1
H 
NMR spectrum (data not shown). The expression of LacNAc repeating units, suggested by 
NMR and linkage analysis (Table II), was confirmed by ESI-MS and MS/MS (Table III).  
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The ESI-MS spectra of the oligosaccharides released from partial acid hydrolysis 
exhibit the ions at m/z 366 assigned to [Hex-HexNAc-H2O+H]
+
, at m/z 528 assigned to 
[Hex2-HexNAc-H2O+H]
+
, at m/z 569 assigned to [Hex-HexNAc2-H2O+H]
+
, at m/z 731 
assigned to [Hex2-HexNAc2-H2O+H]
+
, at m/z 893 assigned to [Hex3-HexNAc2-H2O+H]
+
 
and m/z 1096 assigned to [Hex3-HexNAc3-H2O+H]
+
. MS/MS experiments further 
demonstrated the occurrence of Hex-HexNAc repeating units as it can be seen when 
inducing to fragmentation the ion at m/z 731 assigned to [Hex-HexNAc-Hex-HexNAc-
H2O+H]
+
 (Figure 2b).  
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Fig. 2. ESI-MS/MS spectrum of a) the ion at m/z 728 assigned to the inner core structure 
[Hep-Hep(AEP)-Kdo-H2O+H]
+
 and b) the ion at m/z 731 assigned to the O-chain structure 
[Gal-GlcNAc-Gal-GlcNAc-H2O+H]
+
 resulting from acid hydrolysis.  
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 The resulting MS/MS spectrum showed a dominant fragment ion at m/z 366 corresponding 
to [Hex-HexNAc-H2O+H]
+
 originated by the loss of a Hex-HexNAc motif (365 Da) and 
two low abundant fragments at m/z 528 corresponding to [Hex-HexNAc-Hex-H2O+H]
+
 by 
loss of a HexNAc residue (203 Da) and the ion at m/z 204 [HexNAc-H2O+H]
+
 by 
combined loss of two Hex residues and one HexNAc residue. In addition, the ions at m/z 
903, assigned to [HexNAc-Hep-Hep-Hep-Hep(AEP)+Na]
+
, at m/z 942, assigned to [Hex-
HexNAc-Hep-Hep-Hep-H2O+H]
+
, at m/z 953, assigned to [HexNAc-Hex-HexNAc-Hep-
Hep-H2O+H]
+
, at m/z 1123, assigned to [HexNAc-Hep-Hep-Hep(AEP)-H2O+H]
+
, at m/z 
1315 [HexNAc-Hep-Hep-Hep-Hep(AEP)-H2O+H]
+
 
 
and at m/z, assigned 1430 to [Hex-
HexNAc-Hex-HexNAc-Hep-Hep-Hep)-H2O+H]
+
, show the linkage between the O-chain’s 
most intern GlcNAc and inner core through an Hep residues.  
Gathered structural information strongly suggests that H. pylori PTAV79 LPS 
exhibit a structural organization presented in Fig. 3 similar to what has been found among 
other H. pylori strains (Monteiro 2001). 
αDGlc(1→3)αDGlc(1→4)βDGal(1→7)DαDHep(1→2)LαDHep(1→3)LαDHep(1 →5)Kdo
AEP
7
→
αDHep
2
→
1
7
→
βDGal(1→4)βDGlcNAc(1→3)βDGal(1→4)βDGlcNAc(1- →βDGal(1→4)βDGlcNAc
n
1
i-antigen oligomeric O-chain
inner  coreouter  core
→
→
→
→
→
→
 
 
Fig. 3. Structural organization of H. pylori PTAV79 semi-rough LPSs showing an O-chain 
formed by i-antigens.  
 
Detailed structural studies on H. pylori amylose-rich fraction A 
 Both sugars and linkage analysis show that fraction A is depleted of LPS (Table I 
and II) and is composed of amylose-like glycans. This fraction was also found to be 
enriched in Gro and stearic acid chains (Table I and II).  
Figure 4 shows the FTIR spectrum of fraction B, highlighting the presence of CH, 
CH2, and CH3 asymmetric and symmetric stretching modes of fatty acids at 2959-2852 cm
-
1
 (Adt et al. 2006). Furthermore, the polysaccharides fingerprint region at 1200–800 cm
−1 
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(Coimbra et al. 1998) yields characteristic absorbances at 1090 cm
-1
 and at 1015 cm
-1
, 
suggesting the presence of hexuronic acids (Coimbra et al. 1998, Ferreira et al. 2001).  
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Fig. 4. FT-IR spectrum of fraction B highlighting the Amide bands derived from proteins 
and carbohydrate fingerprint region from 1200-800 cm
-1
 showing GlcA characteristic 
signals.  
 
The presence of hexuronic acids was accessed by linkage analysis comprising the 
reduction of the carboxylic group with LiAlD4 after methylation and prior to hydrolysis, 
reduction with NaBD4 and acetylation. The GC-MS chromatogram resulting from this 
procedure exhibited two additional peak at rrt
1,4Glc 
= 0.8 and rrt
1,4Glc 
= 1.29 assigned to 
terminal GlcA and O-3 linked GlcA residues respectively.  
The 
1
H NMR spectra of fraction A (Figure 5 and Figure 6a) and HSQC showed 
three dominant α-anomeric resonances. Two major unresolved peaks were observed at 
δH1/C1 5.20/100.4 ppm (residue X) and assigned, according to linkage analysis, to O-4 
substituted Glc residues. The two unresolved peaks are mostly likely to arise from two O-4 
linked Glc residues exposed to two distinct chemical environments. A lower intensity 
doublet was found at δH1/C1 5.11/69.6 ppm (J1,2 = 2.91 Hz) (Residue Y) and assigned, 
according to linkage analysis, to O-3 substituted GlcA. In addition, three vestigial 
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 resonances were distinguishable at δH1 5.13, 5.07 and 4.92 ppm and were attributed to O-3 
substituted Glc, terminal Glc, and terminal GlcA, respectively, based on theoretical values 
given by CASPER (Stenutz et al. 1998).  
 
1.01.52.02.53.03.54.04.55.05.56.0 ppm
5.025.045.065.085.105.125.145.165.185.205.225.24 ppm
-3)-α-GlcA(1-
-4)-α-Glc-(1-
6.0
R-CO-CH2-CH2-(CH2)14-CH3
a
d
c
c db
a and b
1H (ppm)5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
5.2 5.1
aminoacids
Hα
 
Fig. 5. 1H NMR spectrum of fraction A highlighting α anomeric resonances for O-4 linked 
Glc, O-3 linked GlcA residues and signals belonging to the C18 fatty acid chain. 
 
2D 
1
H–
1
H COSY (Figure 6a), TOCSY, and 
1
H–
13
C HSQC (Figure 6b) experiments 
allowed to assign some of the ring protons and carbons of the major carbohydrate residues 
present in fraction A (Table IV).  
 
Table IV. 
1
H NMR and 
13
C NMR chemical shifts of monosaccharide units present in H. 
pylori PTAV79 fraction A glycosides (δ, ppm; pD 6.0; 310 K). 
 
 
Residue 
 
 
H1/C1 
 
 
H2/C2 
 
 
H3/C3 
 
 
H4/C4 
 
 
H5/C5 
 
 
H6/C6 
 
 
H6/C6 
X 
→4)-α-D-Glc-(1→ 
 
 
5.21 
100.5 
 
 
3.55 
74.5 
 
 
3.43 
75.4 
 
3.78 
78.1 
 
 
- 
 
3.79/ 
63.4 
 
 
3.88/ 
63.4 
 
Y 
→3)-α-D-GlcA-(1→ 
 
 
5.11/ 
99.6 
 
 
3.96 
74.6 
 
 
3.84     
- 
 
-- - - - 
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Fig. 6. a) 
1
H-
1
H COSY and b) 
1
H-
13
C HSQC NMR spectra of fraction A. 
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 In addition the HMBC spectrum (Figure 7) presented in the α-anomeric region three cross-
peaks, two corresponding to inner-residue connectivities between the C1 and H2 and H3 of 
O-4 linked residues and an inter-residue connectivity between the C1 and the H4 of 
contiguous O-4 linked residue. The latter confirmed the existence of a [→1)-α-D-Glc-
(1→4)-α-D-Glc-(1→] moiety characteristic of amylose-like glycans.  
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Fig. 7. 
1
H-
13
C HMBC
 
NMR spectrum α-anomeric region exhibiting inner and inter-ring 
connectivities between O-4 linked Glc residues. 
 
The 
1
H NMR spectra in Figure 5 further highlighted signals identifiable, according 
to Gunstone et al. (1995) and Jie et al. (1995), with the C-18:0 fatty acid moiety, namely an 
unresolved multiplet at 0.86 ppm belonging to terminal methyl groups, a group of 
multiplets between 1.2 and 1.4 corresponding to methylene signals of [(CH2)n] aliphatic 
chains, and multiplets at 2.26 and 2.06 and assigned to α and β methylene protons linked 
the ester carbonyl group.  
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In addition, the 
1
H NMR spectrum of fraction A (Figure 5) also presented a broad 
band from δHα 4.4 to 4.5 ppm originated by aminoacids Hα protons (Chary and Govil, 
2008), suggesting the presence of proteins. It should be pointed out that aminoacids 
carrying either methyl or methylene groups can further contribute to the signals observed 
between 0.8 and 2.8 ppm. Further reinforcing the hypothesis of the existence of proteins in 
this extract, the FTIR spectrum (Figure 4) exhibited characteristic signals at 1650 cm
-1
 
resulting from C=O group (amide I band) and at 1550 cm
-1
 from N-H group (amide II 
band) (Chapman et al. 1989).  
Gathered information resulting from chemical, chromatographic, and spectroscopic 
analysis performed so far on fraction A has confirmed the presence of the amylose-like 
glycans suggested by linkage analysis (Table II). However, these studies have also 
revealed the presence of several unsigned structural motifs, namely terminal O-3 linked α-
GlcA residues, Gro, fatty acids, and proteic material.  
 
Partial acid hydrolysis of fraction A glycosides 
In order to get more insights on fraction A molecular and structural organization, a 
strategy based on acid hydrolysis was adopted. Primarily, fraction A was submitted to acid 
hydrolysis with 100 mM TFA in order to obtain oligosaccharides that could be analysed by 
ESI-MS. The acid treated material originated the Bio-Gel P2 elution profiles presented in 
Figure 8 which show that a portion of the initial material remained unchanged upon acid 
treatment (Figure 8a), eluted in the void volume of the column. This material was found to 
be essentially sugar-rich (Figure 8b) as the proteic material was almost totally degraded 
(Figure 8c) upon exposure to acid. 
Low molecular weight fragments isolated on the inclusion volume of the column 
were observed in the ESI-MS spectra (Figure 9a), revealing a dominant ion at m/z 439. 
Based on the MS/MS spectrum (Figure 9b), it was assigned to [Glc-Glc-Gro+Na]
+
. 
Vestigial peaks at m/z 365, m/z 527, m/z 689 and m/z 851, assigned to [Glc2+Na]
+
, 
[Glc3+Na]
+
, [Glc4+Na]
+
 and [Glc5+Na]
+
, respectively, were also detected.  
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Fig. 8. Elution profiles determined by a) Lights cattering (total mass), b) A490 (total sugars, 
phenol-H2SO4 method) and c) A562 (total protein, BCA method) for intact fraction A, 
fraction A after hydrolysis with 100mM TFA for 30 min. and hydrolysis of acid-resistant 
material with 500 mM TFA for 60 min.
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Fig. 9. a) ESI-MS spectrum of oligomeric material resulting from acid treatment of 
fraction A with 100 mM TFA at 100ºC for 30 min exhibiting a major ion at m/z 439 
assigned to [Glc-Glc-Gro+Na]
+
 and b) MS/MS spectrum of the ion at m/z 439. 
 
The presence of the glycerol moiety was also evident in the NMR experiments. The 
HSQC of intact fraction A (Figure 6b) showed a cross peak at δC1 69.9 ppm with several 
resonances equivalent protons δH 3.98 and 3.91 ppm and at 4.07 ppm characteristic of O-
substituted glycerol groups (Gunstone et al. 1995). Furthermore, the 
31
P NMR experiments 
carried out at pD 6.5 (data not shown) revealed a single resonance at δ 0.01 ppm that, 
according to Aspinall and Monteiro (1996), Aspinall et al. (1999) and Monteiro (2001), is 
characteristic of a phosphodiester. This signal was found correlated through a 2D 
1
H-
31
P 
HMBC experiment with the above Gro-related resonances at δH 3.98 and 3.91 ppm, in 
accordance with the expect chemical shifts for proton belonging to CH2-O-PO-R moieties 
(Gunstone et al. 1995). The HSQC spectrum also shows a broad low intensity peak around 
δC/H 3.98/63.9 which is thought to be correlated with Gro residues substituted with α-Glc 
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 responsible for shifting the carbon resonances to upper fields (Gunstone et al. 1995). Even 
though 
1
H-
1
H COSY (Fig. 6a) and TOCSY (data not shown) spectra revealed to be fairly 
resolved in the region from 4.1 and 3.9, the observed signals suggest the expected 
connectivity between these resonances.  
The ESI-MS data, highlighting a linkage between the α-(1→4)-Glc moiety and Gro, 
the observation of phosphorylation in the Gro by NMR, and the detection of considerable 
amounts of stearic acid in this fraction, suggests the presence o glycerophospholipids. 
These results further imply that glycerol could act as anchorage points of amylose-like 
glycans to H. pylori cellular-envelope. However, the extremely low abundance of material 
available associated to its high heterogeneity resulted in a major drawback in providing 
unambiguous data linking the fatty acid chain to glycerol residues. Still it should be 
pointed out that the prevalence of fatty acids in a polymeric fraction (Mw >6,000 Da) very 
soluble in water might only be explained by a strong association with polymeric 
hydrophilic molecules such as α-glucans. 
 
Structural study of a polysaccharide containing aldobiouronic acid repeating units 
The 100 mM TFA resistant material recovered on the Bio-Gel P2 void volume 
(Figure 8) was submitted to a new treatment using harsher hydrolytic conditions 
comprising 500 mM TFA at 100ºC for 1 h. The resulting Bio-Gel P2 elution profile 
highlighted that the bulk of the material, composed almost exclusively by sugars, remained 
unchanged (Figure 8b and 8c), thus on the void volume, further demonstrating its high 
resistance to the acid.  
The oligomers originated from this hydrolysis were analyzed by MALDI-TOF-MS 
which resulted in spectra like the one presented in Figure 10. Major ions differing from 
each other in 388 Da (GlcAresGlc) at m/z 699 were assigned to [Glc2-GlcA2-H2O+Na]
+
, at 
m/z 1037 assigned to [Glc3-GlcA3-H2O+Na]
+
, at m/z 1375 assigned to [Glc4-GlcA4-
H2O+Na]
+
, at m/z 1713 assigned to [Glc5-GlcA5-H2O+Na]
+
, at m/z 2051 [-Glc6-GlcA6-
H2O+Na]
+
. Other ions at m/z 861 assigned to [Glc2-GlcA3-H2O+Na]
+
, at m/z 875 assigned 
to [Glc3-GlcA2-H2O+Na]
+
, at m/z 1199 assigned to [Glc3-GlcA4-H2O+Na]
+
, at m/z 1213 
assigned to [Glc4-GlcA3-H2O+Na]
+
, at m/z 1537 assigned to [Glc4-GlcA5-H2O+Na]
+
, at 
m/z 1561 assigned to [Glc5-GlcA4-H2O+Na]
+
, at m/z 1875 assigned to [Glc5-GlcA6-
H2O+Na]
+
 were also identified further suggesting a polysaccharide composed of a 
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aldobiouronic disaccharide GlcA-Glc repeating unit (Gloaguen et al. 1997, Govorchenko et 
al. 1971). Linkage analysis performed on the acid-resistant material collected on the void 
volume of the P2 column (data not shown) confirmed the presence of O-4 linked Glc and 
O-3 linked GlcA residues. This data suggests a polysaccharide composed of [→3)-α-D-
GlcA(1→4)-α-D-Glc(1→] repeating motif. Even though the carboxylic acid group of the 
GlcA residue was found free, the HSQC spectrum of the intact material highlighted 
connectivity between a carbon resonance at δC 177.0 ppm thought to belong to C6 GlcA 
residues and multiplet at δH 2.09 ppm characteristic of a –CH2-CHn group (data not 
shown). This suggests that some of the carboxylic groups in the GlcA moiety are esterified.  
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Fig. 10. MALDI-TOF-MS spectrum of a oligomeric fraction resulting from acid digestion 
of acid-resistant fraction A material with 500 mM TFA at 100ºC during 60 min. 
 
Identification of a glycopeptide containing Ser O- glucuronosyl moieties  
In order to separate the proteic from glycan-rich material, as well as to identify 
possible glycosylated proteins, fraction A was fractionated by SDS-PAGE. Under SDS-
PAGE conditions (Figure 11) it exhibited four distinguishable bands when stained with 
coomassie blue. This observation confirmed the presence of proteins previously suggested 
by the FTIR (Figure 4) and NMR (Figure 5) spectra. The first and second bands were 
observed approximately at 45 kDa, the third band had an Mw estimated around 28 kDa and 
the forth band, showing a large dispersion, corresponded to peptides with Mw inferior to 
  
 
H. pylori LPS lacking fucosylated O-chains 
153 
 
 
 
 11 kDa. However, when stained with PAS to reveal sugar-containing material only three 
bands were observed. The first and second bands appeared strongly stained with PAS and 
corresponded to non-migrated macromolecular glycosides with Mw > 100 kDa and glycans 
with Mw between 100 kDa and 38 kDa respectively. Conversely, the third band 
corresponding to an Mw of around 28 kDa was found only slightly stained with PAS. 
Furthermore this material was also observable using coomassie blue, confirming the 
presence of a glycoprotein. The 28 kDa band then was then recovered from the gel, 
digested with tripsin and the resulting fragments were separated by nano-HPLC and 
analysed by MALDI-TOF-MS. MS/MS experiments (Figure 11b) allowed the 
identification of an ion at m/z 2308 corresponding to a modified peptide with the 
aminoacid sequence PSAVGYQPTLAGEMGKLQER exhibiting an additional 176 Da 
attributed to a GlcA residue. This post-translational modification was found to occur in the 
serine residue at the S2 position as shown by the identification of a2 and b2 fragmentations 
(nomenclature by Roepstorff and Fohlman 1984) resulting in the ions at m/z 333 and 361 
corresponding to the P1-S2 sequence with an additional 176 Da (Figure 11 and Table V). 
Subsequent a- and b-type fragmentations confirmed the mentioned observation by yielding 
ions showing this modification (Table V). In addition, the y18 fragmentation corresponded 
to the sequence AVGYQPTLAGEMGKLQER (m/z 1948) while the y19 fragment showed 
an additional serine residue plus 176 Da (S(GalA)AVGYQPTLAGEMGKLQER, m/z 
2211) (Figure 11 and Table V). 
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Fig. 11.a) Fraction A profile under SDS-PAGE conditions revealed with comassie blue 
(for proteins) and PAS (for glycans). The highlighted band stained both with comassie blue 
and PAS and corresponds to a glycoprotein of approximately 28 kDa. b) MALDI-TOF-
MS/MS of the modified peptide resulting at m/z 2308.02 corresponding to the sequence 
PSAVGYQPTLAGEMGKLQER containing a GlcA in the in S2 aminoacid obtained from 
tryptic digestion of the 28 kDa band the. Specific b and y fragmentations confirming this 
posttranslational modification are highlighted.  
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 Table V. MALDI-TOF-MS/MS a-, b- and y- type fragmentations for the 28 kDa tryptic 
digest PS(GlcA)AVGYQPTLAGEMGKLQER.  
 
Characteristic 
Fragmentation (Da) 
 
 Aminoacid  
a b y 
Theoretical 
Mass (Da) 
Observed 
Mass 
(Da) 
Match 
Error 
(Da) 
Modification 
         
1 P 70.70 98.06      
2 S* 333.13 361.12 2211.01     
3 A 404.17 432.16 1948.00     
4 V 503.23 531.23 1876.96     
5 G 560.26 588.25 1777.89     
6 Y 723.32 751.31 1720.87     
7 Q 851.38 879.37 1557.81     
8 P 948.43 976.43 1429.75     
9 T 1049.48 1077.47 1332.69     
10 L 1162.56 1190.56 1231.65 2308.11 2308.02 -0.09 Glucuronosyl(S)[2] 
11 A 1233.60 1261.59 1118.56     
12 G 1290.62 1318.62 1047.53     
13 E 1419.66 1447.66 990.50     
14 M 1550.70 1578.70 861.46     
15 G 1607.73 1635.72 730.42     
16 K 1735.82 1763.82 673.40     
17 L 1848.9 1876.9 545.30     
18 Q 1976.96 2004.96 432.22     
19 E 2106.01 2134.00 304.16     
20 R        
         
 
* Modified residue. 
 
Discussion 
H. pylori wild type strain PTAV79 was isolated from a symptomatic host with 
gastroesophageal reflux disease. Even though H. pylori is recognized as a highly fastidious 
microorganism (Stevenson et. al. 2000, Testerman et al. 2001), i.e. difficult to culture 
outside their normal environment, this strain showed abnormally low growth rates when 
sub-cultivated in vitro denoting its high adaptation to the gastric niche. Such behaviour 
resulted in a major drawback in obtaining enough biomass for a full structural 
characterization of its cell-surface glycans. So, from more than 4 g of cells, only 
approximately 8.5 mg of a highly heterogeneous material composed of LPS, proteic 
material and polysaccharides could be obtained. This resulted in a major challenge when 
addressing the structural organization of its components and a drawback as far as fully 
accessing certain specific molecular motifs.  
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H. pylori PTAV79 expresses LPS carrying i-antigens 
LPS is a main component of H. pylori outer membrane and has strong implications 
on pathogenesis and virulence of the bacterium. The present study has demonstrated that 
H. pylori PTAV79 expresses semi-rough LPS formed by a conserved core region similar to 
what has been observed among other H. pylori (Monteiro 2001) and oligomeric O-chains 
composed of LacNAc (i-antigen) repeating units. Although clinical isolates normally 
express smooth phenotypes characterized by a polysaccharide moiety showing a core 
oligosaccharide and extended polymeric O-chains, in some cases semi-rough forms can 
also be observed (Monteiro et al. 2001). According to the LPS classification into glycotype 
families proposed by Monteiro et al. (2001), strains expressing semi-rough LPS are placed 
either in group G or H depending on their O-chains antigenic profile. Group G includes 
strains with O-chains having both Type 1 (Le
a
, Le
b
) and Type 2 (Le
x
, Le
y
) Le epitopes 
while group H concerns solely those expressing Type 1 structures. In addition to the above 
mentioned phenotypes, some strains often co-express other fucosylated epitopes such as 
Le
d
 [α-L-Fuc-(1-2)-β-D-Gal-(1-3)-β-D-GlcNAc], α-L-Fuc-(1-3)-α-L-Fuc-(1-4)-β-D-GlcNAc, 
β-D-GlcNAc-(1-3)-α-L-Fuc, α-L-Fuc-(1-3)-Fuc-(1-4)-β-D-GlcNAc as well as linear B 
blood-group [α-D-Gal-(1-3)-β-D-Gal-(1-4)-GlcNAc). However, as far as we know, H. 
pylori PTAV79 is the first strain reported to solely express semi-rough phenotypes 
composed of i-antigen O-chains. Also, none of the above described structural motifs were 
identified.  
H. pylori strain PTAV79 was found to be devoid of fucosylated Le antigens. 
According to previously published works, the expression of Le and related blood groups by 
H. pylori has severe implications in several biological events directly correlated with 
pathogenesis such as modulation of immune response, influencing bacterial colonization 
and adhesion to gastric cells (Broutet et al. 2002, Heneghan 2001, Hynes et al. 2005, 
Moran 2008). It has also been described that strains with high expression of Le
x
 cause 
higher colonization density in patients than those with weaker expression (Heneghan et al. 
2000) therefore enhancing the probability of developing gastric malignancies (Moran 
1996, Rieder et al. 1997). Consequently, it is reasonable to think that the capability of 
strains like PTAV79 to evade immune response as well as successfully colonize the gastric 
mucosa and/or induce a pathological outcome might be seriously compromised. In 
agreement with these considerations is a report concerning a genetic engineered strain 
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 having a knock out of the rfb gene (HP00437JHP0037), encoding a GDP-D-mannose 
pyrophosphorylase required for GDP-Fuc synthesis (Moran et al. 2000). This genetic 
modification resulted in LPS phenotypes composed of Fuc-lacking O-chains, thus i-
antigens, like the ones encountered in strain PTAV79. Cells showing the described 
phenotype presented reduced capability of colonizing mouse stomachs (Moran et al. 2000) 
and ablated interaction with the human gastric mucosa of biopsy specimens in situ 
(Edwards et al. 2000). Also, a mutated H. pylori Sydney strain carrying a rough-form LPS 
devoid of Le O-chains, created by insertional mutagenesis of HP0826 (β4-galT gene), has 
been shown to still be capable of colonizing the murine model, although with less 
efficiency (Logan et al. 2000). Despite the lack of fucosylated Le antigens, H. pylori 
PTAV79 was isolated from a gastric biopsy specimen, vowing for its capability to induce 
successful colonization of the human gastric mucosa. It also suggests that the expression of 
i-antigen phenotypes does not compromise colonization. In addition other strains lacking 
Le epitopes and expressing LPS with either an elongated α-1,6-Glc side branch (Altman et 
al. 2003) and/or 2- and 3-linked D-glycero-α-D-manno-heptopyranose units (Monteiro et al. 
2001) were also found capable of colonizing murine stomach models (Altman et al. 2003, 
Monteiro et al. 2001). Backed by the presented information and new insights brought by H. 
pylori PTAV79, we further reinforce the observation that the expression of fucosylated Le 
epitopes, in particular Le
x
, even though recognized to render a positive contribute, are not a 
pre-requisite for a successful colonization. 
When discussing the possible impacts of fucosylated Le epitopes upon pathology, it 
should be pointed out that a significant proportion of Le-negative strains have been 
identified among H. pylori from asymptomatic subjects (Monteiro et al. 2001, Rasko et al. 
2000a). Le epitopes are known to be able to act as inflammatory agents responsible for 
immune activation upon H. pylori infection, frequently directing pro-inflammatory 
responses against the host (O'Keeffe and Moran 2008). A decreased or absent presentation 
of these antigens may lead to decreased immune-related symptoms and, consequently, an 
asymptomatic colonization. Despite these observations, available information suggests a 
correlation between infection with strain PTAV79 devoid of Le antigens and the 
development of gastric disorders. The identification of recognized pathogenicity markers 
cagA and type s1/m1 vacA (Kusters et al. 2006) further reinforces this strain’s virulence 
potential (Wen 2009). Also, a significant proportion of gastroesophageal reflux disease 
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patients have shown H. pylori colonization (O´Connor 1999). Although the association 
between infection and development of reflux esophagitis remains highly controversial 
(Grande et al. 2008, Yagi et al. 2009), a recent review points out that H. pylori infection 
might induce an increase in acid secretion which can lead to gastroesophageal reflux 
disease (Souza and Lima 2009). The H. pylori-driven decrease of the stomach’s pH may 
even have a direct impact in the modulation and establishment of the O-chains phenotype 
(Moran 2008). It has been demonstrated that upon decrease in pH there is a phase variable 
decrease in Le
x
 expression (Moran et al. 2002). On/off switching of fucosyltransferases 
expression due to a decrease in pH might be responsible for the observation of i-antigens in 
strain PTAV79. 
 
Production of amylose-like glycans 
Noteworthy is also the high amounts of amylose-like glycans expressed by H. 
pylori strain PTAV79. According to Ferreira et al. (2009), H. pylori is known to 
bioaccumulate those polymers under specific environmental pressures. The mentioned 
report extensively discusses the biological importance of this class of glycosides and its 
implications in pathogenesis. It has been stated that its production can be regarded as part 
of a long time survival strategy under nutrient depletion (Bourassa and Camilli 2009). 
Also, they were implicated in the modulation/evasion of the host’s immune response 
(Bittencourt et al. 2006, Gagliardi et al. 2007) and thought to contribute to the formation of 
strong and sticky framework responsible for promoting life on community and protecting 
the cell from external aggressions (Sutherland 2001).  
Even though the exact environmental pressures triggering the expression of 
amylose-like glycans remains mostly unclear, it has been shown that its production is 
accompanied by a decrease in the overall expression of LPS (Ferreira et al. 2009). Such 
decrease was mostly attributed to a reduction in O-chain expression responsible for a shift 
from smooth LPS to semi-rough phenotypes. This was recognized as a typical behaviour 
among laboratory adapted strains upon sub-cultivation in solid medium (Ferreira et al. 
2009). Interestingly, the same phenotype is now being described for H. pylori PTAV79 
which is a freshly recovered clinical isolate further grown in F12 liquid medium. 
Moreover, growth in F12 was recognized to potentiate the expression of smooth LPS 
(Nilsson et al 2008, Ferreira et al. 2009) and decrease the amount of expressed amylose-
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 like glycans (Ferreira et al. 2009). However, upon growth in F12, H. pylori PTAV79 
expressed mainly semi-rough phenotypes and high amounts of amylose-like glycans but 
not smooth type LPSs. Thus, the atypically high expression of polymeric amylose-glycans 
observed for this stain can be an environmental related response of a well adapted 
microorganism to the gastric niche when facing cultivation outside the human reservoir. 
On the other hand, it can in fact correspond to an in vivo phenotype. Nevertheless, F12 
liquid media was found ideal for the rapid isolation, cultivation and identification of H. 
pylori from biopsy specimens overcoming fastidiousness (Sainsus et al. 2008) thus 
showing its potential of mimicking in vivo growth conditions. Reinforcing this last 
observation, cell-surface glycosides isolated from H. pylori strains from in vivo mouse 
models and fresh gastric biopsies have shown similar phenotypes to liquid media grown 
strains (Nilsson et al. 2008). Based on these considerations we are led to think that the 
observed cell-surface glycan pattern might indeed be fully representative of the in vivo 
phenotype. Surprisingly, evidences were found of amylose-like glycans linked to Gro 
residues. In the amylose-rich fraction it was also found a considerable amount of stearic 
acid which is known to be present at H. pylori cell surface (Hirai et al 1995, Inamoto et al. 
1993, Moran et al. 1997). This fatty acid is generally regarded as belonging to Lipid A of 
the LPS moiety (Moran et al. 1997). This fraction was also found to contain phosphate 
groups in phosphodiester bonds. The expression of α-glucosylated glycolipids, namely 
cholesteryl-α-glucosides, cholesteryl-6’-O-acyl-α-glucosides, phospholipids like 
cholesteryl-6’-O-phosphatidyl-α-glucoside, and cholesteryl-6’-O-lysophosphatidyl-α-
glucoside (Lebrun et al. 2006) are not unusual among H. pylori strains. Some of these 
structures were found to contain Gro residues with phosphate groups bridging the 
glycerolipidic moiety (Hirai et al. 1997). These results therefore suggest that amylose-like 
glycans might be linked to the bacteria’s cell surface in the form of 
glyceroglycophospholipids with the α-O-4 linked Glc residues directly linked to Gro.  
 
A polysaccharide composed of aldobiouronic acid repeating units 
By submitting the cell-surface material extracted from H. pylori strain PTAV79 to 
an acid digestion with TFA 500 mM at 100ºC for 1h it was possible to unveil a highly acid 
resistant polysaccharide. The mentioned polysaccharide was found to be composed of 
[→3)-α-D-GlcA(1→4)-α-D-Glc(1→] repeating units. Such structural organization 
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comprising an uronic acid linked to neutral sugar is classified under the general name of 
aldobiouronic acid and has long been recognized as extremely resistant to acidic hydrolysis 
even at high temperatures and acid concentrations (Gloaguen et al. 1997, Govorchenko et 
al. 1971). Such property could be observed when submitting fraction A aldobiouronic acid 
containing material to strong acid hydrolysis at 100ºC for 1 hour.  
Aldobiouronic acids are frequently found as part of bacterial capsular structures 
(Forsee 2009, Gloaguen et al. 1997, Yang et al. 1996). However, this is the first report for 
H. pylori of a polysaccharide recognizable by its unusual high acid resistance under harsh 
conditions. It is also worth mentioning that H. pylori cells face a pH gradient within the 
gastric mucosa, between the mucus layer and the gastric cell surface, from an expected pH 
2 on the luminal side of the gastric mucus layer to almost pH 7 on the cell surface (Moran 
et al. 2002). Still, H. pylori is known to overcome this effect by producing and excreting an 
urease responsible for the metabolization of urea into CO2 and ammonia thus buffering the 
cells surroundings (Kusters et al. 2006).  
Structural resemblances between H. pylori PTAV79 extra-cellular aldobiouronic 
containing polysaccharide and hyaluronan, a linear polysaccharide formed by repeating 
units of D-GlcA and D-GlcNAc [→4)-β-D-GlcA(1→3)-β-D-Glc(1→]n (Itano 2008), 
suggests similar functional properties. Hyaluronan is the major macromolecular 
polysaccharide component of the extra-cellular matrix and is distributed widely throughout 
human connective, epithelial, and neural tissues (Itano 2008). GlcA confers this polymer 
the capability of forming negatively-charged aggregates that imbibe water giving rise to 
hydrogels (Toole 2000) responsible for cellular hydration. The same structures can be 
thought to occur at the surface of H. pylori PTAV79 cells resulting in the formation of an 
additional protective layer against pH variations.  
Also, it should be pointed out that the i-antigen phenotype expressed by H. pylori 
PTAV79 does not favour adhesion to the gastric epithelial cells (Moran 2008). Planktonic 
free swimming states along the mucus layer are thought to be promoted instead leading the 
bacteria to be exposed more frequently to pH gradients that might exert and trigger the 
expression of aldobiouronic acids.  
H. pylori infection may further result in an increased gastric acid secretion that can 
contribute both to the observed gastroesophageal reflux (Souza and Lima 2009) and the 
expression of protective polysaccharides such as the one now described.  
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 Identification of Ser O-glucuronidated protein 
Glycan-rich water soluble material resulting from phenol:water extraction 
performed on intact bacteria are generally not completely devoid of proteic material. In 
particular, lower molecular weight peptides are expected since most of the macromolecular 
protein complexes are retained by the phenol phase (Shnyra et al. 2000). A proteomic 
approach permitted identifying in the aqueous fraction the existence of a 28 kDa 
glycoprotein containing Ser O-GlcA moieties. The presence of GlcA residues in the 
protein chain is responsible for an increase of the protein’s hidrophilicity, thus explaining 
its presence in the aqueous fraction.  
By matching the MALDI-TOF-MS/MS spectra resulting from this glycoprotein’s 
tryptic digests against an internal database created based on all Helicobacter pylori 
available data on Uniprot (2009-07-30) revealed a putative protein. The failure in 
identifying a specific biologic role for the mentioned glycoprotein using this approach 
might result from the incapability of the database to fully represent the high genetic 
variability existing among strains.  
Also, the occurrence of GlcA as a post-translational modification is quite 
uncommon and, as far as we know, has only been reported in human acidic proline-rich 
salivary protein PRP-1 (Jonsson et al. 2000). Most of all, reports directed towards a 
systematic evaluation of H. pylori’s proteomic profiles are up until now rather scarce. This 
is clearly illustrated when searching the PubMed database (www.pubmed.gov) using as 
keywords “proteomics and Helicobacter pylori”. The mentioned insertion renders a mere 
total of 100 publications, 30% of which corresponding to studies published in the past two 
years. Among them, a proteomic study concerning reference strain NCTC 11637 points out 
that H. pylori’s proteins are subjected to a high degree of post-translational modification 
(Lock et al. 2001). Post-translational processing such as the insertion of GlcA now being 
described for strain PTAV79 may play an integral role in the pathogenicity and antigenic 
variability of this organism at the protein level.  
Reports referring the exact post-translational events occurring in H. pylori proteins 
are scarcer. Moese et al. (2001) presented evidences of a tyrosine-phosphorylated cagA 
protein and descriptions for glycosylation were found to be limited to flagellar proteins 
(Schirm et al. 2003, Schirm et al. 2005, Schoenhofen et al. 2006). Such proteins have been 
shown to display up to 19 Ser/Thr O-linked sites modified with residues structurally 
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related to N-acetylpseudaminic acid (Schirm et al. 2003, Schirm et al. 2005). Interestingly, 
this presents similarities with what is now being described for H. pylori PTAV79, namely 
the insertion of acidic group containing sugars and the fact that Ser residues are recognized 
as ideal sites for O-glycosylation. This is, therefore, the first report of an H. pylori 
glycoprotein that does not concern events taking place in flagellar structures.  
 
Concluding remarks 
In resume, over the last twenty years the spotlight in the field of H. pylori cell-
surface glycosides has been pointed out at the LPS, its structure, and its biological role. 
The present work suggests that H. pylori’s cell-surface is composed of a conundrum of 
glycosylated structures. In addition to LPS showing variable phenotypes, H. pylori strains 
have shown to express α-glucosylated biomolecules, namely amylose-like glycans 
(Ferreira et al. 2009) and glycolipids (Lebrun et al. 2006). Also, the identification for strain 
PTAV79 of structures composed of aldobiouronic acid building blocks and glycoproteins 
containing GlcA raises new questions. Among them, addressing how widespread is this 
kind of structures among H. pylori strains, unveiling their biosynthesis and the events 
triggering their expression is of primary concern. In addition, this newly revealed 
structures offer new potential targets when thinking about assembling a multivalent 
carbohydrate-based vaccine against H. pylori. Therefore, studies are being conducted in 
order to evaluate the immunogenic potential of these molecules against H. pylori.  
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 7. Concluding remarks 
 
 Over the last ten years most attention has been devoted to the structural 
characterization of cell-surface LPS from several H. pylori strains. Of particular interest 
was the implication of O-chains bearing Le blood group determinants in adhesion to 
gastric cells, colonization of the gastric niche, and modulation/evasion of the host’s 
immune system. Therefore, the detection of trace amounts of Le epitopes and the 
distinction between isomers Le
a
/Le
x
 and Le
b
/Le
y
 has been of primarily concern and a 
challenging analytical topic.  
This thesis has demonstrated that the mentioned Le isomers can be detected in a 
nano-fentomole range by ESI-MS and distinguished based on their characteristic MS/MS 
spectra. Type 1 Lewis antigens (Le
a
 and Le
b
) could be distinguished from Type 2 (Le
x
 and 
Le
y
) on the basis of specific fragmentations of the GlcNAc unit. It was concluded that O-4 
linked GlcNAc sugars are lost as residues, whereas O-3 linked sugars undergo 
fragmentation both as sugar units as well as sugar residues (unit -18 Da). Additionally, 
Type 2 Le antigens also showed a characteristic cross-ring cleavage 
0,2
A2 of the GlcNAc. 
As a result, the product ions at m/z 388 and 305 were proposed as diagnostic for the 
presence of Le
x
 and at m/z 372 as diagnostic of Le
a
. Also, the product ions at m/z 534 and 
305, characteristic of Le
y
, and at m/z 372, characteristic of Le
b
, are proposed to distinguish 
the tetrasaccharide isomers Le
b
/Le
y
. These purposed ions can also be useful in the 
distinction of Le determinants within a mixture of both isomers. Despite the strong 
influence exerted by the type of analysers on MS/MS spectra, it was also concluded that 
LIT, Q-TOF and QqQ analyzers are capable of generating the ions purposed to distinguish 
the studied Le determinants.  
Several studies have been pointing out that, in addition to the LPS, H. pylori 
expresses other cell-surface glycans, however their structures have remained until now 
mostly unaddressed. This thesis proved insights on some of these structural motifs by 
demonstrating H. pylori is capability to bioaccumulate amylose-like glycans (α-(1→4)-D-
Glc polysaccharide) and to express mannose-rich glycans.  
Bioaccumulation of amylose-like glycans was found enhanced with the 
subcultivation of the bacterium on agar medium, while LPS O-chains expression 
decreased. On the other hand, during exponential growth of the bacterium in F12 liquid 
medium, an opposite behaviour is observed, i.e. there is an increase in the overall amount 
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of LPS and decrease in amylose content. As such, it has been demonstrated that, under 
certain selective pressures induced by specific environmental conditions, H. pylori might 
be led to express a phase-variable cell-surface α-(1→4) Glc polysaccharide as part of a 
long-term survival strategy. Additionally, studies carried out in virulent clinical isolate H. 
pylori PTAV79 revealed that amylose-like glycans are linked to glycerol residues. The 
observation of high amounts of stearic acid, and glycerylphophodiester moieties in 
amylose-like rich fractions suggested the expression of glycoglycerophospholipids. These 
findings strongly suggest that amylose is anchored to the outer cell-surface lipidic layer. 
Even though it is common to observe vestigial amounts of Man in H. pylori cell-surface 
glycan-rich extracts, its assignment has remained until now overlooked, most likely due to 
its low biological abundance. Taking advantage of the high amounts of Man expressed by 
clinical isolate H. pylori 968, it was possible to identify a highly branched mannan formed 
by a backbone of α-(1→6)-linked mannopyranosyl units showing up to 80% substitution in 
the O-2 position. Interestingly, it was concluded that the side chains contain O-2 linked 
Man residues both in α- and β-configurations. The described mannan is a part of a 
heteropolymeric structure containing Glc, Gal, and Glc, having a protein domain.  
 Structural studies conducted in H. pylori PTAV79 LPS allowed the identification of 
O-chains composed of LacNAc (i-antigen) units. The absence of fucosylated Lewis blood 
groups has been reported to negatively influence the bacteria’s capability of colonizing the 
human stomach and promoting gastric malignancies. Results arising from this strain, 
however, showed that the expression of i-antigens does not compromise gastric 
colonization. H. pylori PTAV79 also expressed a polysaccharide composed by an 
aldobiouronic acid repeating unit of [→3)-α-D-GlcA(1→4)-α-D-Glc(1→]. This structure is 
though to play a role in cellular protection against acid environments by allowing the 
formation of hydrogels that aid buffering the surrounding media. In addition, a proteomic 
approach led to the first report of a non-flagelar H. pylori glycoprotein exhibiting O-
glucuronosyl serine residues. Moreover, the expression of glucuronic acid by H. pylori is 
also being described for the first time.  
 In resume, the present thesis revealed the expression of several cell-surface 
structural motifs until now unknown in H. pylori, namely like the expression of 
heteropolymeric protein containing mannans, amylose-glycans, polysaccharides composed 
of albobiuronic acid repeating units, and glycoproteins containing O-glucuronosyl 
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 residues. In addition, the newly described amylose and mannan glycans were found in 
association with fatty acids and proteins, respectively. The coexistence of these structures 
with the LPS in H. pylori cell-surface was further demonstrated. 
This thesis has exposed new H. pylori cell-surface glycans that can act as players in 
host-microbial interactions and contribute to bacterial adhesion, resistance to external 
aggressions and modulation of immune responses. These structures offer new potential 
targets to include when considering the development of carbohydrate-based vaccines 
against H. pylori. 
Future directions should comprise a comprehensive understanding of the events 
triggering the expression of the observed glycans, their biosynthesis, and biological role. 
Also, an evaluation of their capability to induce immune responses against H. pylori ought 
evaluation in order to determine their potential as carbohydrate-based vaccines.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
